<body style="font: 10pt Times New Roman, Times, Serif"> <document>  <type>   10-K   <sequence>    1    <filename>     form10-k.htm     <text>      <title>      </title>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">      </p>      <!-- Field: Rule-Page -->      <div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%">       <div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 18pt">        <b>         UNITEDSTATES        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 18pt">        <b>         SECURITIESAND EXCHANGE COMMISSION        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 12pt">        <b>         Washington,D.C. 20549        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Rule-Page -->      <div style="margin: 0pt auto; width: 100%">       <div style="font-size: 1pt; border-top: Black 1.5pt solid">       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 18pt">        <b>         FORM10-K        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        (MarkOne)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           [X]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            ANNUAL    REPORT PURSUANT TO SECTION 13 OR 15( d ) OF THE SECURITIES EXCHANGE ACT OF 1934           </b>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Forthe fiscal year ended December 31, 2020        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         or        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           [  ]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            TRANSITION    REPORT PURSUANT TO SECTION 13 OR 15( d ) OF THE SECURITIES EXCHANGE ACT OF 1934           </b>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Forthe transition period from         <u>          ________________         </u>         to         <u>          ________________         </u>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CommissionFile Number: 001-36030        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Rule-Page -->      <div style="margin: 0pt auto; width: 100%">       <div style="font-size: 1pt; border-top: Black 1.5pt solid">       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 18pt">        <b>         MarroneBio Innovations, Inc.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (Exactname of registrant as specified in its charter)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Rule-Page -->      <div style="margin: 0pt auto; width: 100%">       <div style="font-size: 1pt; border-top: Black 1.5pt solid">       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Delaware           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            20-5137161           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            (State    or other jurisdiction of           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            (I.R.S.    Employer           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            incorporation    or organization)           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Identification    No.)           </b>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         1540Drew Avenue, Davis, California 95618        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (Addressof principal executive offices and zip code)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (530)750-2800        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         (Registrant’stelephone number, including area code)        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Securitiesregistered pursuant to Section 12(b) of the Act:        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Title    of each class          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Trading    Symbol(s)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Name    of each exchange on which registered          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Common    Stock, $0.00001 par value          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           MBII          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nasdaq    Capital Market          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Rule-Page -->      <div style="margin: 0pt auto; width: 100%">       <div style="font-size: 1pt; border-top: Black 1.5pt solid">       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Securitiesregistered pursuant to Section 12(g) of the Act: None        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Rule-Page -->      <div style="margin: 0pt auto; width: 100%">       <div style="font-size: 1pt; border-top: Black 1.5pt solid">       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Yes[  ] No [X]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [  ]No [X]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuantto Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period thatthe registrant was required to submit such files). Yes [X] No [  ]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 25%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Large    accelerated filer          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 5%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           [  ]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 40%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 25%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Accelerated    filer          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 5%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           [  ]          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Non-accelerated    filer          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           [X]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Smaller    reporting company          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           [X]          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Emerging    growth company          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           [  ]          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectivenessof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registeredpublic accounting firm that prepared or issued its audit report. Yes [  ] No [X]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicateby check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes [  ] No [X]       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof June 30, 2020, the last day of the registrant’s most recently completed second quarter, the aggregate market value ofthe registrant’s voting and non-voting common stock held by non-affiliates was $67,643,673 based upon the closing priceof the common stock as reported on the Nasdaq Capital Market. This calculation excludes the shares of common stock held by eachofficer, director and holder of 5% or more of the outstanding common stock as of June 30, 2020. This calculation does not reflecta determination that such persons are affiliates for any other purposes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indicatethe number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 49%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Class           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Shares    Outstanding at March 16, 2021           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Common    Stock, $0.00001 par value           </b>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            173,483,026           </b>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         DOCUMENTSINCORPORATED BY REFERENCE        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Portionsof the registrant’s Proxy Statement for its 2021 Annual Meeting of Stockholders are incorporated by reference in Part IIIof this Annual Report on Form 10-K where indicated. Such proxy statement is expected to be filed with the Securities and ExchangeCommission within 120 days of the registrant’s fiscal year ended December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">      </p>      <!-- Field: Rule-Page -->      <div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%">       <div style="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">       </div>      </div>      <!-- Field: /Rule-Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font: 10pt Times New Roman, Times, Serif">        <b>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 1 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="text-align: center; width: 100%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <p style="margin: 0pt">       </p>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         TABLEOF CONTENTS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Page           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#a_001">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            PART I.           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    1.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_002">            Business           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           4          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    1A.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_003">            Risk Factors           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           24          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    1B.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_004">            Unresolved Staff Comments           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           37          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    2.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_005">            Properties           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           37          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    3.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_006">            Legal Proceedings           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           38          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    4.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_007">            Mine Safety Disclosures           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           38          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#a_008">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            PART II.           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    5.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_009">            Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           38          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    7.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <a href="#a_010">            Management’s Discussion and Analysis of Financial Condition and Results of Operations           </a>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           39          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    8.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_01">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Financial Statements and Supplementary Data           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           54          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    9.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_02">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Changes in and Disagreements with Accountants on Accounting and Financial Disclosure           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           99          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    9A.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_03">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Controls and Procedures           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           99          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    9B.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_04">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Other Information           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           99          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_05">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            PART III.           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    10.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_06">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Directors, Executive Officers and Corporate Governance           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           100          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    11.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_07">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Executive Compensation           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           100          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    12.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_08">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           100          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    13.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_09">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Certain Relationships and Related Transactions, and Director Independence           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           100          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    14.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_10">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Principal Accounting Fees and Services           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           100          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_11">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            PART IV.           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    15.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_12">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Exhibits, Financial Statement Schedules           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           100          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Item    16.          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_13">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Form 10-K Summary           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           100          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">         <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#b_14">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            SIGNATURES           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           108          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           2           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         SpecialNote Regarding Forward-Looking Statements and Trade Names        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ThisAnnual Report on Form 10-K includes a number of “forward-looking statements” within the meaning of the “safeharbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve manyrisks and uncertainties, and may be identified by the use of the words “would”, “could”, “will”,“may”, “expect”, “believe”, “should”, “anticipate”, “outlook”,“if”, “future”, “intend”, “plan”, “estimate”, “predict”,“potential”, “targets”, “seek” or “continue” and similar words and phrases, includingthe negatives of these terms, or other variations of these terms, that denote future events. These forward-looking statementsinclude: our beliefs with respect to the agricultural industry and related markets, including production levels, consolidationtrends, and market opportunity; our plans and expectations regarding growth in our business, expansion to new markets, diversificationof our product portfolio and strategic acquisitions and partnerships; our ability to effectively manage sales and marketing teamsand distribution networks; our ability to integrate new products, technologies, and employee teams after any strategic acquisition;our expectations regarding revenues and sales, including potential growth in sales, changes to sales mix and expectations regardingseasonality and the impact of weather-related conditions; our expectations regarding discovering, developing, launching, commercializingand registering new products; our plans and expectations with regarding to manufacturing and production; our ability to protectour intellectual property in the United States and abroad; our ability to comply with ongoing and changing regulatory frameworks,including environmental, agricultural, and worker safety requirements, and to obtain product approvals; our ability to maintaina competitive position in our markets; our beliefs regarding our environmental, social, and governance leadership; our plans andexpectations relating to our debt agreements; our ability to use carryforwards; our ability to influence customer perception ofbiological agricultural products; potential impact of the COVID-19 pandemic; our ability to maintain adequate cybersecurity measuresto protect our information technology systems and infrastructure; our belief regarding our access to capital resources throughequity offerings, debt financings, strategic collaborations or other means; our anticipated impact of certain accounting pronouncements;our expectations regarding market risk, including interest rate changes, foreign currency fluctuations and commodity price changes;and our expectations with respect to our future expenditures, available cash and other financial and operating results. Thesestatements reflect our current views with respect to future events and our potential financial performance and are subject torisks and uncertainties that could cause our actual results and financial position to differ materially and adversely from whatis projected or implied in any forward-looking statements included in this Annual Report on Form 10-K. These factors include,but are not limited to, the risks described under Part I–Item 1A—”Risk Factors,” Part II–Item 7—”Management’sDiscussion and Analysis of Financial Condition and Results of Operations,” elsewhere in this Annual Report on Form 10-Kand those discussed in other documents we file with the U.S. Securities and Exchange Commission (“SEC”). We make theseforward-looking statements based upon information available on the date of this Annual Report on Form 10-K, and we have no obligation(and expressly disclaim any such obligation) to update or alter any forward-looking statements, whether as a result of new informationor otherwise except as otherwise required by securities regulations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asused herein, “MBI”, the “Company”, “we”, “our” and similar terms refer to MarroneBio Innovations, Inc., together with its subsidiaries, including Pro Farm Technologies OY (or “Pro Farm”), unlessthe context indicates otherwise.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Exceptas context otherwise requires, references in this Annual Report on Form 10-K to our product lines, such as Regalia, refer collectivelyto all formulations of the respective product line, such as Regalia Maxx, Regalia Rx or Regalia SC, and all trade names underwhich our distributors sell such product lines internationally, such as Sakalia        <sup>         TM        </sup>        . Our logos, Grandevo®, Regalia®,Venerate®, Zequanox®, Haven®, Majestene®, Stargus®, Zelto®, Amplitude®, Jet-Ag®, Jet Oxide®,UBP-110®, Foramin® and other trade names, trademarks or service marks of MBI appearing herein are the property of MBI.We do not intend our use or display of other companies’ trade names, trademarks or service marks to imply relationshipswith, or endorsement or sponsorship of us by, these other companies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 3; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           3           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_001">         </a>         PARTI        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <a name="a_002">       </a>       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ITEM1. BUSINESS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare a growth-oriented agricultural company that supports environmentally sustainable farming practices through the discovery,development and sale of innovative biological products for crop protection, crop health and crop nutrition. Our products are soldthrough distributors and other commercial partners to growers around the world for use in integrated pest management and cropprotection systems that improve efficacy and increase yields and quality while protecting the environment. Our productsare often used in conjunction with or as an alternative to other agricultural solutions to control pests and enhance plant nutritionand health.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourportfolio of 15 products helps customers operate more sustainably while increasing their return on investment. Our products areused globally, and can be applied as foliar treatments or as seed-and-soil treatments, either on their own or in combination withother agricultural products. Our end markets include row crops, such as corn and soybeans, fruits and vegetables, such as tomatoes,leafy greens and cucurbits, trees, nuts and vines, such as almonds and grapes, and greenhouse production, such as ornamentalsand medicinal plants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourresearch and development program uses proprietary technologies to isolate and screen naturally occurring microorganisms and plantextracts to create new, environmentally sound solutions in agriculture. Our research has resulted in novel biological productsthat help the grower:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Protect    crops from diseases, insects and weeds;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Promote    plant health and improve the soil microbiome; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Enhance a crop’s efficient use of nutrients.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourproducts are supported by a robust portfolio of more than 500 issued and pending patents worldwide. Our products are approvedby federal and state government agencies for use in organic and/or conventional farming systems. Mostof our products are produced or packaged at our dedicated, state-of-the-art manufacturing plant in Bangor, Michigan.We also have a minority ownership in a third-party manufacturing facility in Vyborg, Russia.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         IndustryOverview        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Biologicalagricultural products, or biologicals, include bioprotection products, biofertilizers (bionutrition) and biostimulants,and occupy a unique space in agriculture as emerging technologies that offer proven economic and environmental benefits to theconsumer, the grower and the distributor.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forconsumers, biologicals are part of the trend toward accessible, affordable, high-quality food produced in an environmentally sustainablemanner. For growers and distributors, biologicals offer alternative solutions to farm in a way that not only enhances crop qualitybut also protects natural resources and reduces carbon footprint.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Farmerscontinually explore new options in crop production. Biologicals treatments give them innovative tools to increase yields andquality while protecting the safety of their operations and the health of their families, employees and land.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theglobal demand for alternative agricultural solutions drives the need for products that:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Increase    yield and crop quality;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Improve    soil health and nutrient utilization;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Benefit    the soil microbiome; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Provide    greater convenience and flexibility in growing practices.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Tomeet these objectives, an increasing number of growers are implementing integrated pest management (“IPM”)programs. Growers use IPM to produce crops by the most economical means, and with the least possible hazard to people, property,and the environment. Biological agricultural products and crop cultivating techniques such as crop rotation and low-or-no tillageare among the most commonly used IPM practices.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Themarket for biological products is highly fragmented. There are around 300 known biopesticide active substances andorganisms, and this high degree of fragmentation makes it difficult for the distribution channel and growers to differentiatebetween products and suppliers. Channel access favors those who can be long-term trusted partners consistently delivering productsthat provide the highest level of performance and return on investment.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Biologicalsare developed and sold by two groups of agricultural companies. First, major, diversified agricultural suppliers who also sellseeds, fertilizers and chemical treatments for pest and weed control. Second, smaller companies dedicated primarily to research,development and commercialization of biologically based products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve recent acquisitions or partnerships by major agricultural enterprises of biologicals companies signal a trend toward furtherconsolidation, underscoring the value of the sector in the broader agricultural industry landscape.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       Biologicals are delivering double-digitgrowth industrywide, as compared with low-single-digit growth for conventional crop protection products. We believe the marketopportunity is significant: the market for agricultural biologicals, estimated to be more than $7 billion for 2019,still only represented less than 15% of the total crop protection market for the same year, according to marketresearch firms MarketandMarkets and Phillips McDougal, respectively.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <!-- Field: Page; Sequence: 4; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           4           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         OurCompetitive Advantages        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare the leading pure-play, public company in the agricultural biologicals space, with a track record of revenue growth and grossmargin expansion. To establish a leadership position in the biologicals space, we have spent significant time and resources advancingour product lines, expanding our portfolio through internal development and acquisitions, and building our infrastructure, plantcapacity and global footprint. Our competitive advantages include:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Breadthand depth of experience –        </i>        We have been a pioneer in the field of agricultural biological solutions, andhave a track record of serving a full range of specialty and row crops for growers using conventional, organic or regenerativefarming practices.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Unparalledproduct portfolio –        </i>        We offer products across all three categories of biologicals: crop protection, crop healthand crop nutrition. With 15 products to offer, we have size and scale that give us relevance within the agriculturaldistribution network and pull-through demand from growers.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Globalcommercial reach        </i>        – We have partnerships with more than 15 distributors in more than 20 countries, and sellour novel, efficacious products to growers worldwide. We are reaping the benefits of the relationships we have built with partnersin key growing regions outside the United States. We are becoming a less U.S.-centric company, with the potential to expand significantlyin the large growing regions in Latin America and the European Union. We are rapidly diversifying our global mix, with a targetto have our sales closer to an equal split between North America and the rest of the world by 2023.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Rapidintegration of strategic acquisitions        </i>        – We made two strategic acquisitions in the second half of 2019: Pro Farmand the Jet-Ag and Jet-Oxide product families. Both were rapidly integrated into our operations and were immediatecontributors to revenue growth and margin expansion. Pro Farm afforded us rapid entry into the key row crop marketsof Europe and the Commonwealth of Independent States, and is central to our expansion in South America, including Brazil and Argentina.Aggressive field trial programs incorporating the Pro Farm crop nutrition products were conducted in 2020, often in combinationwith existing crop protection products in our historic portfolio. We anticipate the potential for further commercial synergieswithin distribution networks and product lines from this acquisition.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Arobust, cost-efficient research and development pipeline        </i>        – Our breakthrough research and development is basedon a proprietary library of approximately 18,000 micro-organisms and 350 plant extracts. Our 10-year pipeline includes20 potential product candidates, 7 of which are projected to launch through 2022. We are targeting approximately an additional$50 million in revenues from the launch of our pipeline products through 2026.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Speedto market        </i>        – Discovery of new biologicals is cost effective: A new product can be brought to market at less than5% of what it costs to develop a crop protection chemical, and in one-third of the time or less. We believe we have demonstratedour ability to develop and commercialize novel and effective products at commercially competitive rates and standards. We havecontinued to develop and refine these products, reducing manufacturing costs, producing new formulations, applying for expandeduse labels and seeking new overseas markets, in each case at a cost of less than $11 million per product line.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Dedicatedmanufacturing capabilities        </i>        – We operate two packaging and manufacturing facilities, one in Bangor, Michigan (MarroneMichigan Manufacturing, or MMM), and the other, a minority interest in third-party manufacturing in Vyborg, Russia. TheMMM facility has made recent advances that have increased production yields and generally reduced cost of product revenues.This has been achieved through greater scale and improved utilization rates to increase volumes and yields while loweringoverhead. The MMM manufacturing facility is preparing for an expansion that we believe will allow us to bring additional productionin-house, improve gross margins and reduce working capital. We are currently investing more than $1 million in an upgrade of thefacility with a projected two-year payback.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Regulatoryexpertise and patent positions –        </i>        As an early developer of biological agricultural products, we have in-depthexperience seeking approvals and registrations for our unique products in countries around the world. Our commercial efforts aresupported by more than 500 issued and pending patents worldwide.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         OurGrowth Strategy        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave built a full-service biologicals organization with scope and capabilities across the spectrum of biological products in themarket today. Our strategic objective is to capitalize on that position and emerge as a leader in the biologicals spacewith the financial and operational wherewithal to accelerate our path to profitability.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 5; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           5           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Aswe look forward, our goal is to leverage our base business, while accelerating our expansion plans and broadening our global reach.We are committed to launching the brand extensions and pipeline products that offer the greatest return on investment for ourchannel partners and grower customers. We anticipate that synergistic, value-creating acquisitions and partnerships will be partof our strategy. We believe we can continue to tuck in additional product lines as we build a larger commercial presence witha scalable platform.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Oursuccess will be defined by:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Thediversification of our portfolio, whether it be the products we sell, the crops we serve or the geographies we reach.        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           In    2019, our sales were roughly one-third biofungicides, one-third bioinsecticides and bionematicides, and one-third    seed-and-soil treatments. Over the next three years, as sales grow, we are targeting a shift in product mix to seed-and-soil    treatments at approximately 43% and plant health products at approximately 14%, while maintaining a strong position    in crop protection products at approximately 43%.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Specialty    crops were the foundation of our historical sales, but we also are making significant inroads into row crops, including soybeans    and corn. We are targeting an increase in row crops to comprise half of our sales by 2023, up from roughly one-third    of our applications mix in 2019.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    are targeting roughly equal sales between North America and the rest of the world by 2023, which would be a major change    from 2020 when more than 70% of our sales were in North America.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Commerciallaunch of novel, efficacious agricultural biological products through investments in high-priority research and development projectsthat can accelerate the time to market and revenue contributions.        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    believe our pipeline uniquely positions us as a leader in the research, development and commercialization of products    within this rapidly growing sector of agriculture. We are focused on a robust set of options across the entire sector, and    especially in the seed-and-soil treatment market. In addition, we have significant opportunity to build on our leadership    position in bioprotection products, while making further inroads into  major row crops globally.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    have undertaken an in-depth review of our research and development pipeline to ensure it delivers the maximum value for all    key stakeholders – including our grower customers, our distribution channel partners, and our stockholders.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    believe this revamped research and development program is highly responsive to customer needs, while making the most efficient    use of available resources to provide the greatest returns on investment. By our estimates, our pipeline has the potential    to add approximately $50 million in incremental revenues in the 2026 timeframe, and over $100 million in incremental revenues    by 2030. Near-term, we have identified 7 pipeline products that have a high-probability of reaching the market in 2021    and 2022. All are well understood in our pipeline and commercial portfolio, with clear lines of sight into addressable markets,    crops and customer value propositions.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Strategic,accretive acquisitions, as well as investments in partners with complementary technologies that would strengthen ourpipeline or commercial offerings.        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave proactively identified the criteria for our acquisition strategy. Ideal candidates shouldgenerally have:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           A    proven portfolio of efficacious products;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           A    solid suite of intellectual property and protection;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           A    track record of commercial success and growth;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           The    potential for meaningful synergies and cost savings; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Accretion    to earnings within 24 months.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Anypartnerships, mergers or acquisitions should immediately broaden our portfolio, as well as have the opportunity to explore newcombinations between respective technologies and pipelines that will expand our ability to bring novel products to market throughour distribution channel partners.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <!-- Field: Page; Sequence: 6; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           6           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Anunrelenting focus on being brilliant at the basics — driving operational and financial excellence, with a keen eye on netincome, cash flow and a healthy balance sheet.        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    believe we have reached a turning point in our evolution as a commercial provider of sustainable, biological solutions. With    four years of revenue growth at a 28% compounded annual growth rate and an annual gross profit margin greater than    50%, we have established a commercial base from which we can accelerate our velocity and expand our leadership    position in the space.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    are making progress on managing operating expenses relative to the growth of our revenues and gross profit. We will seek to    maintain future operating expenses in line with 2020 levels, plus inflation. We believe this is a level of operating expenses    that can still support our continued strong growth and accelerate our path to profitability.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Warrant    transactions in 2019 and early 2020 strengthened our balance sheet and reduced dilution in a cost effective manner to    support our operational needs.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         OurMarkets        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourbiological product portfolio provides growers with comprehensive solutions from planting to harvest; increasing plant vigorand health; controlling pests and diseases; reducing crop stress; increasing yields; and improving plant nutrient use efficiency,all of which provide growers a better return on investment for their farming operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          BiologicalsProduct Categories         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourproduct categories include products often referred to as biopesticides, bioinsecticides, bionematicides, biofungicides,biostimulants and bionutrition, among others.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         CropProtection:        </i>        Our historical commercial strength has been in the crop protection arena – biological products that protectcrops against fungus, insects and nematodes. These are either sprayed on the leaves of plants and trees at various points in thegrowing season, or used as seed- or soil-based treatments at planting. This is the heart of our portfolio, and we continue toleverage this leading position in the biological control market valued by market research firm DunhamTrimmer in theirGlobal Biocontrol Report for 2019 at $3.8 billion globally. We have strengthened our competitive offerings throughinternal research that has resulted in next-generation advancements, as well as through the 2019 acquisition of the Jet-Agand Jet-Oxide fungicides, bactericides and disinfectants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         CropHealth:        </i>        For 2019, bioinsecticides represented $1.8 billion of the global biological control market accordingto DunhamTrimmer. These products reduce plant stresses or enhance the crop’s tolerance to abiotic or externalstresses, such as lack of water or excessive sunlight. This is a newer opportunity for us, and includes the 2021 launch of Pacesetter,a new product for plant health that is used in combination with conventional products to boost yields and improve the grower’sreturn on investment.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         CropNutrition:        </i>        Our 2019 acquisition of Pro Farm allowed us to establish a global presence in the rapidly expanding biofertilizersmarket segment estimated at $2.3 billion for 2020 by MarketsandMarkets in their agricultural biologicals report. Cropnutrition products encourage better uptake of vital nutrients that allow the plant to withstand stresses and increase output.With the acquisition of Pro Farm, we added proprietary nutrient and biostimulant technology and products for seed and foliar treatments.This portfolio of products uses a proprietary mode of action to stimulate plant growth and improve plant health, resulting inimproved yields and crop quality.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ProFarm’s proven technology is applied in seed and foliar treatments in the major row and specialty crops of corn, cereals,sunflowers, oilseed rape (canola), sugar beets and vegetables, with other crops in development. Pro Farm has distribution agreementsservicing most of the major global agricultural production areas, with particular strength in Europe and the Commonwealth of IndependentStates (CIS), and expansion under way in Latin America, North America, Africa and Asia.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 7; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           7           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ProductApplications         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         FoliarApplications:        </i>        Foliar applications treat the plant by spraying the leaves to protect against pests, reduce stress or encourageplant health and is a broadly used technique in agriculture. Many of our products can be used as foliar treatmentsin specialty crops – such as tomatoes, lettuces and melons – and in trees, nuts and vines – including almondsand grapes. Foliar applications also are commonly used in row crops and in greenhouse settings.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Seedand Soil Applications:        </i>        The seed and soil treatment side of our business has created the most significant change in our productmix. A strategic collaboration established in 2016 with a major U.S. distributor created the first combination of our productsin a seed treatment platform for row crops. Seed treatments provide insurance for growers, as they proactively respond to abiotic(external, environmental) and biotic (living organisms) stresses that are present at the time of planting, informed by growerexperience and known growing conditions. Performance, usage rates, price and compatibility all come into the buying decision.All else being equal, we believe distributors, seed companies and growers will continue to opt for biological treatments. We projectthat our seed and soil treatments could grow to 45% of our portfolio over the next three years.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         BioUnite:        </i>        The BioUnite strategy – which combines the power of biology with the performance of chemistry – remains a cornerstoneof our ability to expand in new and existing markets. The BioUnite program provides growers with specific biological prescriptionsfor tank mixes of novel biological solutions with standard crop protection offerings. BioUnite is a powerful alternative in agrower’s integrated pest management program that eliminates guesswork, enhances performance and yields, and thus increasesthe grower’s return on investment. This proven approach has been tested over the past five years, in more than 200trials for efficiency, safety, affordability and sustainability.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Newpartnerships will allow us to continue to expand our BioUnite offerings globally. We announced an agreement in 2020 with ViveCrop Protection, a leader in precision chemistry solutions and owner of the patented Allosperse® technology. We believe thispartnership will provide a suite of ground-breaking products for U.S. growers by combining one of our leading biologicals withproven conventional chemistry using Vive’s Allosperse Delivery System.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         OurProducts        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thetable below summarizes our current portfolio of commercially available product lines. On average, our bioprotection productsprogress through discovery, development, regulatory approvals, and market launch domestically and internationally within fiveyears or less at a cost generally less than $11.0 million. We have continued to develop and refine these products, resultingin new formulations, expanded-use labels, and new markets.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Allavailable formulations, with the exception of our Pro Farm product lines and Haven, are compliant with the U.S. Department ofAgriculture’s National Organic Program and certified by the Organic Materials Research Institute (“OMRI”).All of our products have a low-risk profile as they are exempt from food tolerance requirements (that is, there are no pesticideresidue concerns), and have an excellent safety profile for workers and consumers. For growers and others whose who work on farms,our products require minimal personal protective equipment (“PPE”), and allow workers to re-enter treated areaswithin four-hours of application, and with zero-day pre-harvest intervals. Our products also are low risk to pollinators,beneficial insects and other non-target organisms. In addition, our nutritional products create conditions for improved soil microbiomeand enhance the plant’s efficient use of water and nutrients.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 8; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           8           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">         <td style="background-color: White; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           NAME          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           MARKET          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           USE          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           DESCRIPTION          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           STATUS          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Emergen          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Row    Crops Nutrition          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foliar    Fertilizer          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutrient    complex for increasing crop health, yield and quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Domestic    Expansion Efforts Under Way, Available Internationally Under a Different Brand Name          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foramin          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    protection          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foliar    Fertilizer          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutrient    complex for increasing crop health, yield and quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Internationally, Domestic Expansion Efforts Under Way          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foramin    ST          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    protection          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutritional    Seed Treatment          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutrient    complex for increasing crop health, yield and quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Internationally, Domestic Expansion Efforts Under Way          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Grandevo          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Home and Garden, Turf and Ornamentals, Seed Treatment          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Insects    and Mites          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Controls    a broad range of sucking and chewing insects through feeding          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically and Internationally          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Haven          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Health,          </font>          <font style="font: 10pt Times New Roman, Times, Serif">           Home and Garden, Turf          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; background-color: White; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Sun    stress/Plant Crop Health/Quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Reduces    sun stress and dehydration and increases yields and quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically and Internationally          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Jet-Ag          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Plant    Disease; Sanitation          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Stops    mold and bacteria on plants and other surfaces          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Jet-Oxide          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Post    Harvest          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Sanitation          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Disinfects    hard surfaces          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Majestene          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Turf and Ornamentals, Seed Treatment          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Plant    Parasitic Nematodes/Soil-Borne Insects          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Controls    soil-dwelling nematodes and certain soil borne insects.          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically, International Expansion Efforts Under Way          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Pacesetter          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Row    Crop Health          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Health          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Improves    yields and quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically, International Expansion Under Way          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Regalia          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Home and Garden, Turf and Ornamentals, Seed Treatment          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Plant    Disease/Crop Health          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Protects    against fungal and bacterial diseases and enhances yields/quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically and Internationally          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Stargus          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Home and Garden, Turf and Ornamentals, Seed Treatment          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Plant    Disease/Crop Health          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Protects    against fungal and bacterial diseases and enhances yields          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically and Internationally          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           UBP          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Nutrition          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foliar    Fertilizer          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutrient    complex for increasing crop health, yield and quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Internationally, Domestic Expansion Efforts Under Way          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           UBP    ST          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Nutrition          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutritional    Seed Treatment          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutrient    complex for increasing crop health, yield and quality          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Internationally, Domestic Expansion Efforts Under Way          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Venerate          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Home and Garden, Turf and Ornamentals, Seed Treatment          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Insects    and Mites          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Controls    sucking and chewing insects on contact          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically and Internationally          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Zelto          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Seed    Treatment, Turf          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Plant    Parasitic Nematodes/Soil-Borne Insects          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Controls    soil-dwelling nematodes and certain soil borne insects          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="background-color: White; font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Commercially    Available Domestically          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <!-- Field: Page; Sequence: 9; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           9           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Emergen        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foliar    Fertilizer          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Row    Crops          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Domestic    Expansion Efforts Under Way, Available Internationally Under a Different Brand Name          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Emergenis a foliar fertilizer that provides additional nutrients to the plant. It optimizes abiotic stress tolerance and enhances conditionsfor higher yields and better return on investment, and can be used as a mixing partner for traditional fungicides and withPacesetter for improved and consistent yield.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Foramin        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foliar    Fertilizer          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crops          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Internationally, Domestic Expansion Efforts Under Way          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Foraminis a foliar fertilizer that enhances conditions for higher yields and better return on investment. It delivers additional nutrientsto the plant through the foliage and optimizes nutrient conditions for increased plant vigor.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Foramin’snutrient composition and novel nutrient delivery mechanism are designed to have an overall positive effect on the plant physiology,mitigating adverse effects of abiotic (external) stresses and improving both yield and quality, especially under less-than-favorablegrowing conditions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ForaminST        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutritional    Seed Treatment          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crops          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Internationally, Domestic Expansion Efforts Under Way          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ForaminST is a nutritional seed treatment that enhances conditions for increased yields and better return on investment. It improvesconditions for nutrient uptake and root growth. Foramin ST is easy to apply and use and compatible with conventional seed treatments.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inthe Foramin ST proprietary process, organic acids and biopolymers are combined with nutrients into a single organic molecularcomplex that allows plants to absorb up to 16 beneficial elements in a novel and more effective way (lower dose and lower cost).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         GrandevoBioinsecticide        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Bioinsecticide,    Biomiticide and Bionematicide          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Home and Garden, Turf and Ornamentals, Seed Treatment          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically and Internationally          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        GrandevoBioinsecticide is a water-dispersible granule based on a new species of microorganism,        <i>         Chromobacterium subtsugae        </i>        . It providesmultiple modes of action to stop insect feeding and reproduction. Grandevo is particularly effective against certain chewing insectsthat destroy plant leaves (such as caterpillars), sucking insects that pierce plants and remove sap (such as        <i>         Lygus        </i>        ),and some flies whose larvae consume the plant’s fruit (such as the spotted wing drosophila). Grandevo has also shownefficacy on corn rootworm, a major pest of corn, and other yield-robbing soil pests.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <!-- Field: Page; Sequence: 10; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           10           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         HavenHeat Stress Manager        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Health          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crops,    Turf and Ornamentals          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically and Internationally          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        HavenHeat Stress Manager is a crop health product that is applied to the leaves of plants to reduce sun stress. Haven reflects lightand heat from leaves, which lowers plant temperatures, resulting in less stress to the crops and higher yields and quality. Havenalso increases the plant’s uptake of water and nutrients when it is under stress.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Havenis based on a technology of naturally derived, plant-based (coconut) compounds. Unlike competing products, Haven does not leavean undesirable deposit or residue on crops. Field trials over the last four years have demonstrated increased quality characteristicson citrus, watermelon, blackberries and grapes, and increased yields on walnuts, almonds, corn, and wheat, often equal to or betterthan the conventional commercial standard.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Jet-Ag        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Fungicide,    Bactericide, and Sanitizer          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crops,    Turf, Structures, Hard Surfaces, and Pipes          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Jet-Agand Jet-Oxide are broad spectrum peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi andbacterial diseases in agriculture and horticultural industries.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Jet-Agcan be used to treat crops and kill or control the growth of disease organisms on plants. It is also an effective soil treatmentprior to planting and inoculation with beneficial microorganisms. Jet-Ag can be used in conjunction with our other products: forexample, research has shown that using Jet-Ag and Regalia in a program can increase control of fire blight, and using Jet-Agand Grandevo can decrease the population of spotted wing drosophila on berries.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Jet-Oxide        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Sanitizer    and disinfectant          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Hard    Surfaces, Fruit and Vegetable Water Treatment and Post-Harvest Treatment          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Jet-Oxideis a fast-acting, easy-to-use post-harvest peroxyacetic acid (“PAA”) sanitizer and industrial disinfectantthat is used in post-harvest packing house sanitation, field equipment sanitation, industrial use, processed fruits and vegetables,and food and beverage sanitation. Jet-Oxide 15% has shown efficacy against E. coli, salmonella, listeria and Human CoronavirusStrain 229E.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         MajesteneBionematicide        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Bionematicide    and Bioinsecticide          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Turf and Ornamentals, Seed Treatment          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically, International Expansion Efforts Under Way          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        MajesteneBionematicide, also a soil insecticide, has been developed based on the microorganism        <i>         Burkholderia rinojensis        </i>        . This nematicideis active against a broad range of nematodes, wireworms and white grubs that damage crops such as soybean, corn, cotton, strawberries,turf, tomatoes, potatoes and sweet potatoes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 11; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           11           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ournext-generation Majestene product – Majestene Pro – is currently in development and we believe it will bea promising new product. In 2019 and 2020, this version demonstrated high performance at substantially lower ratesper acre than our current product for in-furrow applications on corn and soybeans, and for soil and foliar treatments of nematodesand insect pests.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Pacesetter        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Health          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Row    crops          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically, International Expansion Efforts Under Way          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Pacesetter,launched during 2021,       </font>       <font style="font: 10pt Times New Roman, Times, Serif">        is a bio-based plant health product forrow crops such as corn, soybeans, cotton, and cereal grain. When used with conventional fungicides, Pacesetter improvesroot growth and chlorophyll production to deliver yield increases beyond what synthetic fungicides alone can generate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Largedemonstration trials in 2020 showed an average return on investment above six to one and numerous plant health benefits.For corn, longer and wider ear leaf size, increased number of corn kernel rows, and longer and healthier corn kernels wereobserved. Soybeans had healthier plants and more pods per plant.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Regalia                                         Biofungicide        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Biofungicide          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Home and Garden, Ornamentals, Seed Treatment          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically and Internationally          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        RegaliaBiofungicide is the master brand name for our product line of biofungicides and plant growth regulators that improve plant healthand crop quality while preventing disease. Regalia’s active ingredient is        <i>         Reynoutria sachalinensis        </i>        , made from anextract of the giant knotweed plant.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Regaliaacts by turning on a plant’s immune system, a process called induced systemic resistance. It improves overall stress toleranceand enhances the efficacy of conventional fungicides, making it an excellent tank mix or rotation partner for both organic andconventional IPM programs. Target diseases include powdery mildew and fire blight. Regalia also is effective when applied as aseed treatment for use in soybeans, corn and cotton.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         StargusBiofungicide        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Biofungicide          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Home and Garden, Turf and Ornamentals, Seed Treatment          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically and Internationally          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        StargusBiofungicide is based on microbial fermentations of a newly identified        <i>         Bacillus amyloliquefaciens        </i>        strain isolated usingour proprietary screening platform. We have identified different compounds, some of which are novel, produced by the microorganismin Stargus that control a broad range of plant diseases such as molds and down mildew.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <!-- Field: Page; Sequence: 12; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           12           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         UBP        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foliar    Fertilizer          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crops          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Internationally, Domestic Expansion Efforts Under Way          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        UBPis a foliar biological fertilizer that enhances conditions for increased yield and crop quality. It delivers nutrients throughthe foliage and optimizes conditions for tolerance to abiotic stress. UBP is also easy to apply and use, and compatible with commonagrochemicals.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Fieldtrials demonstrate that UBP consistently outperforms standard organic and synthetic fertilizers, and nutrient products in termsof both crop yield and quality. By promoting plant vigor and health, trials also have demonstrated that crops treated with UBPrecover more quickly from herbicide damage.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         UBPST        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Nutritional    Seed Treatment          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crops          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            ●           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Internationally, Domestic Expansion Efforts Under Way          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        UBPST is based on the same underlying technology as UBP. It uses renewable forestry industry byproducts to produce a molecular levelcomplex that contains macro- and micro-nutrients that are more effectively and efficiently delivered to plants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        UBPST is a nutritional seed treatment that improves conditions to aid nutrient uptake and root growth, and results in increased yieldand crop quality. It is easy to apply and use, and compatible with conventional seed treatments.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         VenerateBioinsecticide        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Bioinsecticide    and Biomiticide          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Crop    Protection, Home and Garden, Turf and Ornamentals, Seed Treatment          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically and Internationally          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        VenerateBioinsecticide, a liquid formulation, is based on a microbial fermentation of a new bacterial species,        <i>         Burkholderia rinojensis        </i>        .Compounds produced by the microorganism control a broad range of chewing and sucking insects and mites, as well as flies and plantparasitic nematodes. Venerate Bioinsecticide has also shown positive results when applied both in-furrow or as a seed treatmentagainst soil insects in corn, wheat, and soybeans.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ZeltoBionematicide        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Bionematicide          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Turf          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Available    Domestically          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ZeltoBionematicide protects turf, including golf course fairways and greens, and promotes turf health by improving plant and root health.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 13; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           13           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ZeltoBionematicide is used for the control of plant parasitic nematodes and soil dwelling pests. It works by reducing the nematodepopulation while encouraging rapid plant regeneration. This results in increased turf density and overall improved plant and roothealth.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ProductPipeline         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourproduct pipeline is a significant contributor to our growth strategy. We have expanded the focus of our research and developmentpipeline based on the strengths of our proprietary product lines of crop protection, plant health and biological fertilizers,our research and development infrastructure and manufacturing capabilities; and our market access and global footprint. Our pipelineconsists of products in three categories: bioprotection, seed and soil health, and plant health. These products are further categorizedin terms of their time to market launch: near-term (2021/2022), mid-term (2023/2024) and long-term (2025 and beyond). We haveimplemented a pipeline prioritization strategy that establishes commercial target goals as each pipeline product advancesthrough product development, regulatory reviews, market research assessments and risk adjusted financial projections.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Bioprotection:        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Bioinsecticides:    MBI-206 G2 and Grandevo XC          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Biofungicides:    MBI-110 G2          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Bioherbicide:    MBI-015          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thebioprotection product category is comprised of a wide spectrum of products – including insecticides, fungicides,and herbicides – targeted for mid- to long-term market launches. These products advance our current commercial productsand build on our unique understanding of and experience with  agricultural biologicals from both a scientific and commercialperspective. These products address some of the most significant and challenging unmet market needs, including weed control, pestresistance management, or integrated pest management practices.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Greaterpenetration in existing markets and expansion to new markets – such as row crops – and uses – suchas seed treatments – are the key commercial objectives for these products:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            MBI-206                                                         G2 is the advanced version of Venerate. Our 2020 field research established targeted reduction of product usage from current                                                         64 fl. oz./acre to a significantly lower 5 10 fl. oz./acre, a roughly tenfold reduction in rate of application with                                                         comparable efficacy.           </font>          </p>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Grandevo    XC is the liquid version of the existing dry Grandevo product with better customer acceptance and improved field efficacy.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           MBI-015    is a post-emergence herbicide (sprayed on the weeds after they emerge) for use against a range of weeds, including palmer    amaranth and water hemp, that are developing resistance to leading conventional chemical herbicide. MBI-015 is extension of    MBI-014 and is targeted for use in conventional row crops.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Seedand Soil:        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Seed    : MBI-306 ST, MBI-307, MBI-5P16          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Soil:    MBI-305 G2, MBI-306 Premix, MBI-601,          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thisis the highest growth category in our pipeline, and builds on our strengths in biological crop protection and fertilizer. Themajority of these products are targeted for use worldwide in row crops, such as corn, soybeans, rice and cereals, and insuch high-value crops as tree nuts, grapes and leafy vegetable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 14; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           14           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Akey product for crop protection is MBI-306 and its variants (MBI-305 G2, MBI-306 Premix and MBI-307). MBI-306 is anenhanced version of our current seed and soil applied product, and significantly improves the level of efficacy againsttarget pests. Based on our 2020 field research, we are targeting six-fold reduction in the amount of seed treatment applied,which is a competitive rate compared with to conventional treatments. For soil uses, such as in-furrow applications, our 2020field research also supports a targeted six-fold reduction in rate of application, while providing the same control of cornrootworms, wireworms, lesion nematodes and seed corn maggots. Our ability to provide additional insect control coupled withnematode control gives us greater access to the corn, soybean and cotton soil-applied in-furrow markets. MBI-306 requires anew submission to the U.S. Environmental Protection Agency (“EPA”). We are currently concluding ourtoxicology studies, fermentation and formulation work in order to prepare for the new submission.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       Our pipeline of novel seed applied plant nutrition products that are designed for industrial seed treatment but can also be used in downstreamseed treatment include: New breakthrough formulations with UBP-technology, out of which MBI-5P16 is the first one to be introduced tothe market for row crops (corn, soybeans and OSR) in the United States and EU. Most of these products are also in compliance with newharmonized EU Biostimulant regulation scheduled for 2022 (European parliament, Regulation (EC) No. 2019/1009), which will allow for pan-Europeanmarket access for our plant health products.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         PlantHealth        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Foliar    (Zn Foliar), Reyzox, and seed applied (Optima, Takla, Ympact) plant health products          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">         </td>         <td style="font: 10pt Times New Roman, Times, Serif">         </td>         <td style="font: 10pt Times New Roman, Times, Serif">         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Row    crops          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">         </td>         <td style="font: 10pt Times New Roman, Times, Serif">         </td>         <td style="font: 10pt Times New Roman, Times, Serif">         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           North    America, European Union and Latin America          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Zn    Foliar is foliar-applied product targeted for the Latin American row crop market to address zinc deficiency. Positive field    trial results in 2020 will be expanded upon with broader testing in 2021.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          ●         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          We have partnered with Vive Crop Protection to    combine Regalia with proven conventional chemistry (azoxystrobin) using Vive’s unique Allosperse Delivery System. The    combination product Reyzox will be targeted to the fruits and vegetables market.         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Ympact is a unique plant health product designed for cereals as a seed treatment           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Optima                                         is a second-generation product, optimized product for hybrid crops.           </font>          </p>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Takla    is a specialty seed treatment product under development for severe and specific conditions for the European market. Most of    these products are scheduled for short-term market entry.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare continually investigating new research and development pipeline projects, whether through internal product development, incollaboration with other companies, or as a new product concept. We have established a stage gate process to evaluate and furtheradvance our research and development pipeline. Overall, we estimate the current pipeline will add incremental risk –adjusted revenue growth of approximately $50 million in the long-term timeframe and approximately $100 million by 2030.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Sales,Marketing and Distribution        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inthe United States, we sell our products through our internal sales force, which consists of 29 employees focused on managingdistributor relationships and creating grower demand for our products. In addition, a dedicated team of 8 employees provide technicalservice support to both our customers and sales representatives on the use of our products in IPM and crop production programs,both for conventional growers as well as for an expanding number of organic growers. Our sales force covers all major regionsin the United States, including California and the Pacific Northwest, the Southeast, the Northeast, the Mid-Atlantic and the GreatLakes regions, with an emphasis on high-value specialty crops (fruits, nuts and vegetables). We currently sell our crop protectionproduct lines through leading agricultural distributors, such as Albaugh, Aligned Ag, Helena Chemical, Nutrien Ag,Simplot, and Wilbur Ellis. These are the same distribution partners that most major agrichemicalcompanies use for delivering solutions to growers across the country.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 15; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           15           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wesell our Foramin and UBP products through selected distributors in Europe, Asia and Latin America. In 2020 Pro Farm enteredinto a distribution agreement with PGG Wrightson Seed for Pro Farm seed treatment in Uruguay. Pro Farm is also working with numerouscompanies to improve its biological offerings, such Rizobacter in South America and Ruchi Hi Rich in India. With Pro Farm,we expect to expand our global distribution network. We are hiring sales managers for our Pro Farm products in key territoriesto help achieve our growth goals and provide support to our seed and distribution customers.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Withrespect to sales of Marrone products outside of the United States, we have exclusive legacy international distribution agreementswith major international distributors such as FMC (for certain markets in Latin America) and Syngenta (for specialty crop marketsin Europe). Our current strategy is to work with regional distributors and distributors in key countries who have brand recognition,established customer bases, who can effectively conduct field trials and grower demonstrations with biopesticides and lead orassist in regulatory processes and market development. As such, we have signed a number of distribution agreements with:Agristar, Nufarm, Jocanima, Elephant Vert and Kenya Biologics, Hoptri, Lidorr, AMC/Agrimatco, Disagro and Kyung Nong Corporation.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve we can leverage our existing sales, marketing and distribution network, finding synergies between operations for our products, to bring in additional revenues, while enhancing our overall product portfolio.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wederived approximately 85% and 91% of our total revenues from Regalia, Grandevo, Venerate and UBP ST product familiesfor the years ended December 31, 2020 and 2019, respectively. We currently rely, and expect to continue to rely, on a limitednumber of distributors for a significant portion of our revenues since we sell through highly concentrated, traditional distributionchannels. For the year ended December 31, 2020, our top three distributors accounted for 48% of our total revenues. For the yearended December 31, 2020, approximately 77% of our business was from the U.S. markets. In 2021, however, we expectour product mix to shift significantly due to both sales generated through our Pro Farm subsidiary, sales of our Pro Farm productsand continued progress on registrations of our collective product lines in new countries.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Whilethe biopesticide industry has been growing, customers in the crop production sectors often require on-farm demonstrations of pestmanagement or plant health products, and based on their novel modes of action compared to chemical products, require educationon their use. We are implementing the following strategies to accelerate adoption rates and promote sales of our biologicalpest management and plant health products:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Maintaina focused and effective sales and marketing team that shares our values.        </i>        We believe after several years of investmentwe have been able to build an improved sales and marketing team. In addition, we are now more effectively organizing the dataand educational material that we have amassed over years of operations on our bio-based products as well as organic and sustainableagricultural practices in order to train and equip our sales staff to communicate and educate distributors and growers. We believethat hiring and training sales and marketing staff with a high level of technical expertise and knowledge regarding the capabilitiesof our bio-based products, and unwavering belief in the potential and value of biologicals for crop production, is essentialto expanding adoption of our products by growers and sales to distributors. In addition, we have invested in our field developmentteam to include more technical service activities to support sales. These concerted efforts to build and train our sales and marketingteams are yielding positive results, including growth in sales.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Developan extensive demonstration program.        </i>        We believe that for growers to be convinced that a biological pest management, plant nutritionor plant health product work, they often must see it for themselves. Growers risk their crop each time they try a new product,and often produce only one crop per year on any given plot of land. Further, bio-based pesticide and plant health products areoften applied differently and at different times than conventional chemical products and so may be used incorrectly by an inexperiencedgrower or advisor, decreasing efficacy. We typically conduct on-farm demonstrations with growers in the first year of association,a grower will then in the second year, try one of our products on smaller plots of land and on one crop to ensure successfulapplication, and then progress continued use of our products in future years across more acres, more crops and more productsfrom our product portfolio. In addition, we work with distributors to determine which crops to emphasize in a given year and whicharea to maximize the effectiveness of our demonstration program.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 16; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           16           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Targetearly adopters of new pest management technologies        </i>        . For our biological pest management, plant nutrition and plant health products,we target both distributors and growers, who generally set industry standards through more widespread adoption of new pest managementtechnologies they initially test on smaller portions of their crops. We also target organic growers, who are more willing to takerisks on new products as they have had few alternatives and great demand for increased yields. We plan to continue to recruitthese growers and their consultants to participate in demonstrations and field trials, enabling them to become familiar with ourbiological pest management and plant health products, to experience their benefits firsthand and to promote the use ofour products with other growers in their regions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Educategrowers about the benefits of our biological pest management products        </i>        . Education is critical to best use of biologicals,which often have different modes of action than chemical products. We will continue to perform on-farm demonstrations and providefield data packages to support and validate our product claims. We will also continue to participate in trade shows and conferencesto educate growers and their licensed pest control advisors about the benefits of our biological pest management, plant nutritionand plant health products. We have provided instructional videos, blogposts, webinars, podcasts, teach-ins, by-line articles andan online course on biological pest management products, which can be taken by growers for continuing education creditto maintain crop protection product applicator licenses.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Developand leverage relationships with key industry influencers        </i>        . We will continue to develop relationships early in the product developmentprocess with influential members within our target markets, including large innovative growers, technical experts at leading agriculturaluniversities, licensed pest control advisors, wineries, food processors, produce packers, and retailers. We believe that educatingindustry influencers about the benefits of biologicals and our products increases the likelihood that they will recommend ourproducts to our distributors and end users. In addition, food companies and retailers are driven by consumers to require moresustainability and transparency from their grower-suppliers. This consumer-pushed trend is driving awareness with both the growerand food channel of the benefits of biologicals to soil health, the new movements in regenerative agriculture and sustainablecrop production programs in general.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Leveragethe synergies of our sales teams and businesses domestically and internationally.        </i>        Because of the concentration of large growersin the United States, we can access these customers through our own sales force. For our specialty crop products and seed treatmentswe have distribution agreements with national and regional distributors in North America, Europe, Uruguay and Latin America.We believe we can leverage these existing relationships to expand sales of our Foramin and UBP product lines throughour U.S.-based sales team and distributors and likewise expand sales of our legacy Marrone products through existing ProFarm product distributors. For future products, distribution agreements will be developed with regional and national distributorsor large multinationals on a case-by-case basis, depending on their expertise in the regions. For the fast-growing medicinal plantand hemp market, we have set up several specialty distributors who can benefit from our products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Manufacturing        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourmanufacturing processes for our Marrone products are developed in-house at our Davis, California research and development facilitiesand transferred to our Bangor, Michigan facility, or to our manufacturing partners. Biopesticide formulation, microbial fermentationand product packaging are among the facility’s core competencies. We believe in-house manufacturing enhances control andflexibility in production, ensuring quality, strengthening intellectual property security and lowered manufacturing costsover time to achieve desired margins. The facility has room for expansion to install larger drying capacity and fermentersto accommodate production of multiple products at significantly higher volumes. In 2018 we purchased a packaging line, which wasplaced into service in the first half of 2018 and in 2021, we expect to invest approximately $1 million to be able to achieveincreased in-house manufacturing of our products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wecurrently ferment our Grandevo product in our manufacturing facility but continue to use a third-party contractor for formulatingit into spray-dried powder. The facility also accommodates full-scale production of Regalia. While we have the ability to producethe majority of our products using our own manufacturing capacity, we currently use third parties to manufacture Venerate andMajestene/Zelto as a result of regulatory requirements for the microorganism that underlies their technology. In 2020, we securedthe necessary federal and state approvals to begin Burkholderia rinojenis production at our Michigan facility. Stargus/Amplitudeis also made at a third-party vendor because the Bacillus bacteria produce spores that are hard to contain and could pose contaminationrisks in the manufacturing of our other products. We intend to have fermentation of Bacillus at our facility but will requirea separate facility from our other products. Haven has been produced using a third party, however recently we successfullyvalidated the production at our Michigan facility and plan to bring the manufacturing of the product in-house. Weanticipate ramping up production volumes as we expand the facility in the future. We expect to continue to utilize third-partymanufactures in North America and the EU for supplemental production capacity to meet excess seasonal demand. As needed, we willalso use our own facility or third parties to package and label products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 17; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           17           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theactive ingredient in our Regalia product line is derived from the giant knotweed plant, which is a food and medicinal plant nativeto China and Japan. We have scaled production of Regalia using a reliable, single supplier that acquires raw knotweed from numerousregional sources and performs an extraction process on this plant, following our specification. The resulting dried extract isshipped to our manufacturing plant for formulations, production and packaging. We do not maintain a long-term supply contractwith this supplier, but we have worked with them for ten years. While there can be no assurance that we will continue to be ableto obtain dried giant knotweed plant extract from our supplier in China at a competitive price point, we estimate that our currentsupply of the ingredient will be sufficient to manufacture product to meet the next 10 to 12 months’ demand. Should we elector be required to do so, we have identified and received quality knotweed from a number of possible alternative suppliers,including one from outside China in the event additional inventory or diversified sourcing is necessary.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Amajority of the production of our Pro Farm product lines, as well as associated raw materials, is conducted at a third-party manufacturingfacility in Russia in which we have a 12% ownership stake. A large-scale paper and pulp manufacturing site in close proximityto this plant is the main supplier of the wood waste by-product material we use in production. For our Pro Farm products we takesource custom made bespoke micronutrient mixes formulations from a European third-party supplier and have multiple third-partypostproduction facilities in Europe. Our Jet products are manufactured by a third party located in the United States.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Researchand Development        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave leveraged an innovative and market-focused discovery process to generate a robust product line and pipeline. This has includedisolating approximately 18,000 microorganisms, testing more than 16,000 of them against multiple pest targets and testinga subset of them for plant health and nutrient uptake enhancement. We have then developed more than one product line based onthe same active technology. Developing multiple products based on the same microbe allows for a more efficient use of research,development and manufacturing resources and enables us to leverage capital invested in existing technologies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Atthis time, we are prioritizing our research and development on supporting our existing products and focusing on our pipelineprojects as discussed above. These pipeline products combine our legacy and acquired collective technologies andare targeted for broader categories or bioprotection, plant health and seed and soil health.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, we had 50 full-time equivalent employees dedicated to research and development and patent relatedactivities, 7 of whom hold Ph.D. degrees or doctorates, plus 8 field development personnel who focus on technical supportand demonstration and research field trials. Our research and development team has technical expertise in microbiology, molecularbiology, natural product, formulation and analytical chemistry, biochemistry, fermentation, entomology, nematology, weed science,plant physiology, plant pathology. Our research and development activities include discovery, product development, product support,regulatory, patent and field trial activities, which are principally conducted at our Davis, California facility as well as byour field development specialists on crops in their respective regions. We have made, and will continue to make, substantial investmentsin research and development such as increasing the number and locations of field trials and toxicology and regulatory consultantsfor new products and international expansion, but our Davis research and development headcount has remained relatively flat forseveral years. Our research and development expenses, including patent, regulatory and field trial expenses, were $11.3million and $14.0 million for the years ended December 31, 2020 and 2019, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 18; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           18           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         IntellectualProperty Rights        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Werely on patents and other proprietary right protections, including trade secrets and proprietary know-how, to preserve our competitiveposition. As of December 31, 2020, we had 60 issued U.S. patents and 421 issued foreign patents 17 pending U.S. provisional andnon-provisional patent applications, and 93 pending foreign patent applications relating to microorganisms and natural productcompounds, uses and related technologies. As of December 31, 2020, we have received 8 copyright registrations. As of December31, 2020, we had received 25 U.S. trademark registrations and had 25 trademark applications pending in the United States. As ofDecember 31, 2020, we also had received 167 trademark registrations and had 41 trademark applications pending in various othercountries.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Whenwe find a microbial product in our screen that kills or inhibits one or more pests or pathogens in at least three replicated testsand identify the microorganism and its associated chemistry, we file a patent application claiming any one or more of the following:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    microorganism, its DNA products, as well as mutations and other derivatives;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    use of the microorganism for pest management;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           novel    natural product compounds, their analogs and unique mixtures of compounds produced by the microorganism;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    new use of known natural product compounds for pest management;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           formulations    of the microorganism or compounds; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           synergistic    mixtures of the microorganism or compounds with conventional chemical or other pesticides.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Oneof our commercially available products and certain of our lead product candidates are based on microbes we have identified usingour proprietary discovery process, including Venerate, Majestene/Zelto and MBI-015, which are based on a        <i>         Burkholderia        </i>        bacterium, with respect to which we have 58 issued patents and 16 pending patent applications (both U.S. and foreign), andMBI-110, which are based on a        <i>         Bacillus        </i>        strain, with respect to which we have 29 issued patents and 3 pending patent applications(both U.S. and foreign). Foramin and UBP products are based on technology developed by Pro Farm scientists for producing organicmolecular complexes that facilitate nutrient absorption, and are protected by 3 issued U.S. patents, one issued Canadian patent,and 14 pending patent applications (both U.S. and foreign) comprising issued method of use patents and pending applications formethod of manufacture.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave also entered into in-license and research and development agreements with respect to the use and commercialization of Grandevoand Haven, as well as certain products under development. Under the licensing arrangements for our commercially available products,we are obligated to pay royalty fees in the mid-single digit of net sales of these products. The exclusivity and royalty provisions of these agreements are generally tied to the expiration of underlyingpatents. In addition, the in-licensed U.S. patent for Grandevo is expected to expire in or around 2024, but we have issued U.S.patents and pending U.S. patent applications relating to Grandevo that could expire later than 2024, and we have also filed separatepatent applications for Grandevo of which 11 have been issued in the U.S. on a novel compound and insecticidal uses for nematodes,corn rootworm and a variety of insects, as well as new formulations and other uses. Additionally, we have filed separate patentapplications with respect to Regalia and have been issued 6 U.S. patents.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Whilethird parties thereafter may develop products using the technology under the expired patents, we do not believe that they canproduce competitive products without infringing other aspects of our proprietary technology, and we therefore do not expect theexpiration of the patents or the related exclusivity obligations to have a significant adverse financial or operational impacton our business.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RegulatoryConsiderations        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ouractivities are subject to extensive federal, state, local and foreign governmental regulations. These regulations may preventus or our collaborators from developing or commercializing products in a timely manner or under technically or commercially feasibleconditions and may impose expenses, delays and other impediments to our product development and registration efforts. In the UnitedStates, the EPA regulates our bio-based pest management products under the Federal Insecticide, Fungicide and Rodenticide Act(“FIFRA”), the Federal Food, Drug and Cosmetics Act (“FFDCA”) and the Food Quality ProtectionAct (“FQPA”). In addition, some of our plant health products are regulated as fertilizers, auxiliary plantsubstances, soil amendments, beneficial substances and/or biostimulants in each of the fifty states.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 19; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           19           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        In2004, the United States Congress passed the Pesticide Registration Improvement Renewal Act, which was reauthorized in 2007 and2012, a result of efforts from an industry coalition of pesticide companies and environmental groups, to codify pesticide approvaltimes in return for user fees. This law facilitates faster approval times for biopesticides, with EPA approvals typically receivedwithin 16 to 24 months, compared with 36 months or longer for conventional chemical pesticides. Registration processes for stateand foreign governments vary between jurisdictions and can take up to 12 months for state governments, such as California andNew York, and up to 36 months or more for foreign governments. In some instances, California and Canada will conduct joint reviewswith the EPA, which allows some pesticides to receive concurrent approvals in California, Canada and the United States. However,in most instances, most foreign government submissions will not occur until after a U.S. registration has been secured. To registera crop protection product with the EPA, companies must demonstrate the product is safe to mammals, non-target organisms, endangeredspecies and the environment. To demonstrate the biological pest management product’s safety, required studies mustbe conducted that evaluate mammalian toxicology, toxicological effects to non-target organisms in the environment (ecotoxicologicalexposures) and physical and chemical properties of the product. The registration dossier is subject to both scientific and administrativereviews by EPA scientists and management before registration approval. The scientific review involves thorough evaluation of submitteddata and completion of risk assessments for human dietary and ecotoxicological exposures. Upon completion of this process, theregistration package, including the proposed label, is sent to the Office of General Council for legal review. The final stepin the registration process is administrative sign-off by the EPA director of the Biopesticides and Pollution Prevention Division.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition to EPA approval, we are required to obtain regulatory approval from the appropriate state regulatory authority in individualstates and foreign regulatory authorities before we can market or sell any pest management product in those jurisdictions. Foreigngovernments typically require up to two seasons of locally generated field efficacy data on crop-pest combinations before a productdossier can be submitted for review. California and foreign jurisdictions also require us to submit product efficacy data, whichthe EPA historically has not required, but may request.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wealso generally pursue organic certification, including USDA National Organic Program, Organic Materials Review Institute (“OMRI”),EcoCert and Control Union, for our product portfolio. These certifications often entail a two to four-month review processand, in many instances, require annual or semi-annual audits.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Whilethese regulations substantially increase the time and cost associated with bringing our products to market, we believe that ourmanagement team’s significant experience in bringing our and other companies’ technologies through EPA, state andforeign regulatory approval, efficient development process and ability to leverage our strategic collaborations to assist withregistrations, particularly in Europe and Latin America, have and will continue to enable us to overcome these challenges.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Aroundthe globe, the regulatory process for biostimulants and bionutrients (biofertilizers) is significantly accelerated compared tothat for biopesticides. In the United States, if plant health products are not used to control pests or do not act as plant (growth)regulators, they currently fall outside the legal scope of FIFRA, FFDCA and FQPA and, therefore, we do not need to submit applicationsfor EPA registrations for such products. However, we must still submit state registrations for our plant health products, includingHaven and our Pro Farm products. Products containing microbes of foreign origin may also need to be “deregulated”(or determined not to be a plant pest) under the Plant Protection Act by the USDA Animal and Plant Health Inspection Service priorto use in field trials or for large scale release. Europe and the United States have industry coalitions that have developed moreformal definitions of “biostimulant” and made recommendations for possible streamlined regulatory frameworks. The2018 Farm Bill for the first time proposed a federal definition of biostimulants. As mandated by U. S. Congress in the 2018 FarmBill, in December 2019, the Secretary of Agriculture submitted a study to Congress recommending options for the official definitionand regulation of biostimulants in the United States. Joint federal, state and industry discussions are now underway to reviewthose options and to recommend a suitable path forward and policy framework for the regulation of biostimulants in the UnitedStates.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 20; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           20           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Allof our biopesticide product lines are EPA-approved. However, as with any pesticide, our pest management products will continueto be subject to review by the EPA and state regulatory agencies. The EPA has the authority to revoke the registration or imposelimitations on the use of any of our pest management products if we do not comply with the regulatory requirements, if unexpectedproblems occur with a product or if the EPA receives other newly discovered adverse information. See Part I-Item 1A-”RiskFactors—Risks Relating to Our Business and Strategy—Our inability to obtain regulatory approvals, or to comply withongoing and changing regulatory requirements, could delay or prevent sales of the products we are developing and commercializing.”Our research and development activities are also subject to federal, state and local worker safety, air pollution, water pollutionand solid and hazardous waste regulatory programs and periodic inspection. We believe that our facilities are in substantial compliancewith all applicable environmental regulatory requirements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Competition        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Foragricultural products, performance and value are critical competitive factors. To compete against manufacturers of conventionalchemical pesticides, chemical fertilizers and genetically modified crops, we need to demonstrate the advantages of our productsover these more established products. Many large agrichemical companies are developing, and have introduced, new conventionalchemical pesticides and genetically modified products that they believe are safer and more environmentally friendly than olderconventional chemical products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thepest management market is very competitive and is dominated by multinational chemical and life sciences companies such as SyngentaCrop Protection, Bayer Crop Science, BASF, Corteva Agriscience, UPL, FMC and Sumitomo Corporation. Additionally, universities,research institutes and government agencies may also conduct research, seek patent protection and, through collaborations,develop competitive pest management products. Other companies, including bio-specialized biopesticide businesses such as CertisUSA (owned by Mitsui &amp; Co), Novozymes and Valent Biosciences (subsidiary of Sumitomo Chemical) may prove to be significantcompetitors in the biological pest management and plant health market. Due to the lower regulatory barriers than for cropprotection products, the market for bionutrition and biostimulant products is very fragmented and includes larger playerslike Valagro (recently acquired by Syngenta Crop Protection), UPL and Acadian Seaplants and startups such as Indigo, Bioconsortia,New Leaf Symbiotics and Pivot Bio.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inmany instances, agrichemical companies have substantially greater financial, technical, development, distribution and sales andmarketing resources than we do. Moreover, these companies may have greater brand recognition and may offer greaterdiscounts as a competitive tactic. There can be no assurance that our competitors will not succeed in developing pest managementproducts that are more effective or less expensive than our products or that would render our products obsolete or lesscompetitive. Our success will depend in large part on our ability to maintain a competitive position with our technologies andproducts.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         EnvironmentalSocial and Governance        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inour actions and engagement with stakeholders, we are committed to being a responsible corporate citizen. We aim to be aleader in the movement toward a more sustainable world through the discovery, development and promotion of biologicalsolutions for pest management and plant health. We operate our business with a consistent focus on protecting theenvironment, safeguarding the health and safety of our employees, supporting our local communities, and operating with ethicsand integrity. As reflected in our values, we are committed to aligning with environmental, social and governance(“ESG”) best practices and standards:.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    believe in sustainable business practices – that are economically viable, socially equitable and environmentally responsible.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    strive to conduct all business dealings with integrity, treating all stakeholders, collaborators and trade partners with respect,    fairness and honesty at all times, and we expect the same in return.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    promote a culture of accountability, continuous learning, diversity to bring about better decision-making.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 21; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           21           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve the environmental benefits of our products and our promotion of environmental stewardship, social responsibility and goodgovernance through our leadership in the sustainable agriculture movement puts us in a strong market position as customers,strategic partners, investors and other stakeholders continue to assess ESG factors in their decision making.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Environmental        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourbusiness revolves around producing environmentally responsible products for pest management, plant nutrition and plant health.All of our product families for crop protection are EPA-registered as biopesticides and our biological products enablecustomers to mitigate environmental concerns associated with conventional chemical pesticide products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ingeneral, our products are:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Fermented    microbes or extracted from plants (knotweed and coconuts) and use agricultural or other biological raw materials in these    fermentation or plant extraction processes, resulting in lower fossil fuel usage.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Assessed    by the U.S. EPA, and other regulators, as having the lowest pesticide residue risk levels for pesticidal products,    known legally as being “exempt from the requirement of a food tolerance.”          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          Lower risk to pollinators and other non-target    organisms.         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Biodegradable,    breaking down quickly into carbon, hydrogen and oxygen.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Designed    to increase soil health by supporting or increasing microbial diversity in the soil.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       We are also proud of the results ofa study we conducted in cooperation with the UC-Davis Graduate School of Management showing that switching from conventional chemicalpesticide products to our Regalia, Grandevo, Venerate and Majestene product lines could, potentially, result in average net reductionsof greenhouse gas emissions of 69% to 91% (or 39 to 46 kilograms of CO       <sub>        2       </sub>       equivalents per acre per year).      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <i>       </i>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Social        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ensuringthe safety, health and well-being of our employees, growers and farm workers and the public at large is central to our visionfor our business. Within our workplace, safety is both an individual and shared responsibility including periodic internalsafety audits and safety trainings. In the wake of COVID-19 we have implemented the Centers for Disease Control and Preventionguidelines including masks and social distancing at both our corporate headquarters and our manufacturing plant, restricting allcommercial travel by employees, requiring daily temperature checks, scaling down our operations including at our manufacturingplant, and frequent communications of our safety plans in light of COVID-19. We take a holistic approach to employee healthand well-being by offering wellness programs that promote and incentivize healthy habits, such as physical fitness, smoking cessationand weight loss.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare also proud to support employees at all levels who are interested in making a difference in their local communities throughnonprofit board service, donations and volunteer time. Our recent and current partnerships and projects include:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Partnering    with the fire department, high school science department and various community nonprofits in Bangor, Michigan, where our manufacturing    facility is located;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Supporting    local programs in Yolo County, California, where our headquarters is located, including adopting families in need for Christmas    through the Short Term Emergency Aid Committee, serving on the board of Empower Yolo and donating fresh produce from    our research farm to the local food bank; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Being    actively involved in the national chapter and Sacramento Valley chapters of the Association for Women in Science, as    well as supporting several STEM education initiatives in the region.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       Our high-performing, biological solutionsare safe to manufacture and generally safer for our customers and their workers to handle and use than conventional chemicals-basedproducts, and inherently safer for consumers as well from the perspective of product residue. We launched our cultivated garden(CG) versions of three of our products to enable access to our products to the general public at competitive prices.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <i>       </i>      </p>      <!-- Field: Page; Sequence: 22; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           22           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Governanceand Ethics        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourboard of directors has direct oversight of our ESG strategy, which is implemented internally by our cross-functional ESG steeringcommittee led by the Company’s Chief Sustainability Officer, who also serves as our Senior Vice President of Regulatoryand Government Affairs. Four of our eight directors possess directly relevant sustainability experience, includingtwo directors with large-farm experience. For example,Dr. Pam Marrone, a member of our Board of Directors and our founder, received the Steward of Sustainable Agriculture Award bythe Ecological Farming Association in January 2019 in recognition of her long-term, significant contributions to the well-beingof agriculture and the planet.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OurCode of Business Conduct and Ethics promotes honest and ethical conduct; full, fair, accurate, timely and understandable disclosures;compliance with applicable governmental laws, rules and regulations; protection of Company assets; fair dealing practices; promptreporting of Code violations to the appropriate person; and accountability for adherence to the Code. All employees are requiredto acknowledge our Code of Business Conduct and Ethics, which we make publicly available on our company website along with ourWhistleblower Policy and Board of Directors Committee Charters. Finally, we adhere to the governance requirements establishedby federal and state law, the Securities and Exchange Commission and Nasdaq.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         HumanCapital        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Oursupport of our employees extends to ensuring they are compensated fairly for their work. We believe we provide employees witha competitive and comprehensive pay and benefits package including both cash and non-cash compensation, health benefits and paidtime off to name a few. Our commitment to pay equity is shared by Company leaders. For example,the compensation of our Chief Executive Officer and other senior managers is generally less than 10 timesthat of our lowest-paid full-time employee.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve our human capital is one of our many great assets, so strive for a workplace that realizes the potential of our people:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          We believe entrepreneurial attitudes, agility,    and out of the box thinking and creativity are the lifeblood of innovation.         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    demand open and honest communication and respect for the views of others, and seek to minimize    internal politics and value the input of all employees in the Company’s strategy, goal setting and decision-making.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          We believe that a diverse workforce, with diverse    opinions, working together in teams leads to better decision-making and actively try to enhance diversity in our workforce.         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    promote a culture of accountability, continuous learning, coaching, and mentoring for personal and professional growth.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, we had 145 full-time equivalent employees, of whom 15 hold Ph.D. degrees or doctorates. Approximately 50employees are engaged in research and development and patent related activities, 30 in sales and marketing (including 8 salesand field development personnel who focus on technical support and demonstration and research field trials), 36 in operations,including manufacturing, supply chain and quality assurance, and 30 in management, accounting/finance and administration.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wetake pride in the diversity of our workforce and being an equal opportunity provider. As a growing company focused on innovation,we strive to foster diversity and inclusion, with women representing approximately 49% of all employees (and 22% of senior managementand 59% of our research and development team) and racial or ethnic minorities representing approximately 42% of employees (and33% of senior management).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourcorporate policies provide employees opportunities grow by offering tuition reimbursements, Company-sponsored third partyweb-based learnings, and time for community involvement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Noneof our employees are represented by a labor union.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 23; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           23           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CorporateInformation        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wewere originally incorporated in the State of Delaware in June 2006 as Marrone Organic Innovations, Inc. Our principal executiveoffices are located at 1540 Drew Avenue, Davis, CA 95618. Our telephone number is (530) 750-2800. Our website address is www.marronebioinnovations.com.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_003">         </a>         ITEM1A. RISK FACTORS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Ouroperations and financial results are subject to various risks and uncertainties, including those described below, which couldadversely affect our business, financial condition, results of operations, cash flows, growth prospects and the trading priceof our common stock.        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RisksRelating to Our Financial Position        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wehave incurred significant losses to date and anticipate continuing to incur losses in the future. Unless we significantly increasesales, we may not achieve or maintain profitability and our business may fail.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       We have incurred operating losses sinceour inception in June 2006, we expect to continue to incur operating losses for the foreseeable future and we may never becomeprofitable. As of December 31, 2020, we had an accumulated deficit of $340.8 million, and for the years ended December 31, 2020and 2019, we had a net loss attributable to common stockholders of $20.2 million and $37.2 million, respectively. Our future successdepends on our ability to market and sell in significantly larger volume not only our legacy Marrone products Grandevo, Regaliaand Venerate, from which we have derived substantially all of our revenues until our September 2019 acquisition of Pro Farm, butour other products, including UBP, Foramin, Haven, Jet-Ag, Jet-Oxide, Majestene/Zelto and Stargus, as well as our ability to successfullyintroduce new products like Pacesetter.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       While we have and plan to continueto invest considerable resources in the sale and launch of our products, various factors have impeded higher growth in sales ofthese products. For example, we believe adverse conditions globally, including low commodity prices, may have reduced demand forour products. Delays in regulatory approvals of certain of our products in Europe, Latin America and other jurisdictions haveand may continue to slow international growth, and any delay in a product launch that causes us to miss a growing season may requireus to wait a year to enter that market. Extended drought in some markets and excessive rain in other markets reduced demand forour products as fewer acres are planted, recent changes in weather patterns have resulted in a shortened bloom cycle in differentmarkets in different years and resulted in fewer pesticide and plant health products being used, and certain of our strategiccollaborations have not resulted in the significant increases in sales we expected both inside and outside of the Unites States.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       Lower than expected sales growth asa result of these and other factors may adversely affect our financial results in several ways, including increases in write-offsand inventory obsolescence, higher proportional operating expense levels and increases in our cost of product revenues and decreasesin product margins. Further, if we are unable to achieve our planned operating results and increase sales of our commercializedproducts, our available cash and ability to raise additional capital will decrease, we or our auditors may in future periods concludethat substantial doubt may exist as to our ability to continue as a going concern, which could cause the market price of our commonstock to decline, and our business may fail.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 24; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           24           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Weexpect to require additional financing in the future to maintain and expand our business, and to service our debt. Suchcapital raising may be costly, difficult or not possible to obtain and, if obtained, could significantly dilute current stockholders’equity interests, and we may be unable to repay our secured indebtedness.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weexpect to continue to incur significant losses until we are able to significantly increase our revenue. Accordingly, we expectto need significant additional financing to maintain and expand our business, including, for example, working capital associatedwith increased sales, costs associated with increased headcount, potential capital expenditures to grow capacity at our Bangormanufacturing facility and potential acquisitions of complementary technologies, and businesses and other strategic opportunitiesas well as to meet the financial covenants of and pay the principal and interest under our debt agreements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof March 16, 2021, we have outstanding warrants with certain of our shareholders to purchase approximately 4.9 millionshares of our common stock at $0.75 per share, 3.6 million shares of our common stock at $1.00 per share which, if all exercisedin cash, would result in an aggregate of $7.2 million in proceeds to us and would significantly reduce our need for additionalfinancing. However, there can be no assurances that any of these warrants will be exercised when we require funds or at all, particularlyif our common stock trades at prices below the applicable exercise price. Any exercise of our outstanding warrants will dilutethe ownership of our other stockholders.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wemay also seek additional funds from public or private equity offerings, debt financings, and strategic collaborations involvingup-front cash payments or other means. However, additional capital may not be available on terms acceptable to us, or at all.Any additional equity financing we do raise will be significantly dilutive to stockholders or, in some cases, require usto seek stockholder approval for the financing or result in antidilution adjustments to the prices of our outstanding warrants,reducing potential proceeds from their exercise. Any debt financing, if available, may include restrictive covenants and bearhigh rates of interest. In addition, our existing loan agreements contain certain restrictive covenants that either limit ourability to or require a mandatory prepayment if we incur additional indebtedness and liens and enter into various specified transactions.We therefore may not be able to engage in any of the foregoing transactions unless we obtain the consent of our lenders or prepaythe outstanding amounts under the debt agreements, which could require us to pay additional prepayment penalties. In addition,we may incur substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accountingfees and other costs. We also may be required to recognize non-cash expenses in connection with certain securities we issue, suchas warrants, which may adversely impact our financial results.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Certainof our debt agreements also contain financial covenants, including maintaining minimum current, debt-to-worth and loan-to-valueratios and provisions providing for an event of default if there is a material adverse change in our financial condition or ifwe are in default under certain of our other agreements. We are not in compliance with certain of these covenants and have receivedwaivers from our lenders, none whom have previously declared an event of default on our indebtedness. Breach of covenants includedin our debt agreements, which could result in the lenders demanding payment of the unpaid principal and interest balances. Ifwe fail to pay any principal or interest under our indebtedness when due, or are otherwise in violation of certain covenants underour debt agreements, this may result in the acceleration of our indebtedness, which would have a material adverse effect uponour business and would likely require us to seek to renegotiate these debt arrangements with the lenders, as we may not have sufficientfunds to repay that indebtedness.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ifwe cannot raise more money when needed, or are unable to use our future working capital, borrowings or equity financing to repayor refinance the amounts outstanding under our debt agreements or to renegotiate our debt arrangements with lenders, we may haveto reduce our capital expenditures, scale-back our development of new products, reduce our workforce or license to others productsthat we otherwise would seek to commercialize ourselves. Any of these eventualities would likely have a material adverse impacton our value and the value of our equity.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 25; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           25           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         Our ability to use our net operating losscarryforwards to offset future taxable income may be subject to certain limitations.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       As of December 31, 2020, we had net operating loss carryforwards of $104.2 million. The net operating loss carryforwards for federal andstate purposes were reduced as a result of the effect of an ownership change as defined under Internal Revenue Code (“IRC”)Section 382, the change related to the February 5, 2018 previously disclosed financing transactions. The federal and state reductionswere $176.4 million and $119.1 million, respectively. The federal net operating loss generated after 2017 in the amount of $65.1 millionwill not expire. In addition, as of December 31, 2020, we had federal research and development tax credit carryforwards of $0.6 million,which begin to expire in 2038, and state research and development tax credit carryforwards of $3.1 million, which have no expiration date.The federal research and development tax credit carryforwards were also reduced by the Section 382 ownership change of $2.3 million. Itis possible that we will not generate taxable income to use these loss carryforwards in cases where they are subject to expiration orwhere they are able to be carried forward indefinitely. Additionally, while we believe that foreign loss carryforwards in connection withour acquisition of Pro Farm have been retained, there can no assurance the initial position will not be reversed in future periods bythe foreign taxing authorities.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        Risks Relating to Our Business and Strategy       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wewill need to continue expanding our sales and marketing infrastructure.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wecurrently have limited sales and marketing experience and capabilities. As of December 31, 2020, we employed 29 full-time equivalentsales and marketing personnel, 8 of whom focus on technical support and demonstration and conducting field trials and 5 of whichfocus on marketing. The majority of these sales personnel were hired in 2018 and thereafter. New personnel require significanttraining to attain a high level of technical expertise and knowledge regarding the capabilities of our biological productscompared with conventional chemical pest management products and techniques in order to educate growers and independent distributorson the uses and benefits of our products. We will need to further develop our sales and marketing capabilities and find partnersin order to successfully increase sales of our commercially available products and to commercialize other products we are developing,which may involve substantial costs. There can be no assurance that our field development specialists and other members of oursales and marketing team will successfully compete against the sales and marketing teams of our current and future competitors,many of which may have more established relationships with distributors and growers. Our inability to recruit, train and retainsales and marketing personnel, or their inability to effectively market and sell the products we are developing, could impairour ability to gain market acceptance of our products and cause our sales to suffer.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ifwe are unable to maintain and further establish successful relations with the third-party distributors that are our principalcustomers, or they do not focus adequate resources on selling our products or are unsuccessful in selling them to end users, salesof our products will be adversely affected.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inthe United States, we rely on independent distributors of agrichemicals to distribute and assist us with the marketing and saleof our current product portfolio and other products we are developing. These distributors are our principal customers, and revenuegrowth will depend in large part on our success in establishing and maintaining this sales and distribution channel. However,there can be no assurance that our distributors will be successful in selling our products to end users, or will focus adequateresources on selling them, and they may not continue to purchase or market our products for a number of reasons.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forexample, many distributors lack experience in marketing biological agricultural products, which generally must be used differentlythan conventional chemical products. In addition, many of our distributors are in the business of distributing and manufacturingother, possibly competing, biological agricultural products, including internally developed and commercialized biological productsas well as biological products developed by larger agrichemical companies that negotiate to “bundle” such specialtyproducts with other high demand products. For example, a portion of our sales of Venerate are tied to Albaugh’s promotion,sales and services related to products under its BIOST platform, in addition to the effectiveness of their proprietary blend,which while containing Venerate, is developed by Albaugh and not by us. To the extent our distributors are unsuccessful inselling our products to end users, or in marketing their own products that incorporate our products, they may purchase lower volumesfrom us, which could have a material adverse effect on our business. In addition, our distributors may earn higher margins byselling competing products or combinations of competing products. If we are unable to establish or maintain successful relationshipswith independent distributors, we need to further develop our own sales and demand creation capabilities, which would be expensiveand time-consuming, the success of which would be uncertain.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 26; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           26           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wedepend on a limited number of distributors.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourcurrent revenues are derived from a limited number of key customers, each of which serves as a third-party distributor to ourproducts’ end users. For the years ended December 31, 2020 and 2019, our top three distributors accounted for 48%and 49% of our total revenues, respectively. We expect a limited number of distributors to continue to account for a significantportion of our total revenues for the foreseeable future. This customer concentration increases the risk of quarterly fluctuationsin our revenues and operating results. The loss or reduction of business from one or a combination of our significant distributorscould materially adversely affect our revenues, financial condition and results of operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         The high level of competition inthe market for biological agricultural products may result in pricing pressure, reduced margins or the inability of our productsto achieve market acceptance.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       The markets for biological agriculturalproducts are intensely competitive, rapidly changing and undergoing consolidation. We may be unable to compete successfully againstour current and future competitors, which may result in price reductions, reduced margins and the inability to achieve marketacceptance for our products.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Many entities are engaged in developing biological agricultural products. Our competitors include major multinational agrichemical companies,some of which have developed biological products for our target markets, as well as specialized biological agricultural businesses suchas Certis USA (owned by Mitsui &amp; Co), Novozymes and Valent Biosciences (subsidiary of Sumitomo Chemical). Many of these organizationshave longer operating histories, significantly greater resources, greater brand recognition and a larger base of customers than we do.As a result, they may be able to devote greater resources to the manufacture, promotion or sale of their products, receive greater resourcesand support from independent distributors, initiate or withstand substantial price competition or more readily take advantage of acquisitionor other opportunities. Further, many of the large agrichemical companies have a more diversified product offering, which may give thesecompanies an advantage in meeting customers’ needs by enabling them to offer a broader range of crop protection, plant nutritionand plant health solutions. In addition, we could face competition in the future from new, well-financed start-up companies.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Theproduct candidates we select for development and commercialization may fail to generate significant revenues.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourinternal development efforts are focused on a number of product candidates including in the near term Grandevo XC, Reyzox,Zn Foliar, Optima, Takla, and Ympact.  Simultaneously, we are seeking collaborations with third parties to develop andcommercialize early stage candidates on which we have elected not to expend significant internal resources.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Successfuldevelopment of product candidates will require significant additional investment, including costs associated with research anddevelopment, completing field trials and obtaining regulatory approval, as well as the ability to manufacture our products inlarge quantities at acceptable costs while also preserving high product quality. Difficulties often encountered in scaling upproduction include problems involving production yields, quality control and assurance, shortage of qualified personnel, productioncosts and process controls. In addition, we are subject to inherent risks associated with new products and technologies. Theserisks include the possibility that any product candidate may:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    found unsafe;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    harmful to consumers, growers, farm workers, animals, beneficial insects or the environment;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    harmful to crops when used in connection with conventional chemical pesticides;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           cause    a major crop failure;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    ineffective or less effective than anticipated;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    displaced by new technologies;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           fail    to receive or take longer to receive necessary regulatory approvals;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    difficult to competitively price relative to alternative pest management solutions;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    difficult or impossible to manufacture on an economically viable scale;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    subject to supply chain constraints for raw materials;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           fail    to be developed and accepted by the market prior to the successful marketing of similar products by competitors;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    impossible to market because it infringes on the proprietary rights of third parties; or          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           be    too expensive for commercial use.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourdecisions regarding which product candidates to pursue may cause us to fail to capitalize on product candidates that could havegiven rise to viable commercial products and profitable market opportunities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 27; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           27           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourproduct sales are subject to weather conditions and other factors beyond our control, which may cause our operating results tofluctuate significantly quarterly and annually.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inrecent years, we have increasingly had higher sales during the first half of the year than the second half, and expect this trendto continue. However, the level of seasonality in our business may change due to a number of factors, including our expansioninto new geographical territories, the introduction of new products, the timing of introductions of new formulations and products,the addition or changes to distributors or distributor programs and the impact of weather and climate change. It is possible thatour business may become more seasonal, or experience seasonality in different periods.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notwithstandingany such seasonality, we expect substantial fluctuation in sales year over year and quarter over quarter as a result of a numberof variables on which sales of our products are dependent. Weather conditions, natural disasters and other factors affect plantingand growing seasons and incidence of pests and plant disease, and accordingly affect decisions by our distributors, direct customersand end users about the types and amounts of pest management and plant health products to purchase and the timing of use of suchproducts. In addition, disruptions that cause delays by growers in harvesting or planting can result in the movement of ordersto a future quarter, which would negatively affect the quarter and cause fluctuations in our operating results. Customers alsomay purchase large quantities of our products in a particular quarter to store and use over long periods of time or time theirpurchases to manage their inventories, which may cause significant fluctuations in our operating results for a particular quarteror year.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourexpense levels are based in part on our expectations regarding future sales. As a result, any shortfall in sales relative to ourexpectations could cause significant fluctuations in our operating results from quarter to quarter, which could result in uncertaintysurrounding our level of earnings and possibly a decrease in our stock price.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Biologicalcrop protection and plant health products are not well understood, which necessitates investment in customer education and makeseffectively marketing and selling our products difficult.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Themarket for biological agricultural products is underdeveloped when compared to conventional products. Customers in the crop productionsector are generally cautious in their adoption of new products and technologies. Growers often require on-farm demonstrationsof a given crop protection or plant health product. Initial purchases of the product tend to be conservative, with the growertesting on a small portion of their overall crop. As the product is proven, growers incorporate the product into their rotationalprograms and deploy it on a greater percentage of their operations. As a result, large scale adoption generally takes severalgrowing seasons.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Customershave historically perceived biological agricultural products as more expensive and less effective than conventional products.To succeed, we will need to continue to change that perception. To the extent that the market for biological agricultural productsdoes not further develop or customers elect to continue to purchase and rely on conventional chemical products, our market opportunitywill be limited.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ifwe or our third-party manufacturers are unable to produce our products at a satisfactory quality, in a timely manner, in sufficientquantities or at an acceptable cost, our business could be negatively impacted.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave transitioned a significant amount of our manufacturing processes in-house to our facility in Bangor, Michigan. If severeweather, a fire or natural disaster occurs, a contaminant grows in our fermentations, or a mechanical or labor problem leads toa reduced capacity or shutdown of our fermenters or other equipment, we may not be successful in producing the amount and qualityof product we anticipate in the facility and our results of operations may suffer as a result.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wealso continue to rely on third parties to produce or in the process for manufacturing our products and from time to time, includingthe 12% minority interest in a Russian manufacturing facility and we expect to use third-party manufacturers for supplementalproduction capacity to meet excess seasonal demand and some packaging. Our reliance on third parties to manufacture our productspresents significant risks to us, including the following:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Pushed    out or canceled delivery due to tariff restrictions or infectious disease quarantines including COVID-19;          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 28; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           28           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           reduced    control over delivery schedules, yields and product reliability;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           price    increases;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           manufacturing    deviations from internal and regulatory specifications, including contaminations;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    failure of a key manufacturer to perform its obligations to us for technical, market or other reasons;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           challenges    presented by introducing our fermentation processes to new manufacturers or deploying them in new facilities, including contaminations;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           difficulties    in establishing additional manufacturers if we are presented with the need to transfer our manufacturing process technologies    to them;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           misappropriation    of our intellectual property; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           other    risks in potentially meeting our product commercialization schedule or satisfying the requirements of our distributors, direct    customers and end users.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave not entered into any long-term manufacturing or supply agreements for any of our products, and we may need to enter intoadditional agreements for the commercial development, manufacturing and sale of our products. There can be no assurance that wecan do so on favorable terms, if at all.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourproducts have been produced in quantities, and on timelines, sufficient to meet commercial demand and for us to satisfy our deliveryschedules. However, our dependence upon others for the production of a portion of our products, or for a portion of the manufacturingprocess, particularly for drying and for all our production of Venerate, may adversely affect our ability to satisfy demand, supportagriculture retailers and distributors operating shifting to “just-in-time” inventory approach and meet delivery obligations,as well as to develop and commercialize new products, on a timely and competitive basis. If manufacturing capacity is reducedor eliminated at one or more of our third-party manufacturers’ facilities, we could have difficulties fulfilling our customerorders, which could adversely affect customer relationships, and our net revenues and results of operations could decline.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wemust accurately forecast demand for our products to obtain adequate and cost-effective capacity from our third-party manufacturersand to purchase certain of the raw materials used in our products at cost-effective rates. Our third-party manufacturers are notrequired to supply us products until we place, and they accept, our purchase orders, which generally occurs approximately threemonths prior to the anticipated product delivery date to customers based on our own rolling forecasts. Our purchase orders maynot be accepted and our third-party manufacturers may not be willing to provide us with additional products on a timely basisif they prioritize orders placed by other companies, many of whom are more established than us and order larger volumes of products.In addition, while raw material orders are generally placed one month in advance of suppliers’ orders, because certain ofthe raw materials used in our products are in short supply or are subject to capacity demands, we place some raw material ordersapproximately six months in advance to avoid paying higher prices. Accordingly, if we inaccurately forecast demand for our products,we may be unable to meet our customers’ delivery requirements, or we may accumulate excess inventories of products and rawmaterials.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Failureto achieve expected manufacturing yields and pesticidal activity or contamination of our production runs could negatively impactour operating results.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wedo not know whether a yield problem exists until our products are manufactured. When a yield issue is identified, the productis analyzed and tested to determine the cause. As a result, yield deficiencies may not be identified until well into the productionprocess. We may experience inability to ramp up yields in our own manufacturing facility or third-party manufacturers. In theevent that we continue to rely on third-party manufacturers, resolution of yield problems requires cooperation among, and communicationbetween, us and our manufacturers. Third-party manufacturers as well as our own plant in Michigan may contaminate the runs ofour products while in process, causing a run failure and causing us to miss sales opportunities or a season. We will not succeedif we cannot maintain or decrease our production costs and effectively scale our technology and manufacturing processes with thedesired yields and pesticidal activity and without contaminations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 29; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           29           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Werely on a single supplier based in China for a key ingredient of Regalia.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theactive ingredient in our Regalia product line is derived from the giant knotweed plant, which we obtain from China. Our singlesupplier acquires raw knotweed from numerous regional sources and performs an extraction process on this plant, following ourspecifications, thus creating a dried extract that is shipped to our manufacturing facility in Bangor, Michigan. Although we haveidentified additional sources of knotweed at competitive prices that appear to be reliable and of appropriate quality, there canbe no assurance that we will continue to be able to obtain dried extract from China at a competitive price point, including dueto impact of any deterioration in the trade relationship between the United States and China such as tariffs placed on Chinesegoods exported to the United States, unusual and significant deterioration status of supplier resources due to the outbreak ofCOVID-19, changes in the exchange rate between the U.S. Dollar and the Renminbi and potential actions taken by regulators in China.We endeavor to keep at least 10 - 12 months of knotweed extract on hand at any given time.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Anydecline in U.S. agricultural production could have a material adverse effect on the market for pesticides and on our results ofoperations and financial position.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Conditionsin the U.S. agricultural industry significantly impact our operating results. The U.S. agricultural industry has contracted inrecent periods, and can be affected by a number of factors, including weather patterns and field conditions, current and projectedgrain inventories and prices, domestic and international demand for U.S. agricultural products and U.S. and foreign policies regardingtrade in agricultural products. State and federal governmental policies, including farm subsidies and commodity support programs,as well as the prices of fertilizer products and the prices at which produce may be sold, may also directly or indirectly influencethe number of acres planted, the mix of crops planted and the use of pesticides for particular agricultural applications.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wehave acquired, and may in the future acquire, other companies, employee teams, products or technologies, which could divert ourmanagement’s attention, result in additional dilution to our stockholders, and otherwise disrupt our operations and adverselyaffect our operating results.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave acquired, and we may in the future acquire, other companies, employee teams, or technologies to further complement or expandour product portfolio, enhance our technical capabilities, obtain personnel, or otherwise offer growth opportunities. For example,in September 2019, we completed our acquisition of Pro Farm, which added proprietary nutrient and plant health technology andproducts for seed and foliar treatments to our product portfolio, and also in September 2019, we completed the purchase of substantiallyall rights and assets related to our Jet products. The pursuit of acquisitions may divert the attention of management and causeus to incur various expenses in identifying, investigating, and pursuing suitable acquisitions, whether or not they are consummated,and if an acquired business fails to meet our expectations, or the costs associated with the acquisition outweigh the benefits,our business, operating results, and financial position may suffer.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wemay not be able effectively manage the integration of acquired personnel, operations, and technologies successfully, or effectivelymanage the combined operations following any acquisition, which may prevent us from achieving anticipated benefits from an acquisition.We also may not achieve the anticipated benefits from an acquisition, including the Pro Farm acquisition, due to a number of otherfactors, including:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           acquisition    related costs, liabilities, or tax impacts, some of which may be unanticipated;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ineffective    or inadequate controls, procedures, or policies at the acquired company;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           multiple    product lines or service offerings, as a result of our acquisitions, that are offered, priced, and supported differently;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           potential    unknown liabilities or risks associated with the acquired businesses, including those arising from existing contractual obligations    or litigation matters;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           adverse    effects on our existing business relationships with business partners and customers as a result of the acquisition;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           potential    write-offs of acquired assets and potential financial and credit risks associated with acquired customers;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           inability    to maintain relationships with key customers, suppliers, and partners of the acquired business;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           difficulty    in predicting and controlling the effect of integrating multiple acquisitions concurrently;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           lack    of experience in new markets, products, or technologies;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           diversion    of management’s attention from other business concerns;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           use    of resources that are needed in other parts of our business; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           use    of substantial portions of our available cash to consummate the acquisition.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 30; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           30           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asignificant portion of the purchase price of companies or technologies we acquire may be allocated to acquired goodwill and otherintangible assets, which must be assessed for impairment at least annually. In the future, if our acquisitions do not yield expectedreturns, we may be required to take charges to our operating results based on this impairment assessment process, which couldadversely affect our operating results. Further, even if integration of acquired businesses is successful, we may be requiredto expend additional legal, accounting and other administrative costs with respect to managing subsidiaries in multiple internationaljurisdictions, including compliance with local laws and filing applicable tax returns.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Weare subject to risks associated with our international sales and operations         </i>        </b>        .       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weexpect sales to our international customers to account for an increasing portion of our sales in future fiscal years, includingas a result of the Pro Farm acquisition and its formation as a subsidiary of the Company, through which we now sell directly tocertain of our customers in Europe and South America. As a result of having global operations, the sudden disruption of salescaused by events outside of our control could impact our results of operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourinternational operations are subject to inherent risks, and our future results could be adversely affected by a variety of factors,many of which are outside of our control, including:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           greater    difficulty in collecting accounts receivable and longer collection periods;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           difficulties    of managing manufacturing, infrastructure and legal compliance costs associated with producing products internationally;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           political,    social and economic instability, including wars, terrorism, political unrest, boycotts, public health emergencies, curtailment    of trade and other business restrictions;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           tariff    and trade barriers and other regulatory requirements or contractual limitations on our ability to sell or develop our products    in certain foreign markets;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           less    effective protection of intellectual property than is afforded to us in the United States or other developed countries;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           potentially    adverse tax consequences;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           effects    of changes in currency exchange rates, particularly relative increases in the exchange rate of the U.S. dollar versus other    currencies that could negatively affect our financial results and cash flows; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           changes    in governmental trade policies can lead to the imposition of new duties, tariffs or quotas affecting agricultural commodities,    fertilizer or industrial products. These can alter trade flows, access to supplies or demand, and regional balances for our    products.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Becauseof the importance of international sales, sourcing and manufacturing to our business, our financial condition and results of operationscould be significantly harmed if any of the risks described above were to occur or if we are otherwise unsuccessful in managingour increasingly global business.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourintellectual property is integral to our business. If we are unable to protect our patents and proprietary rights in the UnitedStates and foreign countries, our business could be adversely affected.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Oursuccess depends in part on our ability to obtain and maintain patent and other proprietary rights protection for our technologiesand products in the United States and other countries. If we are unable to obtain or maintain these protections, we may not beable to prevent third parties from using our proprietary rights. It is also possible that we will fail to identify patentableaspects of our research and development output before it is too late to obtain patent protection. As of December 31, 2020, wehad 60 issued U.S. patents and 421 issued foreign patents, 17 pending provisional and non-provisional U.S. patent applicationsand 93 pending foreign patent applications.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 31; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           31           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thepatent position of biotechnology and biochemical companies generally is highly uncertain, involves complex legal and factual questionsand has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercialvalue of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issuedwhich protect our technology or products, in whole or in part, or which effectively prevent others from commercializing competitivetechnologies and products. Changes in either the patent laws or interpretation of the patent laws in the United States and othercountries may diminish the value of our patents or narrow the scope of our patent protection. For example, the U.S. Supreme Courthas ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstancesor weakening the rights of patent owners in certain situations. In addition, recent changes to the patent laws of the United Statesprovide additional procedures for third parties to challenge the validity of issued patents, some of which allow a lower evidentiarystandard to hold a patent claim invalid. The laws of some foreign countries do not protect proprietary rights to the same extentas the laws of the United States, and we may encounter significant problems and costs in protecting our proprietary rights inthese foreign countries.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourpatents, and those patents for which we have license rights, may be challenged, narrowed, invalidated or circumvented. In addition,our issued patents may not contain claims sufficiently broad to protect us against third parties with similar technologies orproducts or provide us with any competitive advantage. We are not certain that our pending patent applications will be issued.Moreover, our competitors could challenge or circumvent our patents or pending patent applications. It is also not possible topatent and protect all knowledge and know-how associated with our products, so there may be areas that are not protected suchas certain formulations and manufacturing processes. Costly and time-consuming litigation could be necessary to enforce and determinethe scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitivebusiness position.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forcertain of our products, we hold co-exclusive licenses to certain of the intellectual property related to these products. Althoughour products that are derived from intellectual property licensed to us on a co-exclusive basis also include our own proprietarytechnology, the third parties with whom we share co-exclusive rights may develop products based on the same underlying intellectualproperty. This could adversely affect the sale of our products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         Significant disruptions of informationtechnology systems or breaches of data security could adversely affect our business.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       We are dependent on information technologysystems and infrastructure, some which are hosted by third party vendors or suppliers, to operate our business. Despite our securitymeasures, potential vulnerabilities can be exploited from inadvertent or intentional actions of our employees, third-party vendors,business partners, or by malicious third parties. Attacks of this nature are increasing in their frequency, levels of persistence,sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide rangeof motives (including, but not limited to, industrial espionage) and expertise, including organized criminal groups, “hacktivists,”nation states and others. In addition to the extraction of sensitive information, such attacks could include the deployment ofharmful malware, ransomware, denial-of-service attacks, phishing attacks social engineering and other means to affect servicereliability. While we have incurred no material cyber-attacks or security breaches to date, any material cyber-related incident,including unauthorized access, disclosure or other loss of information, could result in legal claims or proceedings, investigationsby law enforcement or regulatory bodies, liability under laws that protect the confidentiality of personal information, regulatorypenalties, could disrupt our operations, could compromise our ability to protect our intellectual property rights, could damageour reputation, which could adversely affect our business, financial condition, and operating results, and could negatively impactour stock price.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         Our business is subject to risksarising from the COVID-19 illness.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       The outbreak of COVID-19 and theresulting public health crisis continues to have a widespread impact on our business, our customers, and our businessenvironment, as well as the economic climate in the United States and globally. The initial wave of the COVID-19 outbreakcaused disruption to our business activities, as state and local authorities mandated shutdown, which led us to scale downour headquarters and manufacturing facilities. For the safety of our workforce, employees were encouraged to work from homeif it was not absolutely essential to complete their responsibilities at the physical workspace. Since the initial shutdownorders, we continued to operate certain aspects of our business at a scaled down level and although generally many geographiclocations have reopened with limitations, we cannot determine when our operations will revert to the productivity levels wehad in early- and mid- March 2020. For example, while we cannot directly determine the value of the impact, we generallybelieve that scaling down our operations at our manufacturing plant for safety measures impacted our manufacturing levelsand contributed to the higher idle capacity expense recognized for the year ended December 31, 2020 when compared to December31, 2019. Additionally, the continued spread of COVID-19 and the mitigation measures taken by various governments ofcountries affected, could disrupt the supply chain for, the manufacture or shipment of, and the demand for our products andadversely impact our business, financial condition or results of operations. The COVID-19 outbreak and mitigation measuresmay also have an adverse impact on global economic conditions, which could have an adverse effect on our business andfinancial condition, including by limiting our ability to obtain financing or to rely on our existing financing facilities.Although we presently expect continued revenue growth in 2021 despite the impact of COVID-19, the extent to which theCOVID-19 outbreak impacts our results will depend on future developments that are highly uncertain and cannot be predicted,including new information that may emerge concerning the severity of the virus and the actions to contain its impact. Forexample, our commercial efforts may include on-site farmer demonstrations and attendance at trade shows and conferences, someof which were either limited by travel restrictions we imposed on our employees or due to capacity restrictions imposed bygovernmental agencies, were deferred or cancelled altogether during 2020.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 32; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           32           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        Risks Relating to Product Developmentand Regulatory Matters       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         If our ongoing or future field trialsare unsuccessful, we may be unable to obtain regulatory approval of, or commercialize, our products on a timely basis.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       The successful completion of multiple fieldtrials in domestic and foreign locations on various crops is critical to the success of our productdevelopment and marketing efforts. If our ongoing or future field trials are unsuccessful or produce inconsistent results or unanticipatedadverse side effects on crops or on non-target organisms, or if we are unable to collect reliable data, regulatory approval ofour products could be delayed, or we may be unable to commercialize our products. In addition, more than one growing or treatmentseason may be required to collect sufficient data and we may need to collect data from different geographies to prove performancefor customer adoption. Although we have conducted successful field trials on a broad range of crops, we cannot be certain thatadditional field trials conducted on a greater number of acres, or on crops for which we have not yet conducted field trials,will be successful. Moreover, the results of our ongoing and future field trials are subject to a number of conditions beyondour control, including weather-related events such as drought or floods, severe heat or frost, hail, tornadoes and hurricanes,or low or no natural occurrence of the pests intended for testing. Generally, we pay third parties, such as growers, consultantsand universities, to conduct field tests on our behalf. Incompatible crop treatment practices or misapplication of our productsby these third parties or lack of sufficient occurrence of the identified pests in nature for a particular trial could impairthe success of our field trials.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         Our inability to obtain regulatoryapprovals, or to comply with ongoing and changing regulatory requirements, could delay or prevent sales of the products we aredeveloping and commercializing.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       The field testing, manufacture, sale anduse of crop protection, plant health and plant nutrition products are extensively regulated by the EPA and other state, localand foreign governmental authorities. These regulations substantially increase the time and cost associated with bringing ourproducts to market. If we do not receive the necessary governmental approvals to test, manufacture and market our products, orif regulatory authorities revoke our approvals, do not grant approvals in a timely manner or grant approvals subject to restrictionson their use, we may be unable to sell our products in the United States or other jurisdictions, which could result in a reductionin our future revenues.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       As we introduce new formulations of andapplications for our products, we may need to seek EPA approval prior to commercial sale. For any such approval, the EPA may requireus to fulfill certain conditions within a specified period of time following initial approval. We are also required to obtainregulatory approval from other state and foreign regulatory authorities before we market our products in their jurisdictions,some of which have taken, and may take, longer than anticipated.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Some of these states and foreign countriesmay apply different criteria than the EPA in their approval processes. Although federal pesticide law preempts separate stateand local pesticide registration requirements to some extent, state and local governments retain authority to control pesticideuse within their borders.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       There can be no assurance that we willbe able to obtain regulatory approval for marketing our additional products or new product formulations and applications we aredeveloping. Although the EPA has in place a registration procedure for biopesticides there can be no assurance that all of ourproducts or product extensions will be eligible for this streamlined procedure or that additional requirements will not be mandatedby the EPA that could make the procedure more time consuming and costly for our future products.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Additionally, for certain state registrationand registration in jurisdictions outside of the United States, all products need to be proven efficacious for each proposed crop-pestcombination, which can require costly field trial testing, and a favorable result is not assured. Because many of the productsthat may be sold by us must be registered with one or more government agencies, the registration process can be time consumingand expensive, and there is no guarantee that the product will obtain all required registrations. We have intentionally obtainedregistration in some jurisdictions and not in others. California is one of the largest and most important producers of agriculturalproducts in the world. As such, we view California as one of the most natural and attractive markets for our products, but itis also very stringent in its regulations, generally requiring more time and effort, and lacking legally mandated deadlines forits reviews of reduced-risk biopesticides. Therefore, gaining concurrent approvals with the EPA, other states and other countriesmay not always be achievable. Even if we obtain all necessary regulatory approvals to market and sell our products, they willbe subject to continuing review and extensive regulatory requirements, including periodic re-registrations. The EPA, as well asstate and foreign regulatory authorities, could withdraw a previously approved product from the market upon receipt of newly discoveredinformation, including an inability to comply with their regulatory requirements or the occurrence of unanticipated problems withour products, or for other reasons.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <!-- Field: Page; Sequence: 33; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           33           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         We use hazardous materials in ourbusiness and are subject to potential liability under environmental laws. Any claims relating to improper handling, storage ordisposal of hazardous materials could be time consuming and costly to resolve.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       We are subject to federal, state and locallaws and regulations governing the use, manufacture, storage, handling, disposal and release of hazardous materials and certainwaste products. Our research and development and manufacturing activities involve the controlled use of hazardous materials and/orbiological waste. Some of these materials may be novel, including bacteria with novel properties and bacteria that produce biologicallyactive compounds. We cannot eliminate the risk of accidental contamination or discharge and any injury resulting from these materials.In addition, although we have not currently identified any environmental liabilities, our manufacturing facility may have existingenvironmental liabilities associated with it that may also result in successor liabilities for us, and we will be subject to increasedexposure to potential environmental liabilities as we manufacture our products on a larger scale. We may also be held liable forhazardous materials brought onto the premises of our manufacturing facility before we acquired title, without regard for faultfor, or knowledge of, the presence of such substances, as well as for hazardous materials that may be discovered after we no longerown the property if we sell it in the future. In the event of an accident, or if any hazardous materials are found within ouroperations or on the premises of our manufacturing facility in violation of the law at any time, we may be liable for all cleanupcosts, fines, penalties and other costs. This liability could exceed our resources, and, if significant losses arise from hazardoussubstance contamination, our financial viability may be substantially and adversely affected.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       In addition, we may have to incur significantcosts to comply with future environmental laws and regulations. We cannot predict the impact of new governmental regulations thatmight have an adverse effect on the research, development, production and marketing of our products. We may be required to incursignificant costs to comply with current or future laws or regulations. Our business may be harmed by the cost of compliance.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Our collaborators may use hazardous materialsin connection with our collaborative efforts. To our knowledge, their work is performed in accordance with applicable biosafetyregulations. In the event of a lawsuit or investigation, however, we could be held responsible for any injury caused to personsor property by exposure to, or release of, hazardous materials used by these parties. Further, we may be required to indemnifyour collaborators against all damages and other liabilities arising out of our development activities or products produced inconnection with these collaborations.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         Inability to comply with regulationsapplicable to our facilities and procedures could delay, limit or prevent our research and development or manufacturing activities.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Our research and development and manufacturingfacilities and procedures are subject to continual review and periodic inspection. We must spend funds, time and effort in theareas of production, safety and quality control and assurance to ensure full technical compliance with the regulations applicableto these facilities and procedures. If the EPA or another regulatory body determines that we are not in compliance with theseregulations, regulatory approval of our products could be delayed, or we may be required to limit or cease our research and developmentor manufacturing activities or pay a monetary fine. If we are required to limit or cease our research and development activities,our ability to develop new products would be impaired. In addition, if we are required to limit or cease our manufacturing activities,our ability to produce our products in commercial quantities would be impaired or prohibited, which would harm our business.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <b>        <i>         Our business is subject to variousgovernmental regulations, and compliance with these regulations may cause us to incur significant expenses. If we fail to maintaincompliance with applicable regulations, we may be forced to recall products and cease their manufacture and distribution, whichcould subject us to civil or criminal penalties.        </i>       </b>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       The complex legal and regulatory environmentexposes us to compliance and litigation costs and risks that could materially affect our operations and financial results. Theselaws and regulations may change, sometimes significantly, as a result of political or economic events. They include environmentallaws and regulations, tax laws and regulations, import and export laws and regulations, government contracting laws and regulations,labor and employment laws and regulations, securities and exchange laws and regulations, and other laws such as the Foreign CorruptPractices Act. In addition, proposed laws and regulations in these and other areas could affect the cost of our business operations.We face the risk of changes in both domestic and foreign laws regarding trade, potential loss of proprietary information due topiracy, misappropriation or foreign laws that may be less protective of our intellectual property rights. Violations of any ofthese laws and regulations could subject us to criminal or civil enforcement actions, any of which could have a material adverseeffect on our business, financial condition or results of operations.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         RisksRelated to Ownership of Our Common Stock        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourprincipal stockholders have significant voting power and may take actions that may not be in the best interest of other stockholders.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof March 16, 2021, our executive officers and directors and their affiliates, including Ospraie Ag Science LLC (“Ospraie”),beneficially owned or controlled (i.e., directly or indirectly and including exercisable warrants), an aggregate of approximately79.2 million shares, or 44.6% of our common stock, including 39.5% of our currently outstanding shares. Inaddition, affiliates of Waddell &amp; Reed Financial, Inc. (“Waddell”), beneficially own 16.0% of our commonstock and 15.7% of our currently outstanding shares, Ardsley Advisory Partners (“Ardsley”) beneficially owns9.9% of our common stock and 9.6% of our currently outstanding shares, and Van Herk Investments B.V. beneficiallyown 6.0% of our common stock and 4.0% of our currently outstanding shares. These principal stockholders collectivelybeneficially owned or controlled, directly or indirectly an aggregate of 134.8 million shares or 68.9% of our totalcommon stock outstanding and if all of these security holders act together, or exercise their warrants, they will be able to exertsignificant control over our management and affairs, which could result in some corporate actions that our other stockholdersdo not view as beneficial such as failure to approve change of control transactions that could offer holders of our common stocka premium over the market value of our company. As a result, the market price of our common stock could be adversely affected.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 34; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           34           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Ourcommon stock may experience extreme price and volume fluctuations, and you may not be able to resell shares of our common stockat or above the price you paid.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave had a history of losses, and our business, financial results and stock price have been adversely affected by operatingresults. Since shares of our common stock were sold in our initial public offering in August 2013 at a price of $12.00 pershare, our stock price has ranged between $0.60 and $20.00 through December 31, 2020. The trading price of our common stock willlikely continue to be highly volatile and could be subject to wide fluctuations in price in response to various factors, someof which are beyond our control. These factors include       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    public float relative to the total number of shares of common stock that are issued and outstanding;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           quarterly    variations in our results of operations, those of our competitors or those of our customers;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           announcements    of technological innovations, new products or services or new commercial relationships by us or our competitors;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    ability to develop and market new products on a timely basis;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           disruption    to our operations;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           media    reports and publications about our financials or about pest management products;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           announcements    concerning our competitors or the pest management industry in general;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           our    entry into, modification of or termination of key license, research and development or collaborative agreements;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           new    regulatory pronouncements and changes in regulatory guidelines or the status of our regulatory approvals;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           general    and industry-specific economic conditions, such as the recent uncertainty in the global economy caused by the COVID-19 pandemic;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           any    major change in our board of directors or management;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    commencement of, or our involvement in, litigation;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           changes    in financial estimates, including our ability to meet our future net revenues and operating profit or loss projections; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           changes    in earnings estimates or recommendations by securities analysts.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Substantialfuture sales of our common stock, or the perception in the public markets that these sales may occur, may depress our stock price.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Salesof substantial amounts of our common stock in the public market, or the perception that such sales could occur, could adverselyaffect the market price of our common stock. As of March 16, 2021, we had approximately 173.5 million shares ofcommon stock outstanding, 68.6 million which were held by our directors and officers and their affiliates and an additional50.9 million shares which were held by other beneficial holders of 5% or more of our common stock. Although these sharesare subject in some cases to volume and manner of sale restrictions of Rule 144 of the Securities Act, any determination by holdersof a substantial number of such shares to sell our stock, or the perception that such sales may occur, could cause our stock priceto decline.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition, as of March 16, 2021, we had 9.5 million shares of our common stock available to be awarded under ourequity incentive plans, 4.7 million shares of our common stock issuable upon the settlement of outstanding restricted stockunits, 13.7 million shares of our common stock issuable upon the exercise of outstanding options with a weighted averageexercise price of $2.30 per share and 8.6 million shares of our common stock issuable upon the exercise of outstandingwarrants with a weighted average exercise price of $0.91 per share. These shares may be sold in the public market uponissuance.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Weare a “smaller reporting company” and we cannot be certain if the reduced disclosure requirements applicable to smallerreporting companies will make our common stock less attractive to investors.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare a “smaller reporting company” as defined by the Securities and Exchange Commission. For as long as we continueto be a smaller reporting company, we may choose to take advantage of certain scaled disclosures from various reporting requirementsapplicable to other public companies but not to smaller reporting companies, which include, among other things:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           reduced    disclosure obligations related to Management’s Discussion and Analysis of Financial Conditions and Results of Operations;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           reduced    disclosure obligations regarding executive compensation in our periodic reports and proxy statements;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           reduced    income statement, cash flow, and changes in stockholders’ equity statements from three years to two years.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wecannot predict if investors will find our common stock less attractive if we rely on these exemptions. If some investors findour common stock less attractive as a result, there may be a less active trading market for our common stock and our stock pricemay be more volatile.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 35; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           35           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Wehave in the past identified material weaknesses, and if we fail to establish and maintain proper and effective internal controls,our ability to produce accurate financial statements on a timely basis could be impaired, which could adversely affect our consolidatedoperating results, our ability to operate our business, our stock price and investors’ views of us.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourmanagement is responsible for establishing and maintaining adequate internal control over financial reporting to ensure that informationregarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordancewith GAAP, but in the past, we have identified material weaknesses in these controls. While we believe we have appropriately remediatedprevious material weaknesses in our internal control over financial reporting, we can provide no assurances that other materialweaknesses in our internal control over financial reporting, will not be identified in the future. Remediation of any materialweaknesses requires substantial management time and attention, and ensuring that we have adequate internal control over financialreporting and procedures in place to produce accurate financial statements on a timely basis will continue to be a costly andtime-consuming effort.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Anyfailure to implement effective internal control over financial reporting or to complete and maintain the remediation of our identifiedcontrol deficiencies may result in errors, material misstatements or delays in our financial reporting, failure to meet our financialreporting obligations or failure to avoid or detect fraud in our financial reporting. This in turn would have a material adverseeffect on our business and results of operations and could have a substantial adverse impact on the trading price of our commonstock and our relationships with customers and suppliers.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourmanagement does not expect that our internal control over financial reporting will prevent or detect all errors and all fraud.A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the controlsystem’s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls canprovide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances offraud, if any, within the Company will have been detected.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Unforeseenproblems with the maintenance of our information systems, or failure to design and operate effective internal controls over informationsystems, could have an adverse effect on our operations and could result in ineffective internal control over our financial reporting.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Aswe add functionality and increase the use of our enterprise risk planning or other key information systems,we may incur additional costs and problems could arise that we have not foreseen, including interruptions in service, lossof data, or reduced functionality. Such problems could adversely impact our ability to run our business in an efficient andtimely manner.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition, we do not have extensive experience with implementing controls over our current information systems. While webelieve we have designed the appropriate controls around our information systems, if we have not designed controls withinor around these systems that are effective at preventing and detecting unreliable data, or if we are unable to design or operatecontrols within or around these systems to provide effective control around program changes and access to the systems, we maybe at risk for future material weaknesses. This in turn would have a material adverse effect on our business and results ofoperations and could have a substantial adverse impact on the trading price of our common stock and our relationships with customersand suppliers.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Provisionsin our charter documents and under Delaware law could discourage a takeover that stockholders may consider favorable.         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Provisionsin our amended and restated certificate of incorporation and bylaws may have the effect of delaying or preventing a change ofcontrol or changes in our management. These provisions include the following:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    right of our board of directors to elect directors to fill a vacancy created by the expansion of our board of directors or    the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board    of directors;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    establishment of a classified board of directors requiring that only a subset of the members of our board of directors be    elected at each annual meeting of stockholders;          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 36; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           36           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    prohibition of cumulative voting in our election of directors, which would otherwise allow less than a majority of stockholders    to elect director candidates;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    requirement that stockholders provide advance notice to nominate individuals for election to our board of directors or to    propose matters that can be acted upon at a stockholders’ meeting. These provisions may discourage or deter a potential    acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting    to obtain control of our company;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    ability of our board of directors to issue, without stockholder approval, shares of undesignated preferred stock with terms    set by the board of directors, which rights could be senior to those of our common stock. The ability to authorize undesignated    preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences    that could impede the success of any attempt to acquire us;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    ability of our board of directors to alter our bylaws without obtaining stockholder approval;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    inability of our stockholders to call a special meeting of stockholders and to take action by written consent in lieu of a    meeting;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    required approval of the holders of at least two-thirds of the shares entitled to vote at an election of directors to adopt,    amend or repeal our bylaws;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    required approval of the holders of at least two-thirds of the shares entitled to vote at an election of directors to repeal    or adopt any provision of our certificate of incorporation regarding the election of directors;          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    required approval of the holders of at least 80% of such shares to amend or repeal the provisions of our bylaws regarding    the election and classification of directors; and          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           the    required approval of the holders of at least two-thirds of the shares entitled to vote at an election of directors to remove    directors without cause.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asa Delaware corporation, we are also subject to certain Delaware anti-takeover provisions. Under Delaware law, a corporation maynot engage in a business combination with any holder of 15% or more of its common stock unless the holder has held the stock forthree years or, among other things, the board of directors has approved the transaction. Our board of directors could rely onDelaware law to prevent or delay an acquisition of us.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_004">         </a>         ITEM1B. UNRESOLVED STAFF COMMENTS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <a name="a_005">       </a>       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ITEM2. PROPERTIES        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourheadquarters are located at 1540 Drew Avenue in Davis, California, in a facility consisting of approximately 27,300 square feetof office, laboratory and greenhouse space under a lease entered into in September 2013. This facility accommodates our research,development, sales, marketing, operations, finance and administrative activities. The facility includes a new, state-of-the-artfermentation lab and pilot plant, an expanded formulation lab and pilot with spray drying and granulation capabilities, an insectary,a plant pathology and nematology lab and a plant and weed sciences lab, among others. The initial term of the lease was for aperiod of 60 months. In November 2018, we exercised the first lease extension option, extending the lease term for an additional60 months, as discussed in Note 3 of our consolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weown an 11,400 square-foot manufacturing facility in Bangor, Michigan for the manufacturing of our products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 37; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           37           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wecurrently lease an office space in Finland for use by our Finland subsidiary as their headquarters. The original lease expiredon August 31, 2018, and the lease is now on a month to month arrangement and requiresa three-month written notice prior to termination.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webelieve that our leased facilities and our manufacturing facility are adequate to meet our needs.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_006">         </a>         ITEM3. LEGAL PROCEEDINGS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <a name="a_007">       </a>       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ITEM4. MINE SAFETY DISCLOSURES        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.25pt; text-align: justify; text-indent: -68.25pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <a name="a_008">       </a>       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         PARTII        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_009">         </a>         ITEM5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         MarketInformation for Common Stock        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourcommon stock has been listed on the NASDAQ Global Market under the symbol “MBII” from August 2, 2013 throughSeptember 5, 2016. Since September 6, 2016, our common stock has been listed on the Nasdaq Capital Market.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Holdersof Record        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, there were 70 stockholders of record of our common stock, and the closing price of our common stockwas $1.25 per share as reported on the Nasdaq Capital Market. Because some of our shares of common stock are held by brokers andother institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by theserecord holders.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         DividendPolicy        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave never declared or paid any cash dividend on our common stock. We intend to retain any future earnings and do not expect topay dividends in the foreseeable future.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         EquityCompensation Plan Information        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Informationregarding equity compensation plans approved and not approved by stockholders is summarized in the following table as of December31, 2020:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; border-bottom: Black 1.5pt solid">          PLAN CATEGORY         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          NUMBER OF          <br/>          SECURITIES TO BE          <br/>          ISSUED UPON          <br/>          CONVERSION OF          <br/>          RESTRICTED          <br/>          STOCK UNITS AND          <br/>          EXERCISE OF          <br/>          OUTSTANDING          <br/>          OPTIONS,          <br/>          WARRANTS          <br/>          AND RIGHTS         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          WEIGHTED-AVERAGE          <br/>          EXERCISE PRICE OF          <br/>          OUTSTANDING          <br/>          OPTIONS, WARRANTS          <br/>          AND RIGHTS         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            NUMBER OF            <br/>            SECURITIES REMAINING            <br/>            AVAILABLE FOR            <br/>            FUTURE ISSUANCE            <br/>            UNDER EQUITY            <br/>            COMPENSATION            <br/>            PLANS (EXCLUDING            <br/>            SECURITIES            <br/>            REFLECTED IN COLUMN            <br/>            (a)            <sup>             (1)            </sup>           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          (a)         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          (b)         </td>         <td style="font-weight: bold">         </td>         <td>         </td>         <td colspan="2" style="text-align: right">         </td>         <td>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 34%; text-align: left">          Equity compensation plans approved by stockholders         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 18%; text-align: right">          17,986,498         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 18%; text-align: right">          2.01         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 18%; text-align: right">          4,409,938         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Equity compensation plans not approved by stockholders         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          —         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          —         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          —         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Total         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          17,986,498         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          2.01         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          4,409,938         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <sup>            (1)           </sup>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Consists    of shares available for issuance under our 2013 Stock Incentive Plan.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 38; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           38           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="a_010">         </a>         ITEM7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Youshould read the following discussion of our financial condition and results of operations in connection with our consolidatedfinancial statements and the related notes included in Part II-Item 8- “Financial Statements and Supplementary Data”in this Annual Report on Form 10-K. Additional information regarding the Company is also available in our other reports filedwith the Securities and Exchange Commission, which are also available on our investor relations website, investors.marronebio.com,which we also use, together with our corporate Twitter account, @Marronebio, as a means of disclosing material non-public informationand for complying with our disclosure obligations under Regulation FD. We encourage our investors to monitor and review the informationwe make public in these locations. The information contained in the foregoing locations are not incorporated by reference intothis filing, and the Company’s references to website URLs are intended to be inactive textual references only. In additionto our historical consolidated financial information, the following discussion contains forward-looking statements that reflectour plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Reporton Form 10-K, particularly in Part I-Item 1A-”Risk Factors.”        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weare a growth-oriented agricultural company that supports environmentally sustainable farming practices through the discovery,development and sale of innovative biological products for crop protection, crop health and crop nutrition. Our products are soldthrough distributors and other commercial partners to growers around the world for use in integrated pest management systems thatimprove efficacy and increase yields while protecting the environment. Our products are often used in conjunction with or as analternative to other agricultural solutions to control pests and enhance plant nutrition and health.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourportfolio of 15 products helps customers operate more sustainably while increasing their return on investment. Our products areused globally, and can be applied as foliar treatments or as seed-and-soil treatments, either on their own or in combination withother agricultural products. We target the major markets that use conventional chemical pesticides and fertilizers where our biologicalproducts are used as alternatives or mixed with, conventional chemical products. We also target new markets for which there areno available conventional chemical products, the use of conventional chemical products may not be desirable (including for organicallycertified crops) or permissible either because of health and environmental concerns or because the development of pest resistancehas reduced the efficacy of conventional chemical pesticides. We sell our products through distributors and other commercial partnersto growers who use our bioprotection products to manage pests and plant diseases, our plant health products to reduce crop stressand both our plant health and bionutrition products to increase yields and quality.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         2020Highlights        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing are the more significant financial results for the fiscal year ending December 31, 2020:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Revenues    grew to $38.4 million in 2020, a 30.6% increase compared with $29.4 million in 2019, as sales of the portfolio of products    expanded with current customers, as well as new customers, across new crops and geographies, and in particular, as a result    of sales of our Pro Farm products.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Gross    margins expanded to 59.6% in 2020, compared with 54.9% in 2019, reflecting a favorable mix effect from higher sales of the    Venerate, Regalia and sales of UBP ST product families.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Full-year    operating expenses were $40.1 million in 2020, compared to $44.1 million in operating expenses in 2019, which, however, includes    a $1.4 million decrease from a fully forgiven Payment Protection Program Loan.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Net    loss decreased by $17.0 million to a loss of $20.2 million, or ($0.14) per share, reflecting full year Pro Farm operating    results. Net income for the fiscal year ending December 31, 2019 included Pro Farm acquisition costs of $3.1 million.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Obtained    $22.1 million in connection with exercises under outstanding warrants, including exercises in connection with amendments to    warrant arrangements set to previously expire at December 31, 2020.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 39; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           39           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing are the more significant business highlights for the fiscal year ending December 31, 2020:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    completed our Chief Executive Officer search, with Kevin Helash joining us on August 2, 2020.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    executed distribution agreements with PGG Wrightson Seeds to distribute our Pro Farm UBP Seed Treatment products in Uruguay,    with UPL for Regalia Maxx in the Republic of South Africa, and with Anasac Chile S.A for Grandevo and Venerate in Chile          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    entered into strategic alliances with Rizobacter to deploy novel plant health and crop nutrition technology in South America    and with Vive Crop Protection to bring next-generation crop protection solutions to growers          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Our    Jet-Oxide 15% Sanitizer product was allowed by the U.S. EPA for use on industrial hard surfaces for human coronaviruses          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Regalia    and Stargus were approved by the U.S. EPA for use on hemp, and Regalia Maxx received first approval in Canada for use on cannabis    and hemp          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    increased the experience and diversity of our Board of Directors with the addition of Lara L. Lee, who also became a member    of our Audit Committee and Compensation Committee.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    announced our succession planning with the departure of Chief Financial Officer, Jim Boyd, replaced by Sue Cheung in February    2021.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         BusinessStrategy        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave built a full-service biologicals organization with scope and capabilities across the spectrum of biological products in themarket today. Our strategic objective is to capitalize on that position and emerge as the clear leader in the biologicals spacewith the financial and operational wherewithal to accelerate our path to profitability.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Aswe look forward, our goal is to leverage our base business, while accelerating our expansion plans and broadening our global reach.We are committed to launching the brand extensions and pipeline products that offer the greatest return on investment for ourchannel partners and grower customers. We anticipate that synergistic, value-creating acquisitions and partnerships will be partof our strategy. We believe we can continue to tuck in additional product lines as we build a larger commercial presence witha scalable platform.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourstrategy for the current long-term period includes the diversification of our portfolio which includes expanding our reach globallymoving away from having sales concentrated in the United States continued research and development efforts to acceleratethe time to market and revenue contributions of our pipeline products and continued focus on our current operations tocontinue our growth, profitability and enhance stockholder value.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         FinancialOverview        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourtotal revenues were $38.4 million and $29.4 million for the years ended December 31, 2020 and 2019, respectively, and have risenas growers have adopted our products and have used our products on an expanded number of crops. We generate our revenues primarilyfrom product sales, which are principally attributable to sales of our Regalia, Grandevo and Venerate product lines for the yearended December 31, 2019, including sales of our Pro Farm products for the year ended December 31, 2020, but also sales of ourother products. For the year ended December 31, 2020, 76% of our business has been primarily driven by the U.S. market, whichhas been our historical trends for geographic revenues. In 2021, we expect a larger portion of our business to be driven by internationalmarkets with our Pro Farm products and our continued focus on commercialization progress of our products in new countries. Goingforward, we also believe our revenues will largely be impacted by weather, trade tariffs, natural disasters, infectious diseases,and other factors affecting planting and growing seasons and incidence of pests and plant disease, and, accordingly, the decisionsby our distributors, direct customers and end users about the types and amounts of crop protection and plant health products topurchase and the timing of use of such products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 40; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           40           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wecurrently rely, and expect to continue to rely, on a limited number of distributors for a significant portion of our revenuessince we sell through highly concentrated, traditional distribution channels. Distributors to which 10% or more of our total revenuesare attributable for any one of the periods presented consist of the following:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          CUSTOMER         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold">          DECEMBER 31,         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          A         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          B         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          C         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          D         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 24%; text-align: left">          2020         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 15%; text-align: right">          22         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 15%; text-align: right">          13         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 15%; text-align: right">          13         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 15%; text-align: right">          8         </td>         <td style="width: 1%; text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          2019         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          30         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          9         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          0         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          10         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Whilewe expect product sales to a limited number of distributors to continue to be our primary source of revenues, as we continue todevelop our pipeline and introduce new products to the marketplace, we anticipate that our revenue stream will be diversifiedover a broader product portfolio and customer base, including as a result of our Pro Farm products and customers.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Since2011, we have also recognized revenues from our strategic collaboration and distribution agreements, which amounted to $0.5 million for each of the years ended December 31, 2020 and 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourcost of product revenues was $15.5 million and $13.3 million for the years ended December 31, 2020 and 2019, respectively. Costof product revenues consists principally of the cost of inventory, which includes the cost of raw materials, and third-party servicesand allocation of operating expenses of our manufacturing plant related to procuring, processing, formulating, packaging and shippingour products. Cost of product revenues also include charges recorded for write-downs of inventory and idle capacity at our manufacturingplant. We expect our cost of product revenues related to the cost of inventory to increase and cost of product revenues relatingto write-downs of inventory and idle capacity of our manufacturing plant to decrease as we expand sales and increase productionof our existing commercial products. We expect to see a gradual increase in gross margin over the life cycle of each of our productsas we improve production processes, gain efficiencies and increase product yields. These increases may be offset by additionalcharges for inventory write-downs and idle capacity at our manufacturing plant until overall volume in the plant increases significantly,however we are expecting these charges to decrease over time.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourresearch, development and patent expenses have historically comprised a significant portion of our operating expenses, amountingto $11.3 million and $14.0 million for the years ended December 31, 2020 and 2019, respectively. For the year ended December 31,2020, our expenses for research, development and patent expenses were reduced by $0.7 million in connection with receipt of PaycheckProtection Program (“PPP”) funds. We are seeking collaborations with third parties to develop and commercialize moreearly stage candidates, on which we have elected not to expend significant resources given our efforts on cost containment.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Selling,general and administrative expenses incurred to establish and build our market presence and business infrastructure have generallycomprised the remainder of our operating expenses, amounting to $28.7 million and $30.1 million for the years ended December 31,2020 and 2019, respectively. For the year ended December 31, 2020, our selling, general and administrative expenses were reducedby $0.7 million in connection with receipt of PPP funds. For the year ended December 31, 2019, this also included amounts of $4.3million related to our acquisition strategy and $1.9 million related to our previously reported litigation settlement. We havebeen building a sales and marketing organization that provides for increased training and a better ability to educate and supportcustomers and for our product development staff to undertake responsibility for technical sales support, field trials and demonstrationsto promote sales growth.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Historically,we have funded our operations from the issuance of shares of common stock, preferred stock, warrants and convertible notes, theissuance of debt and entry into financing arrangements, product sales, payments under strategic collaboration and distributionagreements and government grants, but we have experienced significant losses as we invested heavily in our acquisition strategyand research and development. We expect to incur additional losses related to our investment in these endeavors including continueddevelopment, expansion and marketing of our product portfolio.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 41; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           41           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2019, we entered into a warrant amendment and plan of reorganization agreement, which we refer to as the Warrant Facility.Under the Warrant Facility, for certain holders of warrants issued in connection with the February 2018 Financing Transactions(the “February 2018 Warrants”), their warrant expiration date was extended from December 2020 to December 2021, andthese warrant holders agreed, at any time the Company’s stock trades above $1.00, upon request by the Company, to exerciseup to 36,600,000 shares under their respective February 2018 Warrants, in consideration for the delivery of (x) the shares subjectto the February 2018 Warrants so exercised and (y) the delivery of new warrants (“August 2019 Warrants”) to purchasesuch additional number of shares of common stock equal to the amount of shares so exercised and delivered under February 2018Warrants. During 2019, a total exercise of 16,000,000 shares of certain outstanding warrants at $1.00 per share occurred. Includedin our net loss results, for the fiscal year ended December 31, 2019 is a non-cash charge of $1.6 million related to the incrementalfair value of the February 2018 Warrants prior to the August 2019 Warrant amendments due to a modification allowing us to callthe warrants as needed to fund our operations, as well as a non-cash charge of $6.1 million related to the fair value of the August2019 Warrants issued.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InApril 2020, we entered into a Warrant Exchange Agreement (the “Warrant Exchange Agreement”) with a group of historicalinvestors (the “Investors”). Pursuant to the Warrant Exchange Agreement, the Investors have exchanged certain previouslyissued and outstanding warrants to purchase an aggregate of up to 45,977,809 shares of the Company’s common stock, for newwarrants (the “New Warrants”) to purchase an aggregate of up to 29,881,855 shares of Common Stock (the “WarrantShares”). All of the New Warrants were issued to the Investors upon execution of the Warrant Exchange Agreement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheNew Warrants all have an exercise price of $0.75 per share, and expire in five tranches. As of December 31, 2020, a total of 19,133,465Warrant Shares were exercised prior to the first, second, and third tranche expiration dates of May 1, 2020, September 15, 2020,and December 15, 2020. Prior to March 15, 2021 the fourth tranche with respect to 5,862,380 was exercised by the warrant holderfor a total of $4.4 million. The next and final warrant expiration date is December 15, 2021 with respect to 4,885,317Warrant Shares. There can be no assurance that the Investors will exercise the remaining New Warrants prior to their respectiveexpiration date on or prior to December15, 2021. (Refer to Note 9 of our consolidated financial statements).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InDecember 2020, we entered into an amendment (the “Warrant Amendment”) to its previously outstanding warrant to purchase5,333,333 shares of our common stock issued to a historical warrant holder on February 5, 2018. Pursuant to the Warrant Amendment,in exchange for the holder’s agreement to exercise the warrant on December 29, 2020 with respect to 1,777,778 shares atthe warrant’s exercise price of $0.96 per share we agreed to partially extend the warrant’s expiration date by allowingthe holder to exercise (i) 1,777,778 of the subject shares at $1.00 per share by March 25, 2021, and (ii) the remaining 1,777,777shares at $1.04 per share by December 15, 2021. There can be no assurance that the holder will exercise the warrant prior to itsrespective expiration dates. (Refer to Note 9 of our consolidated financial statements)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         KeyComponents of Our Results of Operations        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ProductRevenues         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Productrevenues consist of revenues generated primarily from sales to distributors, net of rebates and cash discounts. Product revenuesconstituted 99% and 98%, of our total revenues for the years ended December 31, 2020 and 2019, respectively. Product revenuesin the United States constituted 77% and 88% of our total revenues for the years ended December 31, 2020 and 2019, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany accounts for all revenues under Accounting Standards Codification (“ASC”) 606,        <i>         Revenue from contracts withCustomers (“ASC 606”)        </i>        in which revenue recognition criteria for distributor sales are satisfied at the time titleand risk of loss passes to the distributor.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify; text-indent: -34.2pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 42; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           42           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          LicenseRevenues         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Licenserevenues generally consist of revenues recognized under our strategic collaboration and distribution agreements for exclusivedistribution rights, either for Regalia, for other commercial products, or for our broader pipeline of products, for certain geographicmarkets or for market segments that we are not addressing directly through our internal sales force. Our strategic collaborationand distribution agreements generally outline overall business plans and include payments we receive at signing and for the achievementof certain testing validation, regulatory progress and commercialization events. As these activities and payments are associatedwith exclusive rights that we provide over the term of the strategic collaboration and distribution agreements, revenues relatedto the payments received are deferred and recognized as revenues over the term of the exclusive period of the respective agreements,which we estimate to be between 5 and 17 years based on the terms of the contract and the covered products and regions. For theyears ended December 31, 2020 and 2019, license revenues constituted 1% and 2%, respectively, of total revenues, respectively.As of December 31, 2020 and 2019, we have received an aggregate of $4.1 million in payments under our strategic collaborationand distribution agreements. In addition, there is $0.8 million in payments under these agreements that we could potentially receiveif certain testing validation, regulatory progress and commercialization events occur.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Costof Product Revenues and Gross Profit         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Costof product revenues consists principally of the cost of raw materials, including inventory costs and third-party services relatedto procuring, processing, formulating, packaging and shipping our products. As we have used our Bangor, Michigan manufacturingplant to produce certain of our products, cost of product revenues includes an allocation of operating costs including directand indirect labor, production supplies, repairs and maintenance, depreciation, utilities and property taxes. The amount of indirectlabor and overhead allocated to finished goods is determined on a basis presuming normal capacity utilization. Operating costsincurred in excess of production allocations, considered idle capacity, are expensed to cost of product revenues in the periodincurred rather than added to the cost of the finished goods produced. Cost of product revenues may also include charges due toinventory adjustments and reserves. In addition, costs associated with license revenues have been included in cost of productrevenues as they have not been significant. Gross profit is the difference between total revenues and cost of product revenues.Gross margin is gross profit expressed as a percentage of total revenues.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave entered into in-license technology agreements with respect to the use and commercialization of two of our commercially availableproduct lines, Grandevo and Haven and certain products under development. Under these licensing arrangements, we typically makeroyalty payments based on net product revenues, with royalty rates varying by product in the mid-single digit of net sales. These royalty payments are included in cost of product revenues, but they havehistorically not been significant. The exclusivity and royalty provisions of these agreements are generally tied to the expirationof underlying patents. The in-licensed U.S. patent for Grandevo is expected to expire in 2024. There are pending in-licensed patentapplications relating to Grandevo, which could expire later than 2024 if issued. The licensed patents for Haven began expiringin November 2019. After the termination of these provisions, we may continue to produce and sell these products. While third partiesthereafter may develop products using the technology under expired patents, we do not believe that they can produce competitiveproducts without infringing other aspects of our proprietary technology, including pending patent applications related to Grandevoand Haven and we therefore do not expect the expiration of the patents or the related exclusivity obligations to have a significantadverse financial or operational impact on our business.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weexpect to see increases in gross profit over the life cycle of each of our products as gross margins are expected to increaseover time as production processes improve and as we gain efficiencies and increase product yields. While we expect margins toimprove on a product-by-product basis, our overall gross margins may vary as we introduce new products, or as we experience changesin the sales mix of these products. In particular, we may experience downward pressure on overall gross margins as we rolloutHaven, Stargus and expand sales of Grandevo. Gross margin has been and will continue to be affected by a variety of factors, includingplant utilization, product manufacturing yields, changes in production processes, new product introductions, product sales mixand average selling prices.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Webegan full-scale manufacturing in our facility in 2014. We continue to use third-party manufacturers for Venerate, Majestene,Haven, Stargus, and for spray-dried powder formulations of Grandevo. We expect gross margins to improve using this facility whensales volumes recover enough to reduce overhead and idle capacity charges from our facility.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 43; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           43           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Research,Development and Patent Expenses         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Research,development and patent expenses include personnel costs, including salaries, wages, benefits and share-based compensation, relatedto our research, development and patent staff in support of product discovery and development activities. Research, developmentand patent expenses also include costs incurred for laboratory supplies, field trials and toxicology tests, quality control assessment,consultants and facility and related overhead costs.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Selling,General and Administrative Expenses         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Selling,general and administrative expenses consist primarily of personnel costs, including salaries, wages, benefits and share-basedcompensation, related to our executive, sales, marketing, finance and human resources personnel, as well as professional fees,including legal and accounting fees, acquisition costs, public company expenses and other selling costs incurred related to businessdevelopment and to acquire or build product and brand awareness. We create brand awareness through programs such as speaking atindustry events, trade show displays and hosting local-level grower and distributor meetings. In addition, we dedicate significantresources to technical marketing literature, targeted advertising in print and online media, webinars and radio advertising. Costsrelated to these activities, including travel, are included in selling expenses.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inorder to drive our strategy and revenue growth, we expect selling, general, and administrative expenses of sales and marketingto increase in the future as we increase our marketing communications campaigns and put more “boots on the ground”,which should increase grower demand, or pull-through, and develop new customers, as well as expand business with existing customers.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          InterestExpense         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Werecognize interest expense on notes payable and other debt obligations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMarch 2017, we entered into an invoice purchase agreement with LSQ Funding Group, L.C. (“LSQ”), which was subsequentlyamended in January 2020, and allows us to receive advances of up to $20.0 million against receivables sold to LSQ.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition to the January 2020 amendment, we simultaneously entered into an Amended Inventory Financing Addendum (the “Addendum”)with LSQ. The Addendum us to request an advance of up to the lesser of (i) 100% of the Company’s unpaid finished goods inventory;(ii) 65% of the appraised value of the Company’s inventory performed on or on behalf of LSQ; or (iii) $3,000,000. Fundsadvance under the Addendum are subject to a monthly inventory management fee of 0.5% on the average monthly inventory funds availableand a daily interest rate of 0.025%.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, we had an outstanding balance of $9.0 million in secured borrowings.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          IncomeTax Provision         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Sinceour inception, we have been subject to income taxes principally in the United States. Due to the acquisition of Pro Farm and aswe further expand our sales into foreign countries, we have become subject to taxation based on foreign statutory rates and oureffective tax rate could fluctuate accordingly.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Incometaxes are computed using the asset and liability method, under which deferred tax assets and liabilities are determined basedon the difference between the consolidated financial statement and tax bases of assets and liabilities using enacted tax ratesin effect during the year in which the differences are expected to affect taxable income. Valuation allowances are establishedwhen necessary to reduce deferred tax assets to the amount expected to be realized. As of December 31, 2020, based on the availableinformation, it is more likely than not that our deferred tax assets will not be realized, and accordingly we have taken a fullvaluation allowance against all of our U.S. deferred tax assets and certain foreign deferred tax assets.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       As of December 31, 2020, we had net operating loss carryforwards of $104.2 million. The net operating loss carryforwards for federal andstate purposes were reduced as a result of the effect of an ownership change as defined under Internal Revenue Code (“IRC”)Section 382, the change related to the February 5, 2018 previously disclosed financing transactions. The federal and state reductionswere $176.4 million and $119.1 million, respectively. The federal net operating loss generated after 2017 in the amount of $65.1 millionwill not expire. In addition, as of December 31, 2020, we had federal research and development tax credit carryforwards of $0.6 million,which begin to expire in 2038, and state research and development tax credit carryforwards of $3.1 million, which have no expiration date.The federal research and development tax credit carryforwards were also reduced by the Section 382 ownership change of $2.3 million. Itis possible that we will not generate taxable income to use these loss carryforwards in cases where they are subject to expiration orwhere they are able to be carried forward indefinitely.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 44; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           44           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourability to use our federal and state net operating loss carryforwards and federal and state tax credit carryforwards to reducefuture taxable income and future taxes, respectively, may be subject to restrictions attributable to equity transactions thatmay have resulted in a change of ownership as defined by Internal Revenue Code Section 382. In the event we have had such a changein ownership, utilization of these carryforwards could be severely restricted and could result in significant amounts of thesecarryforwards expiring prior to benefitting us.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Resultsof Operations        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table sets forth certain statements of operations data as a percentage of total revenues:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Revenues:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; width: 60%">          Product         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: right">          99         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: right">          98         </td>         <td style="width: 1%; text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; padding-bottom: 1.5pt">          License         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          100         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          100         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Cost of productrevenues           <sup>           </sup>          </font>         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          40         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          45         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Gross profit         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          60         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          55         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Operating Expenses:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Research, development and patent         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          30         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          48         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Selling, general and administrative         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          75         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          102         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Total operating expenses         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          105         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          150         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Loss from operations         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (45         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (95         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Other income (expense):         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Interest expense         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (4         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (5         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Loss on modification of warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (5         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Loss on issuance of new warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (4         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (21         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Loss on change in fair value of contingent consideration in connection with the Pro Farm acquisition         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Other income (expense), net         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Total other expense, net         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (8         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (31         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Loss before income taxes         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (53         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (126         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Income tax expense         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (0         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          -         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Net loss         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (53         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )%         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (126         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )%         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Comparisonof the Years Ended December 31, 2020 and 2019         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ProductRevenues        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="6" style="font-weight: bold; text-align: center">          (Dollars in thousands)         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 52%; text-align: left">          Product revenues         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          37,915         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          28,912         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt">          % of total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          99         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          98         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 45; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           45           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Productrevenues increased by $9.0 million, or 31.1%, in 2020 compared to 2019 due to an increase in overall sales across all of the Company’sproduct offerings, driven most significantly by increased sales of the Regalia, Grandevo, Venerate and UBP ST product families.The revenues from Pro Farm products for the 12 months revenue period for the year ended December 31, 2020 increased by morethan the total product revenue increase year over year when compared to a proportionate three and a half months postacquisition revenue period for the year ended December 31, 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         LicenseRevenues        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 76%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="6" style="font-weight: bold; text-align: center">          (Dollars in thousands)         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 52%; text-align: left">          License revenues         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          459         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          461         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt">          % of total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Licenserevenues related to certain strategic collaboration and distribution agreements remained flat compared to 2019 as expected. Licenserevenues do not comprise a significant portion of our total revenues.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Costof Product Revenues        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 76%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="6" style="font-weight: bold; text-align: center">          (Dollars in thousands)         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 52%; text-align: left">          Cost of product revenues         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          15,505         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          13,260         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt">          % of total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          40.4         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          45.1         </td>         <td style="text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Gross profit         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          22,869         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,113         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt">          % of total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          59.6         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          54.9         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Costof product revenues increased by $2.2 million, or 16.9%, in 2020 compared to 2019. Our gross margins increased to 59.6% in 2020from 54.9% in 2019. Cost of products decreased as a percentage of revenues, and gross margins increased in 2020 compared to 2019,primarily due to a favorable mix of higher margin product offerings including Venerate and UBP ST product families andcontinued improved manufacturing and third-party manufacturing efficiencies. For the year ended December 31, 2020, the gross marginsattributable to the product revenues generated by our subsidiary, Pro Farm, had a positive impact to the Company’s overallgross margins due to the incremental revenues for a full twelve months revenue period compared to a three and half monthrevenue period in the 2019 acquisition year.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Research,Development and Patent Expenses        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 76%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="6" style="font-weight: bold; text-align: center">          (Dollars in thousands)         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 52%; text-align: left">          Research, development and patent         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          11,330         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          14,026         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt">          % of total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          29.5         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          47.8         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Research,development and patent expenses decreased by $2.7 million, or 19.2%, in 2020 compared to 2019 in line with management’srefinement of its key product pipeline plans. The majority of the decrease included approximately $1.0 million relatedto field trials, $0.3 million in patent and registration fees, $0.2 million related to consulting fees, $0.1 million related totoxicology studies and $0.3 million from the depreciation of research and development fixed assets. While the majority of thedecrease was based on management’s strategy, we believe that the global impact of COVID-19, also impacted the timing ofcertain of our third-party expenses that may be incurred in future periods, but are not yet readily quantifiable. Additionally,in connection with COVID-19 and our receipt of PPP funds, for the year ended December 31, 2020, our operating expenses for research,development and patent expenses were reduced by $0.7 million.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 46; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           46           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Selling,General and Administrative Expenses        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 76%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="6" style="font-weight: bold; text-align: center">          (Dollars in thousands)         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 52%; text-align: left">          Selling, general administrative expenses         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          28,734         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          30,072         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt">          % of total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          75         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          102         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Selling,general, and administrative expenses decreased $1.3 million, or 4.4%, in 2020 compared to 2019. The majority of the decrease wasattributable to prior period expenses related to our acquisition and litigation costs of $2.5 million in legal fees, $1.2 millionin consulting and outside services costs and $0.7 million in accounting fees and in connection with COVID-19, a decrease of approximately$0.9 million related to travel and travel related expenses and a reduction of $0.7 million in connection with our receipt of PPPfunds during the year ended December 31, 2020. These decreases were offset by the operating cost of Pro Farm for the full yearended December 31, 2020 compared to the three and half months post acquisition in the prior year, $1.6 million related to theamortization of acquired intangible assets, and $0.4 million in severance, wages, stock-based compensation and compensation bonuses.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         OtherIncome (Expense), Net        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="6" style="font-weight: bold; text-align: center">          (Dollars in thousands)         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; width: 64%; text-align: left">          Interest expense         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          (1,443         </td>         <td style="width: 1%; text-align: left">          )         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          (1,474         </td>         <td style="width: 1%; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Loss on modification of warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (72         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,564         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Loss on issuance of new warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,391         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (6,065         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Change in fair value of contingent consideration         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (445         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (342         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Other (expense) income, net         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          407         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          255         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (2,944         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (9,190         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt">          % of total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -8         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -31         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OtherIncome (expense) decreased significantly for the year ended December 31, 2020 compared to 2019. The decrease included $1.5 millionrelated to our modification of certain warrants and by $4.7 million in relation to the call of approximately 6,000,000 and 16,000,000modified warrants for each of the years ended December 31, 2020 and 2019, respectively. Refer to Note 9 of ourconsolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Seasonality        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inrecent years, we have increasingly had higher sales during the first half of the year than the second half. However, the levelof seasonality in our business may change due to a number of factors, such as our expansion into new geographical territories,the introduction of new products, the timing of introductions of new products, and the impact of weather and climate change. Itis possible that our business may become more seasonal, or experience seasonality in different periods, than anticipated, particularlyif we expand into new geographical territories, add or change distributors or distributor programs or introduce new products withdifferent applicable growing seasons. Notwithstanding any such seasonality, we expect substantial fluctuation in sales year overyear and quarter over quarter as a result of the number of variables on which sales of our products are dependent. Weather conditions,new trade tariffs, natural disasters, outbreaks of infectious diseases and other factors affect planting and growing seasons andincidence of pests and plant disease, may, accordingly affect decisions by our distributors, direct customers and end users aboutthe types and amounts of pest management and plant health products to purchase and the timing of use of such products. In addition,disruptions that cause delays by growers in harvesting or planting can result in the movement of orders to a future quarter, whichwould negatively affect the quarter and cause fluctuations in our operating results. Customers also may purchase large quantitiesof our products in a particular quarter to store and use over long periods of time or time their purchases to manage their inventories,which may cause significant fluctuations in our operating results for a particular quarter or year, and low commodity prices maydiscourage growers from purchasing our products in an effort to reduce their costs and increase their margins for a growing season.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 47; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           47           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Liquidityand Capital Resources        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Sinceour inception, our operations have been financed primarily by net proceeds from public offerings of common stock and private placementsof convertible preferred stock, convertible notes and promissory notes, exercise of warrants, and term loans, as well as proceedsfrom the sale of our products and payments under strategic collaboration and distribution agreements and government grants. Asof December 31, 2020, our cash and cash equivalents totaled $15.8 million, and we had an additional $1.6 million of restrictedcash that we are contractually obligated to maintain in accordance with a debt agreement with Five Star Bank.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMarch 2017, we entered into an invoice purchase agreement with LSQ, pursuant to which LSQ may elect to purchase up to $7.0 millionof eligible customer invoices from us. Our obligations under the LSQ financing are secured by a lien on substantially all of theCompany’s personal property; such lien is first priority with respect to the Company’s accounts receivable, inventory,and related property. In January 2020, we entered into a second amendment to the invoice purchase agreement, the terms of whichincluded among other terms an increase to $20.0 million of eligible customer invoices to be purchased and simultaneously enteredinto an addendum to allow the Company to request that LSQ advance a maximum of $3.0 million of the Company’s finished goodsinventory. As of December 31, 2020, we had an outstanding balance of $9.0 million in secured borrowings.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InFebruary 2018 we completed certain financing transactions which resulted in the issuance of an aggregate of 70.5 million sharesof common stock and warrants to purchase an aggregate of 48.9 million shares of common stock, the deleveraging of our balancesheet by reducing principal payments that were outstanding by $49 million, and the deferral of payment on $7.5 million of remainingoutstanding debt until December 31, 2022.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2019, we entered into a warrant amendment and plan of reorganization agreement, which we refer to as the Warrant Facility,with certain holders of the warrants issued in connection with the February 2018 Financing Transactions (the “February 2018Warrants”). The Warrant Facility extended the warrant expiration date from December 2020 to December 2021, and the warrantholders agreed, at any time the Company’s stock trades above $1.00, upon request by the Company, to exercise up to 36.6million of their respective February 2018 Warrants, in consideration for the delivery of (x) the shares subject to the February2018 Warrants so exercised and (y) the delivery of new warrants (which we refer to as the August 2019 Warrants) to purchase suchadditional number of shares of common stock equal to the amount of shares so exercised and delivered under February 2018 Warrants.During years ended December 31, 2020 and 2019, we called the exercise of 6 million and 16 million of these outstanding warrantsat $1.00 per share.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InApril 2020, the Company entered into a Warrant Exchange Agreement (the “Warrant Exchange Agreement”) with a groupof historical investors (the “Investors”). Pursuant to the Warrant Exchange Agreement, the Investors have exchangedcertain previously issued and outstanding warrants to purchase an aggregate of up to 45,977,809 shares of the Company’scommon stock, for new warrants (the “April 2020 Warrants”) to purchase an aggregate of up to 29,881,855 shares ofCommon Stock (the “Warrant Shares”).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheApril 2020 Warrants all have an exercise price of $0.75 per share, and expire in five tranches. As of December 31, 2020, a totalof 19,133,465 Warrant Shares were exercised prior to the first, second, and third tranche expiration dates of May 1, 2020, September15, 2020, and December 15, 2020. Prior to March 15, 2021 the fourth tranche with respect to 5,862,380 was exercised by the warrantholder for a total of $4.4 million. The next warrant expiration date is December 15, 2021 with respect to 4,885,317 WarrantShares. The total aggregate exercise price of all future New Warrants is approximately $3.7 million. There can be no assurancethat the Investors will exercise the New Warrants prior to December 15, 2021. (Refer to Note 9 of our consolidated financialstatements).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InDecember 2020, we entered into an amendment (the “Warrant Amendment”) to its previously outstanding warrant to purchase5,333,333 shares of our common stock issued to a historical warrant holder on February 5, 2018. Pursuant to the Warrant Amendment,in exchange for the holder’s agreement to exercise the warrant on December 29, 2020 with respect to 1,777,778 shares atthe warrant’s exercise price of $0.96 per share we agreed to partially extend the warrant’s expiration date by allowingthe holder to exercise (i) 1,777,778 of the subject shares at $1.00 per share by March 25, 2021, and (ii) the remaining 1,777,777shares at $1.04 per share by December 15, 2021. Prior to the March 25, 2021 expiration date, 1,777,778 December 2020 warrantshares were exercised. There can be no assurance that the holder will exercise the warrant prior to its respective expirationdates. (Refer to Note 9 of our consolidated financial statements)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 48; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           48           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnFebruary 8, 2021, we a shelf registration statement on Form S-3 with the SEC. The shelf registration statement has notyet been declared effective by the SEC. Under the shelf registration statement, if and upon becoming effective, the Company mayoffer and sell, from time to time over a three-year period, various securities in an amount of up to $90 million.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020 debt outstanding includes $3.4 million and $7.3 million due to related parties, in principal and accruedinterest with a maturity date of December 31, 2022. To the extent that debt is not restructured, extended, converted or otherwiseamended, we will be required to repay these debts along with our general operating expenses in that period.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, we were out of compliance with certain covenant requirements under our June 2014 SecuredPromissory Note. However, the lender, Five Star Bank, has waived its right to deem recurring losses, liquidity,going concern, and financial condition as material adverse changes through May 31, 2022. Thereafter, unless the lenderfurther extends its waiver a material adverse change clause could be triggered and the entire unpaid principal and interestbalances would be due and payable upon demand as well as trigger certain covenants under each of our other debt agreements (refer to Note 8 of the consolidated financial statement).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       Since our inception, we have incurredsignificant net losses, and we expect to incur additional losses related to the continued development and expansion of our business.However, we believe that our existing cash and cash equivalents of $15.8 million as of December 31, 2020, expected revenues,the net proceeds from warrants exercised subsequent to December 31, 2020, and cost management as well as cost reductions willbe sufficient to fund operations as currently planned through one year from the date of the issuance of our accompanyingconsolidated financial statements. Changes in our current plans, or slower than expected adoption of our products may requirethat we secure additional sources through equity and/or debt financings, or through other sources of financing, which we cannotpredict, with certainty, will be based on terms acceptable to us or at all. We may also require additional sources of cash forgeneral corporate purposes, which may include operating expenses, working capital to improve and promote our commercially availableproducts, advance product candidates, expand international presence and commercialization, general capital expenditures and satisfactionof debt obligations which are not currently planned.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Additionalinformation regarding risks related to our capital and liquidity is described in this Annual Report filed on Form 10-K in PartI— Item 1A— “Risk Factors”, and further discussion of our going concern assessment can be found inNote 1 to the accompanying consolidated financial statements, both of which should be read in connection with this disclosure.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehad the following debt arrangements in place as of December 31, 2020, in each case as discussed below (dollars in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          PRINCIPAL         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold; text-align: center">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          STATED ANNUAL         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          BALANCE (INCLUDING         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold; text-align: center">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="border-bottom: Black 1.5pt solid; font-weight: bold">          DESCRIPTION         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          INTEREST RATE         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          ACCRUED INTEREST)         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          PAYMENT/MATURITY         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 28%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Promissory Notes           <sup>            (1)           </sup>          </font>         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 18%; text-align: right">          8.00         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 20%; text-align: right">          3,033         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 24%">          Due December 31, 2022         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Promissory Note           <sup>            (2)           </sup>          </font>         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          5.25         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          8,293         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td>          Monthly/June 2036         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Promissory Notes           <sup>            (3)           </sup>          </font>         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          8.00         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,500         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td>          Due December 31, 2022         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Secured Borrowing           <sup>            (4)           </sup>          </font>         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          12.78         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          9,028         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td>          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Varies           <sup>            (5)           </sup>           /March 2021          </font>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Loan Facility         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1.00         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          283         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">          Proportionately each September 2022, 2023, 2024, 2025         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 49; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           49           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       Refer to Note 8 of ourconsolidated financial statements for each of the following debt arrangements:      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (1)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           “—October    2012 and April 2013 Secured Promissory Notes.”          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (2)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           “—June    2014 Secured Promissory Note.”          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (3)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           “—August    2015 Senior Secured Promissory Notes.”          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (4)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           “—LSQ    Financing.”          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (5)          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Payable    through the lender’s direct collection of certain accounts receivable through March 2021.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourdebt arrangements contain certain representations and warranties by and between us and each of the debtors, certain indemnificationprovisions in favor of the lenders and customary restrictive covenants (including limitations on other debt, liens, acquisitions,investments and dividends), and events of default (including payment defaults, breaches of covenants, a material impairment inthe lender’s security interest or in the collateral, and events relating to bankruptcy or insolvency). Refer to Note8 of our consolidated financial statements. As of December 31, 2020, we were in compliance with these covenantsor have obtained the appropriate waivers for non-compliance with such covenants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table sets forth a summary of our cash flows for the periods indicated:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td>         </td>         <td colspan="6">         </td>         <td>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Net cash used in operating activities         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          (15,959         </td>         <td style="width: 1%; text-align: left">          )         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          (21,339         </td>         <td style="width: 1%; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Net cash used in investing activities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,797         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (6,793         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Net cash provided in financing activities         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          27,345         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          16,163         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Net increase (decrease) in cash, cash equivalents, and restricted cash         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          9,589         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (11,969         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          CashFlows from Operating Activities         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Netcash used in operating activities of $16.0 million during the twelve months ended December 31, 2020 primarily resulted from ournet loss of $20.2 million, which included $3.6 million of depreciation and amortization expense, $3.6 million of share-basedcompensation expense, $0.2 million of non-cash interest expense, $0.4 million of change in the fair value of the contingent considerationin connection with the acquisition of Pro Farm, and $1.5 million on loss on modification and issuance of warrants and $0.8 millionin amortization of right of use assets. In addition, net cash used in operating activities resulted from a decrease of $1.4 millionin accounts payables, $0.8 million decrease related to lease liabilities and $1.5 related to inventory, and a $0.6 million decreasein deferred revenue, off-set by an increase of $4.2 million in accounts receivables due to overall revenue growth, and $0.2 millionin prepaids and $0.2 million increase in accrued liabilities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Netcash used in operating activities of $21.3 million during the twelve months ended December 31, 2019 primarily resulted from ournet loss of $37.2 million, which included $2.3 million of depreciation and amortization expense, $3.7 million of share-based compensationexpense, $0.3 million of non-cash interest expense, $0.3 million of change in the fair value of the contingent consideration inconnection with the acquisition of Pro Farm, and $1.6 million on loss on modification of warrants, $6.1 million loss on exerciseof 16.0 million shares underlying warrants, and $0.8 million in amortization of right of use assets. In addition, net cash usedin operating activities resulted from an increase of $1.2 million in accounts payables, $3.2 million increase in accrued liabilitiesmainly for the contingent considerations payable in the future in connection with the Jet-Ag and Pro Farm acquisitions, $0.6 millionrelated to lease liabilities for the adoption of ASC 842 and $0.6 related to inventory, off-set by an increase of $2.6 millionin accounts receivables due to overall revenue growth, $0.7 million in deferred revenue and $0.3 million in prepaids.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 50; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           50           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          CashFlows from Investing Activities         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Netcash used in investing activities was $1.8 million and $6.8 million during the years ended December 31, 2020 and 2019, respectively.Cash flow from investing activities included $1.2 million related to deferred acquisition payments in connection with the acquisitionof our Jet-Ag product lines with the remainder resulting from purchases of property, plant and equipment to support our operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Netcash used in investing activities during the year ended December 31, 2019 included $5.8 million, net related to the acquisitionof Pro Farm, and $0.6 million related to the acquisition of product lines Jet-Ag and Jet-Oxide with the remainder resulting frompurchases of property, plant and equipment to support our operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          CashFlows from Financing Activities         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Netcash provided in financing activities of $27.3 million during the twelve months ended December 31, 2020 consisted primarily of$22.1 million in proceeds from the exercise of warrants, $40.3 million in proceeds from the issuance of debt, $0.2 million inproceeds from employee stock purchases, and $0.1 million in proceeds from exercises of options, offset by reductions and repaymentof debt of $35.3 million.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Netcash provided in financing activities of $16.2 million during the twelve months ended December 31, 2019 consisted primarily of$16.0 million in proceeds from the exercise of warrants and $29.5 million in proceeds from the issuance of debt, offset by reductionsand repayment of debt of $29.5 million.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Off-BalanceSheet Arrangements         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave not been involved in any material off-balance sheet arrangements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          RecentlyIssued Accounting Pronouncements         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       Refer to Note 2 of our consolidatedfinancial statements.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CriticalAccounting Policies and Estimates        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourconsolidated financial statements and the related notes included elsewhere in this Annual Report on Form 10-K are prepared inaccordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptionsthat affect the reported amounts of assets, liabilities, net revenue, costs and expenses, and any related disclosures. We baseour estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances.Changes in accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differsignificantly from the estimates made by our management. We evaluate our estimates and assumptions on an ongoing basis. To theextent that there are material differences between these estimates and our actual results, our future financial statement presentation,financial condition, results of operations and cash flows will be affected. Refer to Note 2 of our consolidated financialstatements for additional information regarding our significant accounting policies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Inventories         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inventoriesare stated at the lower of cost or market value (net realizable value or replacement cost) and include the cost of material andexternal and internal labor and manufacturing costs. Cost is determined on the first-in, first-out basis. We provide for inventoryreserves when conditions indicate that the selling price may be less than cost due to physical deterioration, obsolescence, changesin price levels or other factors. Additionally, we provide reserves for excess and slow-moving inventory on hand that is not expectedto be sold to reduce the carrying amount of excess and slow-moving inventory to its estimated net realizable value. The reservesare based upon estimates about future demand from our customers and distributors and market conditions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 51; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           51           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Goodwill         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Goodwillrepresents the excess of purchase price over the underlying net assets of businesses acquired. Goodwill is reviewed for impairmenton an annual basis as of the first day of the fourth quarter or our fiscal year, or more frequently if events or changes in circumstancesindicate that the carrying amount of goodwill may be impaired. We assess goodwill in accordance with Accounting Standards Codification350,        <i>         Intangibles – Goodwill and other        </i>        (“ASC 330”), by first assessing through a qualitative analysiswhether events and circumstances lead to the conclusion that a quantitative analysis is required.        <font style="background-color: white">         Forthe quantitative test, the review for impairment of goodwill is based on a combination of income-based and market-based approaches.        </font>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Underthe income-based approach, we determine fair value using a discounted cash flow approach that requires significant judgment withrespect to revenue and profitability growth rates, based upon annual budgets and longer-range strategic plans, and the selectionof an appropriate discount rates. Under the market-based approach, we determine fair value by comparing reporting units to similarbusinesses or guideline companies whose securities are actively traded in public markets.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Fairvalue estimates employed in our annual impairment review of goodwill were determined using models involving several assumptions.Changes in assumptions could materially impact fair value estimates. Assumptions critical to our fair value estimates were: (i)discount rates; (ii) projected future revenues and profitability used in the reporting unit; and (iii) projected long-term growthrates used in the derivation of terminal year values. These and other assumptions are impacted by economic conditions and expectationsof management and may change in the future based on period-specific facts and circumstances. While we believe the assumptionsused to estimate future cash flows are reasonable, there can be no assurance that the expected future cash flows will be realized.As a result, impairment charges that possibly would have been recognized in earlier periods may not be recognized until laterperiods if actual results deviate unfavorably from earlier estimates. The use of different assumptions would increase or decreasediscounted cash flows or earnings projections and, therefore, could change impairment determinations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          FairValue of Financial Instruments         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Fairvalue is defined as an exit price that would be received from the sale of an asset or paid to transfer a liability in an orderlytransaction between market participants on the measurement date. A three-tier fair value hierarchy has been established, whichprioritizes the inputs used in measuring fair value as follows: Level 1, observable inputs such as quoted prices in active markets;Level 2, inputs other than the quoted prices in active markets that are observable either directly or indirectly; and Level 3,unobservable inputs in which there is little or no market data, which requires that we develop our own assumptions. This hierarchyrequires the use of observable data, when available, and minimizes the use of unobservable inputs when determining fair value.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          RevenueRecognition         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        UnderASC 606, we recognize revenue for product sales at a point in time following the transfer of control of such products to the customers,which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. We may enter into contractsin which the standalone selling prices (“SSP”) is different from the amount we are entitled to bill the customer.Product revenues consist of revenues generated from sales of our products to distributors and direct customers, net of rebatesand cash discounts.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Werecognize license revenues pursuant to strategic collaboration and distribution agreements under which we receive payments forthe achievement of certain testing validation, regulatory progress and commercialization events. As these activities and paymentsare associated with exclusive rights that we provide in connection with strategic collaboration and distribution agreements overthe term of the agreements, revenues related to the payments received are deferred and recognized over the term of the exclusivedistribution period of the respective agreement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 52; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           52           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Share-BasedCompensation         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Werecognize share-based compensation expense for all stock options and restricted stock units granted to employees and directorsbased on estimated fair values.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weestimate the fair value of restricted stock units based on the closing bid price of our common stock on the date of grant.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weestimate the fair value of stock options on the date of grant using an option-pricing model. The value of the portion of the stockoptions that is ultimately expected to vest is recognized as expense on a straight-line basis over the requisite service period.Forfeitures are estimated on the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ fromthose estimates.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weuse the Black-Scholes-Merton (“BSM”) option-pricing model to calculate the estimated fair value of stock options onthe measurement date (generally, the date of grant). From time to time we also use the Monte Carlo option-pricing model to calculatethe fair value of stock options on the measurement date for such options whereby the BSM option pricing model is deemed not appropriatebased on the terms of the option award terms. The required inputs in each option-pricing model include the expected life of thestock options, estimated volatility factor, risk-free interest rate and expected dividend yield. These inputs are subjective andgenerally require significant judgment.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        If,in the future, we determine that other methods for calculating these assumptions are more reasonable, or if other methods areprescribed by authoritative guidance, the fair value calculated for our stock options could change significantly. Higher volatilityfactors and longer expected lives result in an increase to the share-based compensation expense determined at the date of grant.Share-based compensation expense is recorded in research, development and patent expense and selling, general and administrativeexpense.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheBSM option-pricing model was developed for use in estimating the fair value of traded options that have no vesting restrictionsand are fully transferable, characteristics not present in our stock options. Existing valuation models, including the BSM option-pricingmodel, may not provide reliable measures of the fair values of our stock options. Consequently, there is a risk that our estimatesof the fair values of the stock options on the grant dates may bear little resemblance to the actual values realized upon exercise.Stock options may expire or otherwise result in zero intrinsic value as compared to the fair values originally estimated on thegrant date and reported in the consolidated financial statements. Alternatively, value may be realized from these instrumentsthat is significantly higher than the fair values originally estimated on the grant date and reported in the consolidated financialstatements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Warrants         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thewarrants granted in connection with the April 2020 Warrant Exchange Agreement and the December 2020 Warrant Amendment were accountedfor in equity. For both transactions, the Company estimated the fair value of the warrants issued using the BSM option pricingmodel with similar assumptions and those used for recognition of stock based compensation.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          IncomeTaxes         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weuse the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for theestimated future tax consequences attributable to the differences between the consolidated financial statement carrying amountsof existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enactedtax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered orsettled. To the extent that deferred tax assets cannot be recognized under the preceding criteria, we establish valuation allowances,as necessary, to reduce deferred tax assets to the amounts expected to be realized.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 53; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           53           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <a name="b_01">       </a>       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ITEM8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Page           </b>          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_01">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Report of Independent Registered Public Accounting Firm           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           55          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_02">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidated Balance Sheets as of December 31, 2020 and 2019           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           58          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_03">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidated Statements of Operations for the years ended December 31, 2020 and 2019           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           59          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_04">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2020 and 2019           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           60          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_05">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           61          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_06">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Notes to Consolidated Financial Statements           </font>          </a>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           62          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 54; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           54           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <a name="c_01">        </a>        REPORTOF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Tothe Shareholders and Board of Directors of       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         MarroneBio Innovations, Inc.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Opinionon the Financial Statements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave audited the accompanying consolidated balance sheets of Marrone Bio Innovations, Inc. (the “Company”) as of December31, 2020 and 2019, the related consolidated statements of operations, stockholders’ equity and cash flows for each of thetwo years in the period ended December 31, 2020, and the related notes (collectively referred to as the “financial statements”).In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as ofDecember 31, 2020 and 2019, and the results of its operations and its cash flows for each of the two years in the period endedDecember 31, 2020, in conformity with accounting principles generally accepted in the United States of America.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         Basisfor Opinion        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thesefinancial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion onthe Company’s financial statements based on our audits. We are a public accounting firm registered with the Public CompanyAccounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Companyin accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commissionand the PCAOB.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Weconducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the auditto obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to erroror fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financialreporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but notfor the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.Accordingly, we express no such opinion.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ouraudits included performing procedures to assess the risks of material misstatement of the financial statements, whether due toerror or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidenceregarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principlesused and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.We believe that our audits provide a reasonable basis for our opinion.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         CriticalAudit Matters        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thecritical audit matters communicated below are matters arising from the current period audit of the financial statements that werecommunicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are materialto the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication ofcritical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, bycommunicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts ordisclosures to which they relate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 55; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           55           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         1.Valuation of Goodwill        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Descriptionof the Matter        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asdiscussed in Note 2 to the consolidated financial statements, the Company tests goodwill for impairment annually (or under certaincircumstances, more frequently) at the reporting unit level using either a qualitative or quantitative approach. Under the quantitativeapproach to test for goodwill impairment, the Company compares the fair value of a reporting unit to its carrying amount, includinggoodwill. Generally, the Company estimates the fair value of its reporting unit using a combination of a discounted cash flowsanalysis and market-based valuation methodologies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Auditingthe Company’s quantitative goodwill impairment tests involved subjective auditor judgment due to the significant estimationrequired in management’s determination of the fair value of the reporting unit. The significant estimation was primarilydue to the sensitivity of the underlying assumptions including changes in the weighted average cost of capital, projected revenuegrowth rates and EBITDA margins. These assumptions relate to the expected future operating performance of the Company’sreporting unit, are forward-looking, and are sensitive to and affected by economic, industry and company-specific qualitativefactors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         HowWe Addressed the Matter in Our Audit        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Totest the estimated fair value of the Company’s reporting unit, we performed audit procedures that included, among others,assessing the valuation methodologies used by the Company, involving our valuation specialists to assist in testing the significantassumptions discussed above, and testing the completeness and accuracy of the underlying data the Company used in its valuationanalyses. For example, we compared the significant assumptions used by management to current industry, market and economic trends,the historical results of the reporting unit, and other relevant factors. We also assessed the historical accuracy of management’sestimates and performed sensitivity analyses of significant assumptions used in the annual impairment test to evaluate the changein the fair value of the reporting unit resulting from changes in the significant assumptions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         2.Fair Value of Contingent Consideration        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Descriptionof the Matter        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asdiscussed in note 2 to the consolidated financial statements, the Company’s acquisition-related purchase price contingentconsideration liability, which is estimated using Monte Carlo simulation of a geometric Brownian motion model based upon the Company’sestimated results of the Pro Farm subsidiary for the periods specified in the share purchase agreement of 2021 to 2023 and isremeasured to its estimated fair value at each reporting period, with changes in fair value recorded in the consolidated statementsof operations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Auditingthe valuation of the acquisition-related contingent consideration liability was complex and highly judgmental due to the significantestimation required in determining the fair value. In particular, the fair value estimate was sensitive to significant assumptionssuch as the Company’s estimated results of the Pro Farm subsidiary for the periods specified in the share purchase agreementof 2021 to 2023, future industry, market or economic conditions, and are forward-looking and inherently uncertain.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         HowWe Addressed the Matter in Our Audit        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Toevaluate the estimated fair value of the contingent consideration liability, we performed audit procedures that included, amongothers, assessing the terms of the arrangement, evaluating the methodology used, and testing the significant assumptions discussedabove used by the Company in its analysis. We involved our valuation specialists to assist in the evaluation of the significantassumptions and methodology used by the Company. We also compared the significant assumptions to current industry, market andeconomic trends.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 56; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           56           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         3.Going Concern Analysis        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Descriptionof the matter        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s going concern analysis contains, among other items, the Company’s ability to meet future obligations twelvemonths from the date that the consolidated financial statements were issued based upon management’s cash flow projections.The principal assumptions used in management’s cash flow projections consisted of forecasts related to revenue growth, grossprofit margins and operating expenses.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Auditingthe evaluation of management’s going concern analysis was highly judgmental due to the significant estimation required inmanagement’s cash flow projections. In particular, the significant judgment by management when evaluating the uncertaintyrelated to the Company’s forecasts and a high degree of auditor judgment in evaluating management’s forecasts forat least the next twelve months from the date that the consolidated financial statements were issued.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         HowWe Addressed the Matter in Our Audit        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Toevaluate the going concern analysis, we performed audit procedures that included, among others, testing the completeness and accuracyof the underlying data the Company used in its valuation analyses. For example, we compared the significant assumptions used bymanagement to current industry, market and economic trends, the historical results of the Company, and other relevant factors.We also assessed the historical accuracy of management’s estimates and performed sensitivity analyses of significant assumptionsused in the going concern analysis.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            /s/    Marcum            <font style="font-variant: small-caps">             llp            </font>           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 50%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Marcum           <font style="font-variant: small-caps">            llp           </font>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           We    have served as the Company’s auditor since 2018          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           San    Francisco, CA          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           March    23, 2021          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 57; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           57           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         MARRONEBIO INNOVATIONS, INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="c_02">         </a>         ConsolidatedBalance Sheets        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        (InThousands, Except Par Value)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font-weight: bold">          Assets         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Current assets:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; width: 64%; text-align: left">          Cash and cash equivalents         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          15,841         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          6,252         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Accounts receivable         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          10,113         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          5,925         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt">          Inventories         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,618         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          8,149         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Prepaid expenses and other current assets         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,688         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,390         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 0pt; text-align: left">          Total current assets         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          34,260         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          21,716         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Property, plant and equipment, net         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          12,565         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          13,260         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Right of use assets, net         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,760         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4,567         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Intangible assets, net         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          21,383         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          23,842         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt">          Goodwill         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,740         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,764         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Restricted cash         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,560         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,560         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Other assets         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          929         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,008         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Total assets         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          81,197         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          72,717         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-weight: bold; text-align: left">          Liabilities and stockholders’ equity         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Current liabilities:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Accounts payable         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          1,895         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          3,379         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Accrued liabilities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          11,650         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          12,467         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Deferred revenue, current portion         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          374         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          427         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Lease liability, current portion         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,008         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          913         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Debt, current portion, net         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          9,301         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          3,899         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Total current liabilities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          24,228         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          21,085         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Deferred revenue, less current portion         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,628         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,986         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Lease liability, less current portion         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,050         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,970         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Debt, less current portion, net         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          11,479         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          11,847         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Debt due to related parties         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          7,300         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          7,300         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Other liabilities         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2,102         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2,971         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 0pt; text-align: left; padding-bottom: 1.5pt">          Total liabilities         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          49,787         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          49,159         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Commitments and contingencies         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Stockholders’ equity:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Preferred stock: $0.00001 par value; 20,000 shares authorized and no shares    issued or outstanding at December 31, 2020 and December 31, 2019         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt">          Common stock: $0.00001 par value; 250,000 shares authorized, 167,478 and 139,526 shares issued    and outstanding as of December 31, 2020 and December 31, 2019, respectively         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Additional paid in capital         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          372,226         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          344,206         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Accumulated deficit         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (340,817         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (320,649         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Total stockholders’ equity         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          31,410         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          23,558         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Total liabilities and stockholders’ equity         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          81,197         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          72,717         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seeaccompanying notes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 58; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           58           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         MARRONEBIO INNOVATIONS, INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="c_03">         </a>         ConsolidatedStatements of Operations        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        (InThousands, Except Per Share Data)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Revenues:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; width: 64%">          Product         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          37,915         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          28,912         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; padding-bottom: 1.5pt">          License         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          459         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          461         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Total revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          38,374         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          29,373         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Cost of product revenues         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          15,505         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          13,260         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Gross profit         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          22,869         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          16,113         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 0pt; text-align: left">          Operating Expenses:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Research, development and patent         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          11,330         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          14,026         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Selling, general and administrative         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          28,734         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          30,072         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Total operating expenses         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          40,064         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          44,098         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Loss from operations         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (17,195         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (27,985         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Other income (expense):         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Interest expense         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,443         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,474         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Loss on modification of warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (72         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,564         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Loss on issuance of new warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,391         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (6,065         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Change in fair value of contingent consideration         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (445         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (342         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Other income, net         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          407         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          255         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Total other expense, net         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (2,944         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (9,190         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Net loss before income taxes         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (20,139         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (37,175         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Income tax expense         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (29         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Net Loss         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (20,168         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (37,175         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Basic and diluted net loss per common share:         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (0.14         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (0.32         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Weighted-average shares outstanding used in computing basic and diluted    net loss per common share:         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          148,892         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          117,982         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seeaccompanying notes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 59; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           59           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         MARRONEBIO INNOVATIONS, INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="c_04">         </a>         ConsolidatedStatements Stockholders’ Equity        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        (InThousands)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          TOTAL         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          COMMON STOCK         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          ADDITIONAL         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          ACCUMULATED         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           STOCKHOLDERS’          </p>          <p style="margin-top: 0; margin-bottom: 0">          </p>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          SHARES         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          AMOUNT         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          PAID    IN CAPITAL         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          DEFICIT         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          EQUITY         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 35%">          Balance at January 1, 2019         </td>         <td style="width: 1%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 10%; text-align: right">          110,691         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 1%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 10%; text-align: right">          1         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 1%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 10%; text-align: right">          296,409         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 1%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 10%; text-align: right">          (283,474         </td>         <td style="width: 1%; text-align: left">          )         </td>         <td style="width: 1%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 10%; text-align: right">          12,936         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Net loss         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (37,175         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (37,175         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Net settlement of options         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          47         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          55         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          55         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Share-based compensation         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,686         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,686         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Employee stock purchase plan         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          115         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          128         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          128         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Settlement of restricted stock units         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          7         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Modification of existing warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,564         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,564         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Issuance of common stock in connection with call to exercise warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,000         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,000         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,000         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Issuance of new warrants in connection with call to exercise warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,065         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,065         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Issuance of common stock in connection with Pro Farm acquisition.         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          12,666         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          —         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          20,299         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          —         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          20,299         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Balance at December 31, 2019         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          139,526         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          344,206         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (320,649         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          23,558         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Net loss         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (20,168         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (20,168         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Net settlement of options         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          100         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          108         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          108         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Share-based compensation         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,595         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,595         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Employee stock purchase plan         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          268         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          254         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          254         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Settlement of restricted stock units         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          657         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Issuance of restricted stock units in lieu satisfaction of bonus payment         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          632         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          632         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Financing costs         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (104         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (104         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Exercise of warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          26,927         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          22,072         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          22,072         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Modification of existing warrants         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          —         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          —         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,463         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          —         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,463         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Balance at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          167,478         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          372,226         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (340,817         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          31,410         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seeaccompanying notes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 60; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           60           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         MARRONEBIO INNOVATIONS, INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="c_05">         </a>         ConsolidatedStatements of Cash Flows        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        (InThousands)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt; text-align: center">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Cash flows from operating activities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="width: 64%; text-align: left">          Net loss         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          (20,168         </td>         <td style="width: 1%; text-align: left">          )         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          (37,175         </td>         <td style="width: 1%; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Adjustments to reconcile net loss to net cash used in operating activities:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Depreciation and amortization         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,558         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,349         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Gain on disposal of equipment         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (9         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (21         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Right of use assets amortization         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          807         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          805         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Share-based compensation         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,595         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,686         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Non-cash interest expense         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          226         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          277         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Loss on modification of warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          72         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,564         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Loss on issuance of new warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,391         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,065         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Change in fair value of contingent consideration         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          445         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          342         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Net changes in operating assets and liabilities:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 20pt; text-align: left">          Accounts receivable         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (4,188         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (2,622         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 20pt">          Inventories         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,531         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          599         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 20pt; text-align: left">          Prepaid Expenses and other assets         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (219         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (327         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 20pt; text-align: left">          Accounts payable         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,409         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,204         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 20pt; text-align: left">          Accrued and other liabilities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (148         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,223         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 20pt; text-align: left">          Lease Liability         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (825         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (627         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; padding-left: 20pt; text-align: left">          Deferred revenue         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (618         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (681         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt; padding-left: 0pt; text-align: left">          Net cash used in operating activities         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (15,959         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (21,339         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 0pt; text-align: left">          Cash flows from investing activities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Payment of consideration in connection with previous asset purchase         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,240         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (669         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Business combination, net of cash acquired         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (5,849         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Purchases of property, plant and equipment         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (559         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (296         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">          Proceeds from sale of equipment         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          21         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt; text-align: left">          Net cash used in investing activities         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (1,797         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (6,793         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Cash flows from financing activities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Proceeds from issuance of debt         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          202         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          141         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Proceeds from secured borrowings         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          40,127         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          29,376         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Repayment in secured borrowings         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (34,790         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (27,822         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt">          Repayment of debt         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (524         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1,715         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Equity offering costs         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (104         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt">          Exercise of stock options         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          108         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          55         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Proceeds from employee stock purchase plan         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          254         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          128         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Net settlement of options         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt; padding-left: 10pt">          Exercise of warrants         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          22,072         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          16,000         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; text-align: left">          Net cash provided by financing activities         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          27,345         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          16,163         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Net (decrease) increase in cash and cash equivalents and restricted cash         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          9,589         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (11,969         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt; text-align: left">          Cash and cash equivalents and restricted cash, beginning of period         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          7,812         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          19,781         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt; text-align: left">          Cash and cash equivalents and restricted cash, end of period         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          17,401         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          7,812         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Supplemental disclosure of cash flow information         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt; text-align: left">          Cash paid for interest         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1,166         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1,175         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Supplemental disclosure of non-cash investing and financing activities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt; text-align: left">          Property, plant and equipment included in accounts payable and accrued    liabilities         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          44         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          —         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt; text-align: left">          Fair Value of non-cash consideration issued in acquisition transactions         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          —         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          23,917         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt; text-align: left">          Conversion of accrued liabilities into equity associated with the granting    of restricted stock units         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          632         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          —         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seeaccompanying notes.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 61; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           61           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         MARRONEBIO INNOVATIONS, INC.        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="c_06">         </a>         Notesto Consolidated Financial Statements        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        December31, 2020       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         1.Summary of Business, Basis of Presentation        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        MarroneBio Innovations, Inc. (the “Company”), formerly Marrone Organic Innovations, Inc., was incorporated under the lawsof the State of Delaware on June 15, 2006, and is located in Davis, California. In July 2012, the Company formed a wholly-ownedsubsidiary, Marrone Michigan Manufacturing LLC (“MMM LLC”), which holds the assets of a manufacturing plant the Companypurchased in July 2012. In September 2019, the Company closed its acquisition of Pro Farm Technologies OY, a Finnish limited company,which consisted of Pro Farm Technologies OY and its five subsidiaries Pro Farm International Oy (Finland), Pro Farm OU (Estonia),Pro Farm Technologies Comercio de Insumos Agricolas do Brasil ltda. (Brazil – 99% controlling interest), Pro FarmInc. (Delaware), and Glinatur SA (Uruguay) (collectively “Pro Farm”). As a result of the acquisition, Pro Farm becamea wholly-owned subsidiary of the Company. On December 31, 2019, Pro Farm Russia, LLC was formed as a subsidiary under Pro FarmTechnologies OY. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.All significant intercompany balances and transactions have been eliminated in consolidation.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theaccompanying consolidated financial statements and notes thereto have been prepared in accordance with the rules and regulationsof the Securities and Exchange Commission (“SEC”) for Form 10-K and include all of the information and disclosuresrequired by accounting principles generally accepted in the United States of America (“GAAP”) for financial reporting.Certain amounts in the prior periods’ financial statements and related footnote disclosures have been reclassified to conformto the current presentation with no impact on previously reported net income or stockholders’ equity.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany makes biological crop protection, plant health and nutrition products. The Company targets the major markets that useconventional chemical products, including certain agricultural markets where its biological products are used as alternativesfor, or mixed with, conventional chemical products. The Company also targets new markets for which (i) there are no availableconventional chemical products or (ii) the use of conventional chemical products may not be desirable or permissible either becauseof health and environmental concerns (including for organically certified crops) or because the development of pest resistancehas reduced the efficacy of conventional chemical products. The Company delivers EPA-approved and registered biological crop protectionproducts and other biological products that address the global demand for effective, safe and environmentally responsible products.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Liquidity         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany funds operations primarily with the proceeds from the sale of its products, promissory notes and term loans, netproceeds from the private placements of convertible notes, as well as with the proceeds from other equity instruments. TheCompany will need to generate significant revenue growth to achieve and maintain profitability. As of December 31, 2020, theCompany had a working capital surplus of $10,032,000, including cash and cash equivalents of $15,841,000. In addition, as ofDecember 31, 2020, the Company had debt and debt due to related parties of $20,780,000 and $7,300,000, respectively, forwhich the underlying debt agreements contain various financial and non-financial covenants, as well as certain materialadverse change clauses. As of December 31, 2020, the Company had a total of $1,560,000 of restricted cash relating to thesedebt agreements. (Refer to Notes 8 of these  consolidated financial statements)       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 62; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           62           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InApril 2020, the Company entered into a Warrant Exchange Agreement (the “Warrant Exchange Agreement”) with a groupof historical investors (the “Investors”). Pursuant to the Warrant Exchange Agreement, the Investors have exchangedcertain previously issued and outstanding warrants to purchase an aggregate of up to 45,977,809 shares of the Company’scommon stock, for new warrants (the “April 2020 Warrants”) to purchase an aggregate of up to 29,881,855 shares ofCommon Stock (the “Warrant Shares”). All of the New Warrants were issued to the Investors upon execution of the WarrantExchange Agreement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheApril 2020 Warrants all have an exercise price of $0.75 per share, and expire in five tranches. As of December 31, 2020, a totalof 19,133,464 Warrant Shares were exercised prior to the first, second, and third tranche expiration dates of May 1, 2020,September 15, 2020, and December 15, 2020. Subsequently on March 15, 2021, 5,862,380 Warrant Shares were exercised leaving onlythe fifth tranche with an expiration date of December 15, 2021 with respect to 4,885,317 warrant shares remaining. There can beno assurance that the Investors will exercise the remaining April 2020 Warrants prior to their respective expiration date. (Referto Note 9 of these  consolidated financial statements).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InDecember 2020, the Company also entered into an amendment (the “Warrant Amendment”) to a previously outstanding warrantto purchase 5,333,333 shares of the Company’s common stock issued to a historical warrant holder (the “Holder”)on February 5, 2018. Pursuant to the Warrant Amendment, in exchange for the Holder’s exercise of the warrant on December29, 2020, with respect to 1,777,778 shares at the warrant’s exercise price of $0.96 per share the warrant’s expirationdate was partially extended and allows the Holder to exercise warrants to purchase (i) 1,777,778 shares at $1.00 per share byMarch 25, 2021, and (ii) 1,777,777 shares at $1.04 share by December 15, 2021. Subsequently on March 19, 2021, 1,777,778 December2020 warrant shares were exercised. (Refer to Note 9 of these  consolidated financial statements).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany could breach covenants contained within the debt agreements or if the material adverse change clauses are triggered, theentire unpaid principal and interest balances would be due and payable upon demand. Without entering into a continuation of itscurrent waiver, which expires May 31, 2022, entering into strategic agreements that include significant cash payments upfront,significantly increasing revenues from sales or raising additional capital through the issuance of equity, the Company expectsit will exceed its maximum debt-to-worth requirement under the June 2014 Secured Promissory Note with Five Star Bank. Further,a violation of a covenant in one debt agreement will cause the Company to be in violation of certain covenants under each of itsother debt agreements. Breach of covenants included in the Company’s debt agreements, which could result in the lendersdemanding payment of the unpaid principal and interest balances, will have a material adverse effect upon the Company and wouldlikely require the Company to seek to renegotiate these debt arrangements with the lenders. If such negotiations are unsuccessful,the Company may be required to seek protection from creditors through bankruptcy proceedings. The Company’s inability tomaintain compliance with its debt covenants could have a negative impact on the Company’s financial condition and abilityto continue as a going concern.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s historical operating results, including prior periods of significant losses and negative use of operatingcash flows which may indicate probable substantial doubt exists related to the Company’s ability to continue as agoing concern for the next 12 months from the date of issuance of these consolidated financial statements. The Companybelieves that its existing cash and cash equivalents at December 31, 2020, together with expected revenues, cost managementand warrant exercises which have occurred subsequent to December 31, 2020, will be sufficient to fund operations as currentlyplanned through one year from the date of the issuance of these consolidated financial statements and therefore has alleviateddoubts related to the Company’s ability to continue as a going concern.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 63; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           63           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         2.Significant Accounting Policies        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Useof Estimates         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thepreparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptionsthat affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the dateof the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actualresults could differ from those estimates.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany believes that the assumptions and estimates associated with the Company’s forecast used in its going concern, goodwilland contingent consideration assessments, revenue recognition, including assumptions and estimates used in determining the timingand amount of revenue to recognize for those transactions with variable considerations, warrants and share-based compensation,and inventory valuation, have the greatest potential impact on the consolidated financial statements. Therefore, the Company considersthese estimates to be its significant estimates.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Concentrationsof Credit Risk         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Financialinstruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents,accounts receivable and debt. The Company deposits its cash and cash equivalents with high credit quality domestic financial institutionswith locations in the U.S and globally. Such deposits may exceed federal deposit insurance or foreign deposit guarantee fundslimits. The Company believes the financial risks associated with these financial instruments are minimal.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s customer base is dispersed across many different geographic areas, and currently most customers are pest managementdistributors in the U.S. Generally, receivables are due up to 120 days from the invoice date and are considered past due afterthis date, although the Company may offer extended terms from time to time.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe years ended December 31, 2020 and 2019, 24% and 12%, respectively, of the Company’s revenues were generated frominternational customers. The Company’s international customers were concentrated in the European Union.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s principal sources of revenues were its Regalia, Grandevo, Venerate and UPB ST product lines for the yearsended December 31, 2020 and 2019, accounting for 85% and 91%, respectively, of the Company’s total revenues.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Customersto which 10% or more of the Company’s total revenues are attributable for any one of the periods presented consist of thefollowing:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          CUSTOMER         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; border-bottom: Black 1.5pt solid">          DECEMBER 31,         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          A         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          B         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          C         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          D         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 44%; text-align: left">          2020         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 10%; text-align: right">          22         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 10%; text-align: right">          13         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 10%; text-align: right">          13         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 10%; text-align: right">          8         </td>         <td style="width: 1%; text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          2019         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          30         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          9         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          0         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          10         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Customersto which 10% or more of the Company’s outstanding accounts receivable are attributable as of either December 31, 2020 or2019, consist of the following:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          CUSTOMER         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; border-bottom: Black 1.5pt solid">          DECEMBER 31,         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          A         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          B         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          2020         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          49         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          14         </td>         <td style="width: 1%; text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          2019         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          44         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          9         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 64; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           64           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Concentrationsof Supplier Dependence         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theactive ingredient in the Company’s Regalia product line is derived from the giant knotweed plant, which the Company obtainsfrom China. The Company currently relies on one supplier for this plant. Such single supplier acquires raw knotweed from numerousregional sources and performs an extraction process on this plant, creating a dried extract that is shipped to the Company’smanufacturing plant. While the Company does not have a long-term supply contract with this supplier, the Company does have a long-termbusiness relationship with this supplier. The Company endeavors to keep 10-12 months of knotweed extract on hand at anygiven time, but an unexpected disruption in supply could have an effect on Regalia supply and revenues. Although the Company hasidentified additional sources of raw knotweed, there can be no assurance that the Company will continue to be able to obtain driedextract from China at a competitive price.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany continues to rely on third parties to formulate Grandevo into spray-dried powders, for all of its production of Venerate,Majestene/Zelto, Stargus and Haven, and from time to time, third-party manufacturers for supplemental production capacity to meetexcess seasonal demand and for packaging. The Company’s products have been produced in quantities, and on timelines, sufficientto meet commercial demand and for the Company to satisfy its delivery schedules. However, the Company’s dependence uponothers for the production of a portion of its products, or for a portion of the manufacturing process, particularly for dryingand for all of its production of Venerate, may adversely affect its ability to satisfy demand and meet delivery obligations, aswell as to develop and commercialize new products, on a timely and competitive basis. The Company has not entered into any long-termmanufacturing or supply agreements for any of its products, and it may need to enter into additional agreements for the commercialdevelopment, manufacturing and sale of its products. There can be no assurance that it can do so on favorable terms, if at all.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ProFarm products are currently partially sourced by suppliers from one manufacturing plant in Russia, in which the Company owns a12% interest. The Company plans for enough inventory on hand to fill its revenue forecasts for 12 months at any given time, butan unexpected disruption in supply could have an adverse effect on the supply and revenues related to the subsidiary. Althoughthe Company has identified additional manufacturers who are capable suppling the products, there can be no assurance that theCompany will continue to be able to obtain products at a competitive price.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Cashand Cash Equivalents         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany considers all highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents.Cash and cash equivalents consist of cash on deposit, money market funds and certificates of deposit accounts with U.S. and globalfinancial institutions. The Company is exposed to credit risk in the event of default by financial institutions to the extentthat cash and cash equivalents balances with financial institutions are in excess of amounts that are insured including for amountsheld at U.S. by the Federal Deposit Insurance Corporation and in Finland by the Deposit Guarantee Fund. The Company has not experiencedany losses on these deposits. The following table provides a reconciliation of cash, cash equivalents and restricted cash to amountsshown in the statement of cash flows (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">          DECEMBER 31,         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">          DECEMBER 31,         </td>         <td style="text-align: center; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="text-align: center">         </td>         <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2020         </td>         <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Cash and cash equivalents         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          15,841         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          6,252         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Restricted cash, less current portion         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,560         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,560         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Total cash, cash equivalents and restricted cash         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          17,401         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          7,812         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          RestrictedCash         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s restricted cash consists of cash that the Company is contractually obligated to maintain in accordance with theterms of its June 2014 Secured Promissory Note. Refer to Note 8 of the consolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 65; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           65           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          AccountsReceivable         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thecarrying value of the Company’s receivables represents their estimated net realizable values. The Company generally doesnot require collateral and estimates any required allowance for doubtful accounts based on historical collection trends, the ageof outstanding receivables and existing economic conditions. If events or changes in circumstances indicate that specific receivablebalances may be impaired, further consideration is given to the collectability of those balances and the allowance is recordedaccordingly. Past-due receivable balances are written-off when the Company’s internal collection efforts have been unsuccessfulin collecting the amount due. During the years ended December 31, 2020 and 2019, no receivables balances were written off. Asof December 31, 2020 and 2019, the Company had no allowance for doubtful accounts.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Inventories         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inventoriesare stated at the lower of cost or market value (net realizable value or replacement cost) and include the cost of material andexternal and internal labor and manufacturing costs. Cost is determined on the first-in, first-out basis. The Company providesfor inventory reserves when conditions indicate that the selling price may be less than cost due to physical deterioration, obsolescence,changes in price levels or other factors. Additionally, the Company provides reserves for excess and slow-moving inventory onhand that is not expected to be sold to reduce the carrying amount of excess and slow-moving inventory to its estimated net realizablevalue. The reserves are based upon estimates about future demand from the Company’s customers and distributors and marketconditions.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inventories,net consist of the following (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="text-align: center; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">          2020         </td>         <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Raw materials         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          2,487         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          1,610         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Work in progress         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          987         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          783         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Finished goods         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          3,144         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          5,756         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          6,618         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          8,149         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe year ended December 31, 2020, the Company recorded, as a component of cost of product revenues, adjustments to inventory reservesof $387,000 due to quantities on hand that may not be used or sold prior to expiration, and an adjustment of $1,770,000 as a resultof actual utilization of the Company’s manufacturing plant being less than what is considered normal capacity.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe year ended December 31, 2019, the Company recorded, as a component of cost of product revenues, adjustments to inventory reservesof $248,000 due to quantities on hand that may not be used or sold prior to expiration, and an adjustment of $969,000 as a resultof actual utilization of the Company’s manufacturing plant being less than what is considered normal capacity.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Property,Plant and Equipment         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Property,plant and equipment are recorded at cost and are depreciated using the straight-line method over their estimated useful lives.The Company generally uses the following estimated useful lives for each asset category:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom; background-color: White">         <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: left">          ASSET CATEGORY         </td>         <td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center">          ESTIMATED USEFUL LIFE         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Building         </td>         <td>         </td>         <td style="text-align: right">          30 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Computer equipment         </td>         <td>         </td>         <td style="text-align: right">          2-3 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Machinery and equipment         </td>         <td>         </td>         <td style="text-align: right">          3-20 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Office equipment         </td>         <td>         </td>         <td style="text-align: right">          3-5 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Furniture         </td>         <td>         </td>         <td style="text-align: right">          3-5 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Leasehold improvements         </td>         <td>         </td>         <td style="text-align: right">          Shorter of lease term or useful life         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Software         </td>         <td>         </td>         <td style="text-align: right">          3 years         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Maintenance,repairs and minor renewals are expensed as incurred. Expenditures that substantially increase an asset’s useful life arecapitalized. The Company did not recognize any amounts related to impairment for the years ended December 31, 2020 and 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 66; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           66           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          IntangibleAssets         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Intangibleassets are acquired individually or as part of a group at fair value. Intangible assets with definitive lives are amortized overthe useful life of the intangible asset, which is the period over which the asset is expected to contribute directly or indirectlyto the entity’s future cash flows.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom; background-color: White">         <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: left">          ASSET CATEGORY         </td>         <td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center">          ESTIMATED USEFUL LIFE         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Customer Relationship         </td>         <td>         </td>         <td style="text-align: right">          15 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Developed Technology         </td>         <td>         </td>         <td style="text-align: right">          10 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Tradenames         </td>         <td>         </td>         <td style="text-align: right">          10-15 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Non-compete         </td>         <td>         </td>         <td style="text-align: right">          6 years         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          In Process Research and Development         </td>         <td>         </td>         <td style="text-align: right">          11 years         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany evaluates intangible assets for impairment at least annually and more often whenever events or changes in circumstancesindicate that the carrying value may not be recoverable. Whenever any such impairment exists, an impairment loss will be recognizedfor the amount by which the carrying value exceeds the fair value. The Company’s intangible assets include customer relationships,patents, trademarks, and in process research and development. The Company has not recorded impairment to intangible assets forthe years ended December 31, 2020 and 2019.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Impairmentof Long-Lived Assets         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Impairmentlosses related to long-lived assets are recognized in the event the net carrying value of such assets is not recoverable and exceedsfair value. The Company evaluates the recoverability of its long-lived assets whenever events or changes in circumstances indicatethat the carrying value of an asset may not be recoverable. The carrying amount of a long-lived asset (asset group) is not recoverableif it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (assetgroup). If the carrying amount of a long-lived asset (asset group) is considered not recoverable, the impairment loss is measuredas the amount by which the carrying value of the asset or asset group exceeds its estimated fair value.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Goodwill         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Goodwillrepresents the excess of purchase price over the underlying net assets of businesses acquired. Goodwill is reviewed for impairmenton an annual basis as of the first day of the Company’s fiscal fourth quarter or more frequently if events or changes incircumstances indicate that the carrying amount of goodwill may be impaired. The Company assesses goodwill in accordance withAccounting Standards Codification 350,        <i>         Intangibles – Goodwill and other        </i>        (“ASC 350”) by first assessing througha qualitative analysis whether events and circumstances lead to the conclusion that a quantitative analysis is required. For thequantitative test, the review for impairment of goodwill is based on a combination of income-based and market-based approaches.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Underthe income-based approach, the Company determines fair value using a discounted cash flow approach that requires significant judgmentwith respect to revenue and profitability growth rates, based upon annual budgets and longer-range strategic plans, and the selectionof an appropriate discount rates. Under the market-based approach, the Company determines fair value by comparing reporting unitsto similar businesses or guideline companies whose securities are actively traded in public markets.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Fairvalue estimates employed in our annual impairment review of goodwill were determined using models involving several assumptions.Changes in assumptions could materially impact fair value estimates. Assumptions critical to the Company’s fair value estimateswere: (i) discount rates; (ii) projected future revenues and profitability used in the reporting unit; and (iii) projected long-termgrowth rates used in the derivation of terminal year values. These and other assumptions are impacted by economic conditions andexpectations of management and may change in the future based on period specific facts and circumstances. While the Company believesthe assumptions used to estimate future cash flows are reasonable, there can be no assurance that the expected future cash flowswill be realized. As a result, impairment charges that possibly would have been recognized in earlier periods may not be recognizeduntil later periods if actual results deviate unfavorably from earlier estimates. The use of different assumptions would increaseor decrease discounted cash flows or earnings projections and, therefore, could change impairment determinations.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 67; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           67           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Forthe year ended December 31, 2020, the Company completed qualitative assessment and although there were no indications of a potentialimpairment also completed a quantitative assessment. Based on the results of the assessment, the fair values of the Company’sgoodwill exceeded the respective carrying value and therefore the Company has not recorded impairment to goodwill as of December31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          FairValue         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        AccountingStandards Codification 820,        <i>         Fair Value Measurements        </i>        (“ASC 820”), clarifies that fair value is an exit price, representingthe amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.As such, fair value is a market-based measurement that should be determined based on assumptions that market participants woulduse in pricing an asset or liability.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        ASC820 requires that the valuation techniques used to measure fair value must maximize the use of observable inputs and minimizethe use of unobservable inputs. ASC 820 establishes a three-tier value hierarchy, which prioritizes inputs that may be used tomeasure fair value as follows:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Level    1—Quoted prices in active markets for identical assets or liabilities.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Level    2—Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for    identical or similar assets or liabilities in inactive markets or other inputs that are observable or can be corroborated    by observable market data for substantially the full term of the assets or liabilities.          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Level    3—Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market    participants would use in pricing the asset or liability.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thechange in fair value for the reporting period was driven by the result of the unobservable fair value model, a Monte Carlo simulationin a risk-neutral framework assuming Geometric Browning Motion. The most significant input to the model was the estimated resultsof the Pro Farm subsidiary for the periods specified in the share purchase agreement of 2021 – 2023. The following representsother inputs used in determining the fair value of the contingent consideration liability:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Discount rate         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          15.5         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          15.2         </td>         <td style="width: 1%; text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Volatility         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          45.8         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          33.6         </td>         <td style="text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Credit spread         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          9.0         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          10.8         </td>         <td style="text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Risk-free rate         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          0.19         </td>         <td style="text-align: left">          %         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1.66         </td>         <td style="text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         DiscountRate        </i>        . Discount rate is based on an adjusted weighted cost of capital contribution considering an estimated operational leverageratio and a risk-free rate, each determined by publicly traded peer group median except the risk-free rate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EstimatedVolatility Factor        </i>        . Volatility factor is based on the adjusted weighted cost of capital, operating asset volatility, operatingleverage ratio and risk-free interest rate, each determined by publicly traded peer group median except the risk-free rate.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         CreditSpread        </i>        . Credit spread cased on the Company’s financial ratio in comparison with those of publicly traded peer group.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         InterestRate        </i>        . Interest rate based on US Constant Maturity Treasury rates for the same period as the period of performance of 2021to 2023.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 68; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           68           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thechange in the fair value estimate is recognized in the Company’s consolidated statement of operations in Other Income (expense)under caption Change in fair value of contingent consideration. The contingent consideration will be determined at each reportingperiod and will be settled with the issuance of the Company’s common shares.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          DeferredRevenue         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        UnderASC 606, when the Company receives consideration, or such consideration is unconditionally due, from a customer prior to transferringcontrol of goods or services to the customer under the terms of a sales contract, the Company records deferred revenue, whichrepresents a contract liability. The Company recognizes deferred revenue as net sales after the Company has transferred controlof the goods or services to the customer and all revenue recognition criteria are met. The Company’s deferred revenue isbroken out as follows:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Product revenues         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          189         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          299         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Financing costs         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          581         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          609         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          License revenues         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,232         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,505         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Total deferred revenues         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,002         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,413         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Less current portion         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (374         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (427         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          Long term portion         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1,628         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1,986         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          RevenueRecognition         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        UnderASC 606, the Company recognizes revenue for product sales at a point in time following the transfer of control of such productsto the customers, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. The Companymay enter into contracts in which the standalone selling prices (“SSP”) are different from the amount the Companyis entitled to bill the customer. Product revenues consist of revenues generated from sales of the Company’s products todistributors and direct customers, net of rebates and cash discounts.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ProductSales.        </i>        The Company recognizes revenue for product sales at a point in time following the transfer of control of such productsto the customers, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. The Companymay enter into contracts in which the standalone selling prices (“SSP”) is different from the amount the Company isentitled to bill the customer. As of December 31, 2020 and 2019, the Company had deferred product revenue in the amount of $189,000and $299,000, respectively, associated primarily with billings in excess of SSP.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         LicensesRevenues.        </i>        The Company recognizes license revenues pursuant to strategic collaboration and distribution agreements under whichthe Company receives payments for the achievement of certain testing validation, regulatory progress and commercialization events.As these activities and payments are associated with exclusive rights that the Company provides in connection with strategic collaborationand distribution agreements over the term of the agreements, revenues related to the payments received are deferred and recognizedover the term of the exclusive distribution period of the respective agreement. Through December 31, 2020, the Company has receivedan aggregate of $4,100,000 in payments under these strategic collaboration and distribution agreements of which no amounts wasrecognized as of December 31, 2020 and 2019. In addition to the amounts already received, an additional $800,000 in payments underthese agreements could potentially receive if certain testing validation, regulatory progress and commercialization events occur.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         FinancingComponent Revenues.        </i>        The Company recognizes a financing component, if material, when the Company receives consideration fromthe customer, and when the Company expects control of the product or service to be transferred to the customer in a period ofgreater than one year from the date of receipt of the consideration. As such, the financing component is determined to be long-termand therefore recorded in the consolidated balance sheet as part of deferred revenues. For each year ended December 31, 2020 and2019 the Company recognized $32,000 and $252,000, respectively of financing revenues.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 69; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           69           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Revenuerecognition requires the Company to make a number of estimates that include variable consideration. For example, customers mayreceive sales or volume-based pricing incentives or receive incentives for providing the Company with marketing-related information.The Company makes estimates surrounding variable consideration and the net impact to revenues. In making such estimates, significantjudgment is required to evaluate assumptions related to the amount of net contract revenues, including the impact of any performanceincentives and the likelihood that customers will achieve them. In the event estimates related to variable consideration change,the cumulative effect of these changes is recognized as if the revised estimates had been used since revenue was initially recognizedunder the contract. Such revisions could occur in any reporting period, and the effects may be material.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Fromtime to time, the Company offers certain product rebates to its distributors and growers, which are estimated and recorded asreductions to product revenues, and an accrued liability is recorded at the later of when the revenues are recorded, or the rebateis being offered.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ContractAssets.        </i>        The Company does not have contract assets since revenue is recognized as control of goods are transferred or as servicesare performed or such contract assets are incurred or expensed within one year of the recognition of the revenue.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ContractLiabilities.        </i>        The contract liabilities consist of deferred revenue. The Company classifies deferred revenue as current or noncurrentbased on the timing of when the Company expects to recognize revenue. Generally, all contract liabilities, excluding deferredrevenue, are expected to be recognized within one year and are included in accounts payable in the Company’s consolidatedbalance sheet.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Research,Development and Patent Expenses         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Researchand development expenses include payroll-related expenses, field trial costs, toxicology costs, regulatory costs, consulting costsand lab costs. Patent expenses include legal costs relating to the patents and patent filing costs. These costs are expensed tooperations as incurred. During the years ended December 31, 2020 and 2019, research and development expenses totaled $10,316,000and $12,924,000, respectively, and patent expenses totaled $1,014,000 and $1,102,000, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Shippingand Handling Costs         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Amountsbilled for shipping and handling are included as a component of product revenues. Related costs for shipping and handling havebeen included as a component of cost of product revenues. Shipping and handling costs for the year ended December 31, 2020 and2019 were $1,473,000 and $1,180,000, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Advertising         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany expenses advertising costs as incurred and has included these expenses as a component of Selling, General and Administrativecosts. Advertising costs for the years ended December 31, 2020 and 2019 were $631,000 and $708,000, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Share-BasedCompensation         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany recognizes share-based compensation expense for all stock options and restricted stock units granted to employees anddirectors based on estimated fair values.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany estimates the fair value of restricted stock units based on the closing bid price of the Company’s common stockon the date of grant.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany estimates the fair value of stock options on the date of grant using an option-pricing model. The value of the portionof the stock options that is ultimately expected to vest is recognized as expense on a straight-line basis over the requisiteservice period. Forfeitures are estimated on the date of grant and revised, if necessary, in subsequent periods if actual forfeituresdiffer from those estimates.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 70; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           70           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany uses the Black-Scholes-Merton option-pricing model to calculate the estimated fair value of stock options on the measurementdate (generally, the date of grant). The required inputs in the option-pricing model include the expected life of the stock options,estimated volatility factor, risk-free interest rate and expected dividend yield. These inputs are subjective and generally requiresignificant judgment. During the years ended December 31, 2020 and 2019, the Company calculated the fair value of stock optionsgranted based on the following assumptions:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-weight: bold; text-align: center">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          <font style="font: 10pt Times New Roman, Times, Serif">           <b>            DECEMBER 31,           </b>          </font>         </td>         <td style="font-weight: bold; text-align: center">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          <font style="font: 10pt Times New Roman, Times, Serif">           <b>            DECEMBER 31,           </b>          </font>         </td>         <td style="font-weight: bold; text-align: center">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">         </td>         <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">         </td>         <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          Expected life (years)         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: center">         </td>         <td style="width: 16%; text-align: center">          2.14-6.08         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           5.33-6.08          </font>         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Estimated volatility factor         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           57.9%-59.9%          </font>         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           51%-54%          </font>         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Risk-free interest rate         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           0.28%-0.96%          </font>         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           1.41%-2.44%          </font>         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Expected dividend yield         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td style="text-align: center">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          —         </td>         <td style="text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>        </i>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ExpectedLife        </i>        . Expected life represents the period that share-based payment awards are expected to be outstanding. The Company usesthe “simplified method” in accordance with Staff Accounting Bulletin (“SAB”) No. 107,        <i>         Share-Based Payment        </i>        (“SAB No. 107”), and SAB No. 110,        <i>         Simplified Method for Plain Vanilla Share Options        </i>        (“SAB No. 110”), tocalculate the expected term of stock options determined to be “plain vanilla.” Under this approach, the expected termis presumed to be the midpoint between the vesting date and the contractual end of the stock option grant. For stock options grantedwith an exercise price not equal to the determined fair value, the Company estimates the expected life based on historical dataand management’s expectations about exercises and post-vesting termination behavior. The Company will use the simplifiedmethod until it has sufficient historical data necessary to provide a reasonable estimate of expected life in accordance withSAB No. 107 and SAB No. 110.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EstimatedVolatility Factor        </i>        . For the year ended December 31, 2020, estimated volatility factor is based on the Company’s tradinghistory adjusted for certain periods of the Company’s trading history, not indicative of normal trading. For the year endedDecember 31, 2019, the Company’s common stock had limited trading history, the Company calculated the estimated volatilityfactor based on both the volatility of its common stock adjusted for certain periods of the Company’s trading history, notindicative of normal trading and the volatility of the common stock of comparable agricultural biotechnology companies, givingthe volatility of its common stock additional weight.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Risk-FreeInterest Rate        </i>        . The Company calculates the risk-free interest rate based on the implied yield currently available on U.S. Treasuryconstant-maturity securities with the same or substantially equivalent remaining term as the expected life of the stock options.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ExpectedDividend Yield        </i>        . The Company has not declared dividends, nor does it expect to in the foreseeable future. Therefore, a zerovalue was assumed for the expected dividend yield.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EstimatedForfeitures        </i>        . The Company considers voluntary and involuntary termination behavior and actual stock option forfeitures whenestimating forfeitures. If, in the future, the Company determines that other methods for calculating these assumptions are morereasonable, or if other methods are prescribed by authoritative guidance, the fair value calculated for the Company’s stockoptions could change significantly. Higher volatility factors and longer expected lives result in an increase to the share-basedcompensation expense determined at the date of grant. Share-based compensation expense is recorded in the Company’s research,development and patent expense and selling, general and administrative expense.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Warrants         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany has a number of outstanding warrants. From time to time the terms of the warrants may be exchanged, amended or otherwisemodified. Historically, the Company’s warrants have been deemed stand alone equity instruments and as such changes to theoriginal terms of the warranted have been accounted for a modification under Accounting Standards Codification (“ASC”)718,        <i>         Compensation – Stock Based Compensation        </i>        .       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 71; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           71           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theissuances of August 2019 Warrants resulted in the Company incurring a non-cash charge of $1,391,000 in connection with the fairvalue of new warrants issued in place of the called warrants. The Company’s fair value of the new warrants issued was estimatedutilizing a Black Scholes option pricing model. The following table outlines assumptions utilized for the warrant issuance:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             WARRANTS             <br/>             EXERCISED/ISSUED             <br/>             DURING THE TWELVE             <br/>             MONTHS ENDED             <br/>             DECEMBER 31,            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2020            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Contractual life (years)         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.01-3.04          </font>         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="width: 80%; text-align: left">          Estimated volatility factor         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: right">          53         </td>         <td style="width: 1%; text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Risk-free interest rate         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           1.58-1.66%          </font>         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Expected dividend yield         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ContractualLife.        </i>        Contractual life represents the period that the warrants are expected to be outstanding. The Company estimates the contractualperiod, the period between the date of the modification and the expiration date of the warrant, which is an appropriate estimateof the expected term.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EstimatedVolatility Factor.        </i>        Estimated volatility factor is based on the Company’s trading history, which is adjusted for certainperiods of the Company’s trading history that are not indicative of normal trading.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Risk-FreeInterest Rate.        </i>        The Company calculates the risk-free interest rate based on the implied yield currently available on U.S. Treasuryconstant-maturity securities with the same or substantially equivalent remaining term as the expected life of the stock options.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ExpectedDividend Yield.        </i>        The Company has not declared dividends, nor does it expect to in the foreseeable future. Therefore, a zerovalue was assumed for the expected dividend yield.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnApril 29, 2020, the Company then entered into a warrant exchange agreement (“Warrant Exchange Agreement”) with certainholders of warrants under the August 2015 Senior Secured Promissory Notes, the Securities Purchase Agreement and the Warrant ReorganizationAgreement. Pursuant to the Warrant Exchange Agreement, the Company agreed to exchange an aggregate of 45,977,809 warrants (“August2015 Warrants”, “February 2018 Warrants 1 &amp; 2”, and all “August 2019 Warrants” collectively,“the exchanged warrants”) for 29,881,855 warrants (“April 2020 Warrants”), refer to Note 9 of the consolidatedfinancial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefair value of the April 2020 Warrants was not greater than the fair values of the exchanged warrants immediately prior to themodification date and therefore had no impact on the Company’s year ended results. The fair value of each exchanged warrantsimmediately prior to the modification were estimated utilizing either a Black Scholes Merton or Monte Carlo option pricing model.The fair value of each April 2020 Warrants immediately after the modification were estimated utilizing a Black Scholes Mertonoption pricing model. The following table outlines the range of assumptions utilized in the option pricing models:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: center; padding-bottom: 1.5pt">         </td>         <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">         </td>         <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            EXCHANGED            <br/>            WARRANTS           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">         </td>         <td style="text-align: center; padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: center">         </td>         <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             APRIL 2020            </b>           </font>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             WARRANTS            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt; text-align: center">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Contractual life (years)         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           0.68-3.31          </font>         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           0.38-1.63          </font>         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Estimated volatility factor         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           43-52%          </font>         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           38-46%          </font>         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Risk-free interest rate         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           0.14-0.26%          </font>         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           0.10-0.19          </font>          %         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Expected dividend yield         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          —         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          —         </td>         <td style="text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ContractualLife.        </i>        Contractual life represents the period that the warrants are expected to be outstanding. The Company estimates the contractualperiod, the period between the date of the modification and the expiration date of the warrant, which is an appropriate estimateof the expected term.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 72; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           72           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EstimatedVolatility Factor.        </i>        Estimated volatility factor is based on the Company’s trading history adjusted for certain periodsof the Company’s trading history, not indicative of normal trading.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Risk-FreeInterest Rate.        </i>        The Company calculates the risk-free interest rate based on the implied yield currently available on U.S. Treasuryconstant-maturity securities with the same or substantially equivalent remaining term as the expected life of the stock options.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ExpectedDividend Yield.        </i>        The Company has not declared dividends, nor does it expect to in the foreseeable future. Therefore, a zerovalue was assumed for the expected dividend yield.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InDecember 2020, the Company also entered into an amendment (the “Warrant Amendment”) to a previously outstanding warrantto purchase 5,333,333 shares of the Company’s common stock issued to a historical warrant holder (the “Holder”)on February 5, 2018. Pursuant to the Warrant Amendment, in exchange for the Holder’s exercise of the warrant on December29, 2020, with respect to 1,777,778 shares at the warrant’s exercise price of $0.96 per share the warrant’s expirationdate was partially extended and allows the Holder to exercise warrants to purchase (i) 1,777,778 shares at $1.00 per share byMarch 25, 2021, and (ii) 1,777,777 shares at $1.04 share by December 15, 2021 (Refer to Note 9 of the consolidated financialstatements).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefair value of the February 2018 Warrants was greater than the fair values of the exchanged warrants immediately prior to the modificationdate and therefore the Company recognized $72,000 of additional expense in connection with the modification for the year endedresults. The fair value of each exchanged warrants immediately before and after the modification were estimated utilizing theBlack Scholes Merton option pricing model. The following table outlines the range of assumptions utilized in the option pricingmodels:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold; text-align: left">         </td>         <td style="white-space: nowrap; font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            DECEMBER 2020           </b>          </font>         </td>         <td style="font-weight: bold; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">         </td>         <td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            WARRANTS           </b>          </font>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%; text-align: left">          Contractual life (years)         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           0.24-0.96          </font>         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Estimated volatility factor         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           15-58%          </font>         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Risk-free interest rate         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           0.10%-0.11%          </font>         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Expected dividend yield         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: center">          —         </td>         <td style="text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ContractualLife.        </i>        Contractual life represents the period that the warrants are expected to be outstanding. The Company estimates the contractualperiod, the period between the date of the modification and the expiration date of the warrant, which is an appropriate estimateof the expected term.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EstimatedVolatility Factor.        </i>        Estimated volatility factor is based on the Company’s trading history adjusted for certain periodsof the Company’s trading history, not indicative of normal trading.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Risk-FreeInterest Rate.        </i>        The Company calculates the risk-free interest rate based on the implied yield currently available on U.S. Treasuryconstant-maturity securities with the same or substantially equivalent remaining term as the expected life of the stock options.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ExpectedDividend Yield.        </i>        The Company has not declared dividends, nor does it expect to in the foreseeable future. Therefore, a zerovalue was assumed for the expected dividend yield.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          IncomeTaxes         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany uses the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognizedfor the estimated future tax consequences attributable to the differences between the consolidated financial statement carryingamounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured usingenacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recoveredor settled. To the extent that deferred tax assets cannot be recognized under the preceding criteria, the Company establishesvaluation allowances, as necessary, to reduce deferred tax assets to the amounts expected to be realized.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 73; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           73           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020 and 2019, all deferred tax assets, except the deferred tax asset generated during the year relatedto foreign entities, were fully offset by a valuation allowance. The realization of deferred tax assets is dependent upon futurefederal, state and foreign taxable income. The Company’s judgments regarding deferred tax assets may change due to futuremarket conditions, as the Company expands into international jurisdictions, due to changes in U.S. or international tax laws andother factors.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thesechanges, if any, may require material adjustments to the Company’s deferred tax assets, resulting in a reduction in netincome or an increase in net loss in the period in which such determinations are made. The Company recognizes liabilities foruncertain tax positions based upon a two-step process. To the extent that a tax position does not meet a more-likely-than-notlevel of certainty, no benefit is recognized in the consolidated financial statements. If a tax position meets the more-likely-than-notlevel of certainty, it is recognized in the consolidated financial statements at the largest amount that has a greater than 50%likelihood of being realized upon ultimate settlement. The Company’s policy is to analyze the Company’s tax positionstaken with respect to all applicable income tax issues for all open tax years in each respective jurisdiction. As of December31, 2020, the Company concluded that there were no additional uncertain tax positions required to be recognized in its consolidatedfinancial statements. In connection with the Company’s acquisition of Pro Farm, the Company acquired approximately $22,000in uncertain tax position.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany recognizes interest and penalties related to income tax matters in income tax expense. No amounts were recognized forinterest and penalties during the years ended December 31, 2020 and 2019. In connection with the Company’sacquisition of Pro Farm, amounts of interest and penalties were not significant or material.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ForeignCurrency         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefunctional currency of the Company’s subsidiary Pro Farm is the U.S. dollar. Assets and liabilities have been convertedto the U.S. dollar reporting currency using the exchange rates in effect on the consolidated balance sheet dates. Equity accountsare converted at historical rates, except for the change in retained earnings during the year which is the result of the incomestatement conversion process. Revenue and expense accounts are converted using the weighted average exchange rate during the period.The cumulative conversion adjustments associated with the net assets of foreign subsidiaries and the Company’s normal operationsare recorded in “Other income (expense)” in the consolidated statement of operations in the amounts of $0.3 millionand $0.1 million for the periods ended December 31, 2020 and 2019, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ComprehensiveLoss         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Comprehensiveloss represents the net loss for the period adjusted for the results of certain changes to stockholders’ equity that arenot reflected in the consolidated statements of operations, if applicable. From time to time the Company is impacted by foreigncurrency translation in the consolidation of the Company’s subsidiaries.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          SegmentInformation         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany is organized as a single operating segment, whereby its chief operating decision maker assesses the performance of andallocates resources to the business as a whole.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          RecentlyAdopted Accounting Pronouncements         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InJanuary 2017, the FASB issued ASU No. 2017-04, “Intangibles – Goodwill and Other (Topic 350), (“ASU No. 2017-04”),which requires the annual goodwill impairment test compare the fair value of the reporting unit with its carrying value. On January1, 2020, the Company adopted the ASU on a prospective basis and completed the quantitative assessment component of its annualgoodwill impairment test based on the fair value and the carrying value of the goodwill. The adoption of this standard did nothave a material impact on the consolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 74; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           74           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820), (“ASU No. 2018-13”), which modifiesthe disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement. The provisions of ASU No. 2018-13are effective for annual reporting periods beginning after December 15, 2019 and interim reporting periods within those annualperiods, with early adoption permitted. Amendments on changes in unrealized gains and losses, the range and weighted average ofsignificant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurementsuncertainty should be applied prospectively for only the most recent interim or annual periods presented in the initial year ofadoption with all other amendments applied retroactively to all periods presented upon their effective date. The Company has completedthe assessment of the ASU on a prospective basis as of January 1, 2020 and determined no material impact of the standard on theconsolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2018, the FASB issued ASU No. 2018-15, “Intangibles – Goodwill and Other-Internal-Use Software (Subtopic 350-40),(“ASU No. 2018-15”), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangementthat is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-usesoftware. The provisions of ASU No. 2018-15 are effective for annual reporting periods beginning after December 15, 2019 and interimreporting periods within those annual periods, with early adoption permitted. The Company has completed the assessment of theASU on a prospective basis as of January 1, 2020 in which it determined no material impact of the standard on the consolidatedfinancial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InNovember 2018, the FASB issued ASU No. 2018-18, “Collaborative Arrangements (Topic 808): Clarifying the Interactions betweenTopic 808 and Topic 606” (“ASU No. 2018-18”), which clarifies certain transactions between collaborative arrangementparticipants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer inthe context of a unit of account including aligning Topic 808 with the guidance in Topic 606. The provisions of ASU No. 2018-18are effective for annual reporting periods beginning after December 15, 2019 and interim reporting periods within those annualperiods, with early adoption permitted, including adoption in any interim period for public business entities for periods forwhich consolidated financial statements have not yet be issued. This ASU shall be applied retrospectively to the date of initialapplication of Topic 606. The Company has completed the assessment of the ASU on a prospective basis as of January 1, 2020, anddetermined that there was no material impact of the standard on the consolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          RecentlyIssued Accounting Pronouncements         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InJune 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurementof Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 introduces a new forward-looking approach,based on expected losses, to estimate credit losses on certain types of financial instruments, including trade receivables. Theestimate of expected credit losses will require entities to incorporate considerations of historical information, current informationand reasonable and supportable forecasts. ASU 2016-13 also expands the disclosure requirements to enable users of consolidatedfinancial statements to understand the entity’s assumptions, models and methods for estimating expected credit losses. Forpublic business entities that meet the definition of a Securities and Exchange Commission (“SEC”) filer, ASU 2016-13is effective for annual and interim reporting periods beginning after December 15, 2019, and the guidance is to be applied usingthe modified-retrospective approach. Earlier adoption is permitted for annual and interim reporting periods beginning after December15, 2018. In November 2018, the FASB issued ASU No. 2018-19, “Codification Improvements to Topic 326, Financial Instruments– Credit Losses,” (“ASU No. 2018-19”), in April 2019, the FASB issued Accounting Standards Update No.2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging,and Topic 825, Financial Instruments (“ASU 2019-04”), in May 2019, the FASB issued Accounting Standards Update No.2019-05, Financial Instruments—Credit Losses (Topic 326) (“ASU 2019-05”), in November 2019, the FASB issuedAccounting Standards Update No. 2019-10, Financial Instruments—Credit Losses, (Topic 326), Derivatives and Hedging (Topic815), and Leases (Topic 842): Effective Date (“ASU 2019-10”) and Accounting Standards Update No. 2019-11, FinancialInstruments—Credit Losses (“ASU 2019-11”), and in February 2020, the FASB issued Accounting Standards UpdateNo. 2020-02, Financial Instruments—Credit Losses, (Topic 326) and Leases (Topic 842) (“ASU 2020-02”). ASU 2020-02,delayed the effective date for certain entities including entities meeting the SEC’s definition of a Smaller Reporting Company.The Company is currently evaluating ASU 2016-13 and all related ASUs to determine the impact to its consolidated financialstatements and related disclosures and anticipates delaying the adoption of ASU 2016-13.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InDecember 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Tax”(“ASU No. 2019-12”), which removed certain exceptions and updated certain provisions related to the accounting for incometax. The provisions of ASU No. 2019-12 are effective for annual reporting periods beginning after December 15, 2020, and interimreporting periods within those annual periods, with early adoption permitted, including adoption in any interim period for publicbusiness entities for periods for which consolidated financial statements have not yet been issued or made available for issuance.This ASU shall be applied on a retrospectively or modified retrospective basis. The Company has not yet determined the impactof implementing this new standard on the consolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 75; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           75           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2020, the FASB issued ASU No. 2020-06, “Debt-Debt with Conversion and Other Options (Sub Topic 470-20) and Derivativesand Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contractsin an Entity’s Own Equity” (“ASU No. 2020-06”), which removed certain separation models for convertible instrumentsincluding no longer separating an embedded conversion features from the host contract that are not required to be accounted foras derivatives or do not result in substantial premiums accounted for as paid-in capital and a convertible debt instrument willbe accounted for as a single liability measured at its amortized cost and a convertible preferred stock will be accounted foras a single equity instrument measured at its historical cost, as long as no other features required bifurcation and recognitionas derivatives and included disclosure amendments for convertible instruments. The provisions of the ASU also amended Subtopic815-40 by removing certain conditions from the previous settlement guidance, required instruments classified as an asset or liabilitybe measured subsequently with changes reported in earnings and clarified the FASB’s view on penalty payments, disclosurerequirements and reassessment on both freestanding and embedded features. Lastly, the provisions of the ASU also included amendmentsto the calculation of earnings per share. The provisions of ASU No. 2020-06 are effective for fiscal years beginning after December15, 2021 including interim reporting periods within those fiscal years, with early adoption permitted, but no earlier than fiscalyears beginning after December 15, 2020 excluding entities eligible to be smaller reporting companies as defined by the SEC andfor all other entities for fiscal years beginning after December 15, 2023. This ASU shall be applied on a modified retrospectiveor full retrospective method of transition. The Company has not yet determined the impact of implementing this new standard onthe consolidated financial statements.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         3.Right of Use Assets and Lease Liabilities        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InSeptember 2013 and then amended in April 2014, the Company entered into a lease agreement for approximately 27,300 square feetof office and laboratory space located in Davis, California. The initial term of the lease was for a period of 60 months and commencedin August 2014. In November 2018, the Company exercised the first lease extension option, extending the lease term for an additional60 months. The monthly base rent is $44,000 per month for the first 12 months with a 3% increase each year thereafter. Concurrentwith the April 2014 lease agreement, the Company entered into a lease agreement with an affiliate of the landlord to lease approximately17,400 square feet of office and laboratory space in the same building complex in Davis, California. The initial term of the leasewas for a period of 60 months and commenced in August 2014. The monthly base rent is $28,000 with a 3% increase each year thereafter.In November 2018, the Company exercised the first lease extension option, extending the lease term for an additional 60 months.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       On January 19, 2016, the Company enteredinto an agreement with a sublessee to sublease approximately 3,800 square feet of vacant office space located in Davis, Californiapursuant to the terms of its lease agreement. The initial term of the sublease is for a period of approximately 43 months andcommenced on February 1, 2016. The monthly base rent is approximately $5,000 per month for the first 12 months with a 5% increaseeach year thereafter. The lease was not renewed and was on a month to month arrangement through November 2019.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJanuary 1, 2019, the Company adopted ASU No. 2016-02, “Leases (Topic 842)” (ASU 2016-02) using the modified retrospectivetransition method allowing it to apply the new standard at the adoption date and to recognize a cumulative-effect adjustment tothe opening balance of retained earnings on the date of adoption. Under this transition method, the prior comparative period continuesto be reported under the accounting standards in effect for that period.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany elected to use the package of practical expedients permitted which allows (i) an entity not to reassess whether any expiredor existing contracts are or contain leases; (ii) an entity need not reassess the lease classification for any expired or existingleases; and (iii) an entity need not reassess any initial direct costs for any existing leases. The Company made an accountingpolicy election to adopt the short-term lease exception which allows the Company to not recognize on the balance sheet those leaseswith terms of 12 months or less resulting in short-term lease payments being recognized in the consolidated statementsof income on a straight-line basis over the lease term. All of the Company’s leases were previously classified as operatingand are similarly classified as operating lease under the new standard.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 76; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           76           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Adoptionof the new standard resulted in recognition of both right-of-use assets and lease liabilities of approximately $5,324,000 and$5,510,000 as of January 1, 2019, respectively, inclusive of any deferred rent as of December 31, 2018. As the right-of-use assetsand lease liabilities were substantially the same at adoption, the Company did not record a cumulative effect adjustment to theopening balance of retained earnings.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s operating leases have remaining terms ranging from less than one year to five years. The leases are for officespace and various office equipment. The Company determines if an arrangement includes a lease at the inception of the agreementand the right-of-use asset and lease liability is determined at the lease commencement date and is based on the present valueof estimated lease payments. The Company’s lease agreements contain both fixed and variable lease payments, none of whichare based on a rate or an index. Fixed lease payments are included in the determination of the right-of-use asset and lease liability.Variable lease payments that are not based on a rate or index are expensed when incurred. The present value of estimated leasepayments is determined utilizing the rate implicit in the lease agreement if that rate can be determined. If the implicit ratecannot be determined, the present value of estimated lease payments is determined utilizing the Company’s incremental borrowingrate. The incremental borrowing rate is determined at the lease commencement date and is estimated utilizing similar or collateralizedborrowing instruments adjusted for the terms of leasing arrangement as necessary. Some of the leases include an option to renewthat can extend the lease term. For those leases which are reasonably certain to be renewed, the Company included the renewalperiod in the lease term. The Company’s lease agreements do not contain any material residual value guarantees or materialrestrictive covenants. As of December 31, 2020, the weighted average incremental borrowing rate and the weighted average remaininglease term for the operating leases held by the Company were 7.08% and 3.7 years, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thecomponents of lease expense were as follows (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; font-style: italic">         </td>         <td>         </td>         <td colspan="2" style="text-align: center">         </td>         <td>         </td>         <td>         </td>         <td colspan="2" style="text-align: center">         </td>         <td>         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td>         </td>         <td colspan="2" style="text-align: center">         </td>         <td>         </td>         <td>         </td>         <td colspan="2" style="text-align: center">         </td>         <td>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Operating lease cost         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          1,149         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          1,154         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Short-term lease cost         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          175         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          88         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Sublease income         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (26         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (93         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Total operating lease costs:         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1,298         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1,149         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Maturitiesof lease liabilities for each future calendar year as of December 31, 2020 are as follows (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          OPERATING         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          LEASES         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%; text-align: left">          2021         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          1,231         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          2022         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,267         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          2023         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,293         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          2024         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          867         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Total lease payments         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4,658         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Less: imputed interest         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          600         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Total lease obligation         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4,058         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Less lease obligation, current portion         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,008         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Lease obligation, non-current portion         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          3,050         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 77; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           77           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         4.Property, Plant and Equipment        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Property,plant and equipment consist of the following (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%">          Land         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          1         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          1         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Buildings         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,562         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6,562         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Computer equipment and software         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          564         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          564         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Furniture, fixtures and office equipment         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          416         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          379         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Machinery and equipment         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,047         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          15,768         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Leasehold improvements         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,410         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,410         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Construction in progress         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          367         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          155         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Gross property, plant and equipment         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          26,367         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          25,839         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Less accumulated depreciation and amortization         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (13,802         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (12,579         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          Property, plant and equipment, net         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          12,565         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          13,260         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany recognized depreciation and amortization expense of $1,210,000 and $1,565,000 during the years ended December 31, 2020and 2019, respectively. The total depreciation and amortization for disposed assets during the year ended December 31, 2020 and2019 was $23,000 and $48,000, respectively.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         5.Intangible Assets        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany’s intangible assets consist of the following (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 87%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          Customer Relationships         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          2,244         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          2,333         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Developed Technology         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,362         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,362         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Tradenames         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,106         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,125         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Non-compete         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          90         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          93         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          In Process Research and Development         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2,713         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2,713         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Gross intangibles         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          24,515         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          24,626         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Less accumulated amortization         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (3,132         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (784         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Intangibles, net         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          21,383         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          23,842         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany recognized amortization expense during the year ended December 31, 2020 and 2019 of $2,348,000 and $784,000. The Companyexpects to recognize approximately $2,348,000 in each of the future periods from 2021 through 2024, $2,338,000 in 2025 with theremainder to be recognized in periods thereafter. The weighted average life of the intangible assets is 9.8 years. During theyear ended December 31, 2020, changes to the Company’s initially recognized intangibles were in connection to the contingentconsideration estimate included in the initial recognition of intangible assets associated with the Company’s asset acquisitionof the Jet Ag product lines.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         6.Net Loss per Share        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Basicnet loss per share is calculated by dividing the net loss attributable to common stockholders by the weighted average number ofcommon shares outstanding during the period. Diluted net loss per share reflects the potential dilution that could occur if securitiesor other contracts to issue common stock, such as stock options, restricted stock units, convertible notes, convertible preferredstock and warrants, result in the issuance of common stock which share in the losses of the Company. Certain potential sharesof common stock have been excluded from the computation of diluted net loss per share for certain periods as their effect wouldbe anti-dilutive. Such potentially dilutive shares are excluded when the effect would be to reduce the loss per share. The treasurystock method has been applied to determine the dilutive effect of options and warrants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 78; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           78           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table sets forth the potential shares of common stock as of the end of each period presented that are not included inthe calculation of diluted net loss per share because to do so would be anti-dilutive (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Stock options outstanding         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          13,380         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          11,821         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Warrants to purchase common stock         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          14,534         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          52,647         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Restricted stock units outstanding         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4,588         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,405         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Common shares to be issued in lieu of agent fees         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          498         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          498         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Employee stock purchase plan         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          18         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          8         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Maximum contingent consideration shares to be issued         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          5,972         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          5,972         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          38,990         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          73,351         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Subsequent to December 31, 2020, prior tothe Tranche 4 expiration date of March 15, 2021, 5,862,380 April 2020 Warrant Shares were exercised. Subsequentto December 31, 2020, prior to the March 25, 2021 expiration date, 1,777,778 December 2020 warrant shares were exercised.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         7.Accrued Liabilities        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Accruedliabilities consist of the following (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 87%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left">          Accrued compensation         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          3,495         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          2,730         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Accrued warranty costs         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          475         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          327         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Accrued customer incentives         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4,288         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          5,102         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Accrued liabilities, acquisition related         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,463         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,722         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Accrued liabilities, other         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,929         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2,586         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Accrued Liabilities         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          11,650         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          12,467         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ProductWarranty         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany warrants the specifications and/or performance of its products through implied product warranties and has extended productwarranties to qualifying customers on a contractual basis. The Company estimates the costs that may be incurred during the warrantyperiod and records a liability in the amount of such costs at the time product is shipped. The Company’s estimate is basedon historical experience and estimates of future warranty costs as a result of increasing usage of the Company’s products.The Company periodically assesses the adequacy of its recorded warranty liability and adjusts the amount as necessary. Changesin the Company’s accrued warranty costs during the period are as follows (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%">          Balance at December 31, 2019         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          327         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Warranties issued (released) during the period         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          148         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Settlements made during the period         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          -         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 2.5pt">          Balance at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          475         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ContingentConsideration         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, the contingent consideration in connection with the Company’s acquisition of Pro Farm was recordedat its fair value. The following table provides a reconciliation of the activity for the contingent consideration measured betweenthe most recent reporting period and as of the balance sheet date based on the fair value using significant inputs including theunobservable inputs (Level 3) (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          CONTINGENT CONSIDERATION          <br/>          LIABILITY         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 78%">          Fair value at September 13, 2019         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 18%; text-align: right">          1,395         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">          Change in estimated fair value recorded of contingent consideration         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          342         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Fair value at December 31, 2019         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,737         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">          Change in estimated fair value recorded of contingent consideration         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          445         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Fair value at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          2,182         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 79; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           79           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thechange in fair value for the reporting period was driven by the result of the unobservable fair value model, a Monte Carlo simulationin a risk-neutral framework assuming Geometric Browning Motion. The most significant input to the model was the estimated resultsof the Pro Farm subsidiary for the periods specified in the share purchase agreement of 2021 – 2023.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thechange in the fair value estimate is recognized in the Company’s consolidated statement of operations in Other Income (expense)under caption Change in fair value of contingent consideration. Management has not finalized the earned contingent considerationfor the fiscal year ended December 31, 2020 which is due before March 31, 2021 to the prior owners of Pro Farm. The fair valueamount to be paid in 2021 is estimated at $698,000 and will be settled with the issuance of the Company’s common sharesin 2021.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         8.Debt        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Debt,including debt due to related parties, consists of the following (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          Secured promissory notes (“October 2012 and April 2013 Secured Promissory    Notes”) bearing interest at 8.00% per annum, interest and principal due at maturity (December 31, 2022), collateralized    by substantially all of the Company’s assets.         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          3,425         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          3,425         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Secured promissory note (“June 2014 Secured Promissory Note”) bearing    interest  at prime plus 2% (5.25% as of December 31, 2020) per annum, payable monthly through June 2036,    collateralized by certain of the Company’s deposit accounts and MMM LLC’s inventories, chattel paper,    accounts, equipment and general intangibles, net of unamortized debt discount as of December 31, 2020 and December 31, 2019    of $166 and $185.         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          8,106         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          8,404         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Secured revolving borrowing (“LSQ Financing”) bearing interest at (12.80% annually)    payable through the lenders direct collection of certain accounts receivable through March 2021, collateralized by    substantially all of the Company’s personal property.         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          8,966         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          3,629         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Senior secured promissory notes due to related parties (“August 2015 Senior Secured Promissory Notes”) bearing interest at 8% per annum, interest and principal payable at maturity (December 31, 2022), collateralized by substantially all of the Company’s assets.         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          7,300         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          7,300         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Research loan facility (“2018 Research Facility”) bearing interest at 1.00% per annum, interest payments are due annually on the anniversary date of the facility with principal payable in 25% increments on the anniversary date of the facility beginning on the fourth anniversary of the loan (September 2022), net of imputed interest as of December 31, 2020 and 2019 of $41 and $8, respectively.         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          283         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          81         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Financial institution facility (“2018 Bank Facility”) bearing interest at Euribor plus 2.40% (2.60% as of December 31, 2019) per annum, interest payable monthly and principal payable at maturity (February 29, 2020), 60% guaranteed by Export Credit Agency of Finland for a fee of 2.49%.         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          -         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          207         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Debt, including debt due to related parties         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          28,080         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          23,046         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Less debt due to related parties, non-current         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (7,300         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (7,300         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Less current portion         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (9,301         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (3,899         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">          Debt, non-current         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          11,479         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          11,847         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 80; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           80           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, aggregate contractual future principal payments on the Company’s debt, including debt due to relatedparties, are due as follows (in thousands):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="border-bottom: Black 1.5pt solid; font-weight: bold">          PERIOD ENDING DECEMBER 31,         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          DEBT         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           DEBT TO RELATED          </p>          <p style="margin-top: 0; margin-bottom: 0">           PARTY          </p>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%; text-align: left; padding-left: 30pt">          2021         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          9,320         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: right">          -         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-left: 30pt">          2022         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,903         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          5,000         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-left: 30pt">          2023         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          474         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-left: 30pt">          2024         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          494         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-left: 30pt">          2025         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          518         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt; padding-left: 30pt">          Thereafter         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          6,302         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          -         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-left: 10pt">          Total future principal payments         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          20,011         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          5,000         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Interest payments included in debt balance           <sup>            (1)           </sup>          </font>         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          976         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2,300         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">          Total future debt payments         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          20,987         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          7,300         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            <sup>            </sup>           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            <sup>             (1)            </sup>           </i>          </font>         </td>         <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            Due    to the debt extinguishment requirement, the Company has included both accrued interest and future interest in the debt balance    for certain outstanding debt, as further discussed in Note 8 and 16.           </i>          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefair value of the Company’s outstanding debt obligations, which excludes debt due to related parties, as of December 31,2020 and 2019 was $20,780,000 and $15,746,000, respectively. The Company used 5.25%, the current interest rate, to value the variablerate debt. This debt is classified as Level 3 within the fair value hierarchy.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          October2012 and April 2013 Secured Promissory Notes         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnOctober 2, 2012, the Company borrowed $7,500,000 pursuant to senior notes (“October 2012 Secured Promissory Notes”)with a group of lenders. On April 10, 2013, the Company entered into an amendment to increase, by up to $5,000,000, of which $4,950,000was issued (collectively, “April 2013 Secured Promissory Notes”), bringing the total amount outstanding under thenotes to $12,450,000. On February 5, 2018, the Company converted $10,000,000 of the principal amount of indebtedness outstandingunder the October 2012 and April 2013 Secured Promissory Notes to an aggregate of 5,714,285 shares of common stock and warrantsto purchase 1,142,856 shares of common stock, such that the total amount outstanding under the notes was decreased to $2,450,000,which remains outstanding as of December 31, 2020.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Aspart of the terms of February 5, 2018 conversion, the maturity of the October 2012 and April 2013 Secured Promissory Notes wasextended to December 31, 2022, the interest rate was reduced from 14% to 8% and all interest payments under the October 2012 andApril 2013 Secured Promissory Notes were deferred to the maturity of the notes. This loan is collateralized by substantially allof the Company’s assets. The October 2012 and April 2013 Secured Promissory Notes contain representations and warrantiesby the Company and the lender, certain indemnification provisions in favor of the lenders and customary covenants and events ofdefault. The October 2012 and April 2013 Secured Promissory Notes also contain several restrictive covenants. The Company is incompliance with all related covenants, or has received an appropriate waiver of these covenants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconjunction with the conversion, the Company accounted for the partial debt extinguishment under the troubled debt restructuringaccounting guidance and as a result, the amount of the debt on the Company’s consolidated balance sheet related to the October2012 and April 2013 Secured Promissory Notes is $3,425,000, which includes all interest payments due on the note as compared tothe contractual amount outstanding of $2,450,000. The Company has not recognized interest expense on the October 2012 and April2013 Secured Promissory Notes since the conversion date of February 5, 2018.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Additionally,in conjunction with the terms of the October 2012 Secured Promissory Notes and the April 2013 Secured Promissory Notes, the Companyagreed to pay a fee of 7% of the funded principal amount to the agent that facilitated the financing transactions between theCompany and the collective lenders which resulted in payment of 498,000 shares to the Company’s common stock in lieu ofa cash. These shares are issuable at the maturity of the note or December 2022. The Company has included this liability in othernon-current liabilities.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 81; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           81           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          June2014 Secured Promissory Note         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InJune 2014, the Company borrowed $10,000,000 pursuant to a business loan agreement and promissory note (“June 2014 SecuredPromissory Note”) with Five Star Bank (“Lender”) which bears interest at 5.25% as of December 31, 2020. Theinterest rate is subject to change and is based on the prime rate plus 2.00% per annum. The June 2014 Secured Promissory Noteis repayable in monthly payments of $65,404 and adjusted from time-to-time as the interest rate changes, with the final paymentdue in June 2036. Certain of the Company’s deposit accounts and MMM LLC’s inventories, chattel paper, accounts, equipmentand general intangibles have been pledged as collateral for the promissory note. The Company is required to maintain a depositbalance with the Lender of $1,560,000, which is recorded as restricted cash included in non-current assets. The total amount offinance related cost related to this debt initially was $304,000, currently treated as a debt discount and is being amortizedover the life of the loan.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany may prepay 20% of the outstanding principal loan balance each year without penalty. A prepayment fee of 10% will be chargedif prepayments exceed 20% in the first year, and the prepayment fee will decrease by 1% each year for the first ten years of theloan.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Underthis note the Company is required to maintain a current ratio of not less than 1.25-to-1.0, a debt-to-worth ratio of no greaterthan 4.0-to-1.0 and a loan-to-value ratio of no greater than 70% as determined by Five Star Bank. The Company is also requiredto comply with certain affirmative and negative covenants under the loan agreement discussed above. In the event of default onthe debt, Five Star Bank may declare the entire unpaid principal and interest immediately due and payable. As of December 31,2020, the Company was not in compliance with all of the required covenants, as such, the Company has obtained a waiver from thelender for the non-compliance through May 31, 2022.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table reflects the activity under this note:       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 65%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%; text-align: left">          Principal balance, net at December 31, 2019         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          8,404         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Principal payments         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (820         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Interest         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          503         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Debt discount amortization         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          19         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Principal balance, net at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          8,106         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          LSQFinancing         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMarch 24, 2017, the Company entered into an Invoice Purchase Agreement (the “LSQ Financing”) with LSQ Funding Group,L.C. (“LSQ”), pursuant to which LSQ may elect to purchase up to $7,000,000 of eligible customer invoices from theCompany. The Company’s obligations under the LSQ Financing are secured by a lien on substantially all of the Company’spersonal property; such lien is first priority with respect to the Company’s accounts receivable, inventory, and relatedproperty, pursuant to an intercreditor agreement, dated March 22, 2017 (the “Three Party Intercreditor Agreement”),with administrative agents for the October 2012 and April 2013 Secured Promissory Notes holders and the August 2015 Senior SecuredPromissory Notes holders.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Advancesby LSQ may be made at an advance rate of up to 80% of the face value of the receivables being sold. Upon the sale of the receivable,the Company will not maintain servicing. LSQ may require the Company to repurchase accounts receivable if (i) the payment is disputedby the account debtor, with the purchaser being under no obligation to determine the bona fides of such dispute, (ii) the accountdebtor has become insolvent or (iii) upon the effective date of the termination of the LSQ Financing. LSQ will retain its securityinterest in any accounts repurchased from the Company.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJanuary 7, 2020, the Company entered into a Second Amendment to the Company’s Invoice Purchase Agreement with LSQ. The amendment,among other things, (i) increases the amount in which LSQ may elect to purchase up to $20,000,000 of eligible customer invoicesfrom the Company from $7,000,000; (ii) increases the advance rate to 90% from 85% and 70% from 60%, respectively, of the facevalue of domestic and international receivables being sold; (iii) decreases the invoice purchase fee rate from 0.40% to 0.25%;(iv) increases the funds usage fee from 0.020% to 0.025%; (v) extends the 0% aging and collection fee percentage charged at thetime when the purchased invoice is collected from 90 days to 120 days, and increases the fee percentage charged thereafter from0.35% to 0.75%; and (vi) decreases the early termination fee from 0.75% to 0.50%.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 82; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           82           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inaddition to the Amendment, the Company simultaneously entered into an Amended Inventory Financing Addendum (the “Addendum”)with LSQ. The Addendum allows the Company to request an advance up to the lesser of (i) 100% of the Company’s unpaid finishedgoods inventory; (ii) 65% of the appraised value of the Company’s inventory performed on or on behalf of LSQ; or (iii) $3,000,000.Funds advance under the Addendum are subject to a monthly inventory management fee of 0.5% on the average monthly inventory fundsavailable and a daily interest rate of 0.025%.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therewas $8,966,000 and $3,629,000, respectively, in outstanding balance under the LSQ Financing as of December 31, 2020 and 2019.As of December 31, 2020 and 2019, the Company had $7,254,000 and $5,082,000, respectively included in accounts receivable thatwere transferred under this arrangement.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          September2018 Research Facility         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InSeptember 2018, the Company’s subsidiary Pro Farm entered into a research loan facility under the Finnish Government InnovationFunding initiative with the Innovation Centre Business Finland, in the amount of $326,000 (€282,000) and subsequently drewdown $94,000 (€80,000) and $232,000 (€158,000), respectively, in September 2018 and November 2020 in connection withresearch and development costs. The note bears interest at 3% below the reference rate for Finnish Government Aid, with a minimumof 1% interest annually. The current effective interest rate as of December 31, 2020 is 1.00%. The loan facility requires repaymentin increments of 25% on each of the anniversary date of the loan after the third anniversary of the loan execution date as suchthe balance of the loan has been classified as long-term. The terms of the loan facility allow for partial debt forgivenessif so determined by the State Council for the Financing of Research, Development and Innovation at the lender’s discretion.As of December 31, 2020, the outstanding principal balance net of imputed interest was $283,000 (€238,000).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          September2018 Bank Facility         </i>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InSeptember 2018, the Company’s subsidiary Pro Farm entered into a bank facility with Nordea Bank AB, under which the Companymay borrow up to $266,000 (€230,000). The note bears interest at the Euribor three-month rates plus 2.4% which as of September30, 2019 was increased to 2.60%. The bank facility includes a usage commitment fee of 0.95% and required repayment on its maturitydate of February 28, 2019. On February 20, 2018, the bank facility was extended until August 31, 2019, and on August 30, 2019,the bank facility was again extended until February 29, 2020, and then to May 31, 2020 with all terms remaining the same. Uponmaturity, the bank facility was paid in full.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         9.Warrants        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnAugust 6, 2019, the Company entered into a warrant amendment and plan of reorganization agreement (“Warrant ReorganizationAgreement”) with certain holders of the February 2018 Warrants. Pursuant to the Warrant Reorganization Agreement, the Companyagreed to extend the expiration date under the February 2018 Warrants held by such holders from December 2020 to December 2021,and the holders agreed, at any time the Company’s stock trades above $1.00 and upon request by the Company, to exerciseup to 36,600,000 of their respective February 2018 Warrants, in consideration for the delivery of (x) the shares subject to theFebruary 2018 Warrants so exercised and (y) the delivery of new warrants (“August 2019 Warrants”) to purchase suchadditional number of shares of common stock equal to the amount of shares so exercised and delivered under February 2018 Warrants.Accordingly, up to a maximum of 36,600,000 new shares were issuable pursuant to the August 2019 Warrants. In August and throughDecember 2019, the Company requested under the Warrant Reorganization Agreement, the exercise of 16,000,000 February 2018 Warrants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InFebruary 2020, the Company requested an additional exercise of 6,000,000 February 2018 Warrants, resulting in the Company issuingan additional 6,000,000 common shares and 6,000,000 August 2019 Warrants (“Exercise 3”). The issuance of the August 2019Warrants resulted in the Company incurring a non-cash charge of $1,391,000 in connection with the fair value of new warrants.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 83; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           83           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnApril 29, 2020, the Company then entered into a warrant exchange agreement (“Warrant Exchange Agreement”) with certainholders of warrants under the August 2015 Senior Secured Promissory Notes, the Securities Purchase Agreement and the Warrant ReorganizationAgreement. Pursuant to the Warrant Exchange Agreement, the Company agreed to exchange an aggregate of 45,977,809 warrants (“August2015 Warrants”, “February 2018 Warrants 1 &amp; 2”, and all “August 2019 Warrants” collectively, the “Exchangedwarrants”) for 29,881,855 warrants (“April 2020 Warrants”).       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheApril 2020 Warrants have terms expiring for a total of (i) 3,392,581 Warrant Shares on May 1, 2020, (ii) 2,714,065 Warrant Shareson September 15, 2020, (iii) 13,027,512 Warrant Shares on December 15, 2020, (iv) 5,862,380 Warrant Shares on March 15, 2021,and (v) 4,885,317 Warrant Shares on December 15, 2021. All April 2020 Warrants have an exercise price of $0.75 per share. TheApril 2020 Warrants are exercisable in cash, provided that they may be exercised via net exercise if the Company does not havea registration statement registering the shares underlying the April 2020 Warrants effective as of March 31, 2021. As of December31, 2020 all April 2020 Warrants with expiration dates of May, 1, 2020, September 15, 2020 and December 15, 2020 were exercisedprior to their expiration date providing the Company with proceeds of $3,392,000, $2,714,000 and $13,027,000, respectively, foran aggregate proceed of $19,133,000.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany has accounted for the Warrant Exchange Agreement as a modification under ASC 718. The fair value of the April 2020 Warrantswas not greater than the fair values of the Exchanged warrants immediately prior to the modification date and therefore had noimpact on the Company’s year ended results.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InDecember 2020, the Company also entered into an amendment (the “Warrant Amendment”) to a previously outstanding warrantto purchase 5,333,333 shares of the Company’s common stock issued to a historical warrant holder (the “Holder”)on February 5, 2018. Pursuant to the Warrant Amendment, in exchange for the Holder’s exercise of the warrant on December29, 2020, with respect to 1,777,778 shares at the warrant’s exercise price of $0.96 per share the warrant’s expirationdate was partially extended and allows the Holder to exercise warrants to purchase (i) 1,777,778 shares at $1.00 per share byMarch 25, 2021, and (ii) 1,777,777 shares at $1.04 share by December 15, 2021       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany has accounted for the Warrant Amendment as a modification under ASC 718. The fair value of the February 2018 Warrantswas greater than the fair values of the exchanged warrants immediately prior to the modification date and therefore the Companyrecognized $72,000 of additional expense in connection with the modification for the year ended results.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 84; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           84           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table summarizes information about the Company’s common stock warrants activities for the year ended December31, 2020 and the warrants outstanding as of December 31, 2020 (in thousands, except exercise price data):       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 7pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">       <tbody>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             SHARES            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             SUBJECT                                         TO            </b>           </font>          </p>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             YEAR            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             ENDED            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             NUMBER                                         OF            </b>           </font>          </p>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           <b>            YEAR           </b>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             ENDED            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             NUMBER                                         OF            </b>           </font>          </p>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             YEAR            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             ENDED            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             NUMBER                                         OF            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             SHARES                                         OR            </b>           </font>          </p>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             YEAR            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             ENDED            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             NUMBER                                         OF            </b>           </font>          </p>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             YEAR            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             ENDED            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             NUMBER                                         OF            </b>           </font>          </p>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             SHARES            </b>           </font>          </p>          <p style="margin-top: 0; margin-bottom: 0">           <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">            <b>             SUBJECT                                         TO            </b>           </font>          </p>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           <b>           </b>          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           ISSUE          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           EXPIRATION          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           WARRANTS          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           WARRANTS          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           WARRNTS          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           WARRANTS          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           WARRANTS          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           WARRANTS          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           WARRANTS          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           DATE          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           DATE          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           EXERCISE          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           OUTSTANDING          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           EXCHANGED          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           EXERCISED          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           ISSUED          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           MODIFIED          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           EXPIRED          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           OUTSANDING          </font>         </td>         <td style="padding-bottom: 1.5pt; font: bold 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           DESCRIPTION          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           MM/YY          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           MM/YY          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           PRICE          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/31/2019          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/31/2020          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/31/2020          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/31/2020          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/31/2020          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/31/2020          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/31/2020          </font>         </td>         <td style="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif; width: 22%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           June    2013 Warrants          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           06/13          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           06/23           <sup>            (1)           </sup>          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           8.40          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           27          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 5%; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           27          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           August    2015 Warrants          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           08/15          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           08/23          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1.91          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           4,000          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (4,000          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           November    2016 Warrants          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           11/16          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           11/26          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           2.38          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           125          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           125          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           November    2017 Warrants          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           06/17          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           06/27          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1.10          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           80          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           80          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           February    2018 Warrants 1          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           02/18          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1.00          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           6,750          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (1,378          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (15          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (5,333          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (24          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           February    2018 Warrants 2          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           02/18          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1.25          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           5,065          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (4,000          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (1,065          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           August    2019 Warrant          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           09/19          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/21          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1.00          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           20,600          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (14,600          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (6,000          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           August    2019 Warrant (Call Option)          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           Various    after 08/19          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           01/23          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1.75          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           16,000          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (22,000          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           6,000          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           April    2020 Warrants, Tranche 1          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           04/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           05/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           0.75          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (3,393          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           3,393          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           April    2020 Warrants, Tranche 2          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           04/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           09/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           0.75          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (2,714          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           2,714          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           April    2020 Warrants, Tranche 3          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           04/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           0.75          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (13,027          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           13,028          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (1          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           April    2020 Warrants, Tranche 4          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           04/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           03/21          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           0.75          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           5,862          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           5,862          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           April    2020 Warrants, Tranche 5          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           04/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/21          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           0.75          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           4,885          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           4,885          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           December    2020 Warrants, Tranche 1          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           0.96          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (1,778          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1,778          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           December    2020 Warrants, Tranche 2          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           03/21          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           03/20          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1.00          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1,778          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1,778          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           December    2020 Warrants, Tranche 3          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/21          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           12/21          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           $          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1.04          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1,777          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 1.5pt solid; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           1,777          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>        <tr style="font: 7pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           52,647          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (45,978          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (26,927          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           35,882          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           -          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           (1,090          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           )          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>         <td style="border-bottom: Black 2.5pt double; font: 7pt Times New Roman, Times, Serif; text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">           14,534          </font>         </td>         <td style="font: 7pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">          <font style="font-family: Times New Roman, Times, Serif; font-size: 7pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           (1)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           The    June 2013 Warrants expire upon the earlier to occur of (i) the date listed above; (ii) the acquisition of the Company by another    entity by means of any transaction or series of related transactions (including, without limitation, any transfer of more    than 50% of the voting power of the Company, reorganization, merger or consolidation, but excluding any merger effected exclusively    for the purpose of changing the domicile of the Company); or (iii) a sale of all or substantially all of the assets of the    Company unless the Company’s stockholders of record as constituted immediately prior to such acquisition or sale will,    immediately after such acquisition or sale (by virtue of securities issued as consideration for the Company’s acquisition    or sale or otherwise), hold at least fifty percent (50%) of the voting power of the surviving or acquiring entity.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheJune 2013 Warrants became exercisable on the date of the IPO. The August 2015 and November 2016 were immediately exercisable andremain exercisable subject to certain exceptions. The November 2017 Warrants vested over a period of six months and remain exercisable.The February 2018 Warrants were immediately exercisable and remain exercisable subject to certain exceptions.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theweighted average remaining contractual life and exercise price for warrants outstanding as of December 31, 2020 is 0.64 yearsand $0.85, respectively. The intrinsic value of the warrants on December 31, 2020 was $6,203,000.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Subsequentto December 31, 2020, prior to the March 15, 2021, expiration date of Tranche 4 of the April 2020 Warrants, 5,862,380 warrantshares were exercised. Additionally, prior to the March 25, 2021, expiration date, 1,777,778 December 2020 warrant shares wereexercised.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         10.Stock Option Plans        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnMay 31, 2019, the Company’s stockholders approved an Employee Stock Purchase Plan (the “ESPP”) whereby employeesmay purchase Company stock through payroll deductions over each six-month period beginning on June 1 and December 1 (the “OfferPeriod”). The total maximum number of shares available for purchase under the ESPP is 1,000,000. The purchase price of theshares will be 85% of the lower of the fair market value of the shares at the beginning or at the end of the Offer Period. TheESPP is a tax qualified plan under Section 423 of the Internal Revenue Code. All employees, including officers, are eligible toparticipate in the ESPP. A participant may withdraw all uninvested payment balances credited to their account at any time. Anemployee whose stock ownership in the Company exceeds 5% of the Company’s outstanding common stock is not eligible to participatein the ESPP. The ESPP is compensatory and the 15% discount will be expensed over the Offer Period. The Company has accounted forthe ESPP in accordance with ASC 718, Compensation – Stock Based Compensation. As of December 31, 2020 and 2019, the Companyrecorded stock-based compensation expense of approximately $74,000 and $34,000, respectively.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 85; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           85           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InJuly 2006, the Company authorized the 2006 Equity Incentive Plan, as amended, (“2006 Plan”). The 2006 Plan provided forthe issuance of up to 1,434,000 shares of common stock underlying awards. The 2006 Plan was terminated in December 2011 and nonew stock awards may be granted under the 2006 Plan.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        The2006 Plan allowed holders to exercise stock options prior to their vesting. The common stock received by the employee is restrictedand follows the same vesting schedule as the underlying option. In the event the employee voluntarily or involuntarily terminatesemployment from the Company, the Company retains a right to repurchase the unvested common stock at the original option exerciseprice. For each of the periods ended December 31, 2020 and 2019, no options had been exercised that was subject to repurchase.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, options to purchase 23,000 shares of the Company’s common stock at a weighted-average exercise priceof $1.19 per share were outstanding under the 2006 Plan, of which all were vested. During the year ended December 31, 2020, 49,000and 25,000 options were exercised and cancelled, respectively, under the 2006 Plan.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InJuly 2011, and as amended in September 2012, the Company authorized the 2011 Stock Plan (“2011 Plan”). The 2011 Plan providedfor the issuance of up to 1,167,000 shares of common stock underlying awards, plus any shares of common stock underlying awardspreviously issued under the 2006 Plan that terminate or expire after the date of authorization of the 2011 Plan, subject to certainadjustments. In addition, the 2011 Plan provided that the Company not deliver more than 2,446,000 shares upon the exercise ofincentive stock options issued under both the 2006 Plan and 2011 Plan. The 2011 Plan was terminated in August 2013 and no newstock awards may be granted under the 2011 Plan.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, options to purchase 281,000 shares of the Company’s common stock at a weighted-average exercise priceof $7.51 per share were outstanding under the 2011 Plan, of which all were vested. During the year ended December 31, 2020, nooptions were exercised and cancelled under the 2011 Plan.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2013, the Company’s board of directors adopted the 2013 Stock Incentive Plan (“2013 Plan”) covering officers,employees, and directors of, and consultants to, the Company. Under the 2013 Plan, the Company may grant incentive stock options,non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and dividend equivalent rights.At the time the 2013 Plan was established, the maximum aggregate number of shares of the Company’s common stock that couldbe issued pursuant to the 2013 Plan was 1,600,000, plus the number of shares of common stock that were reserved for issuance pursuantto future grants under the 2011 Plan at that time. The number of shares authorized for issuance pursuant to the 2013 Plan automaticallyincreases by any additional shares that would have otherwise returned to the 2011 Plan as a result of the forfeiture, terminationor expiration of awards previously granted under the 2011 Plan. In addition, the number of shares authorized for issuance pursuantto the 2013 Plan will increase by a number equal to the lesser of (i) 3.5% of the number of shares of the Company’s commonstock outstanding on the last day of the immediately preceding fiscal year or (ii) a lesser number of shares determined by theadministrator.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, options to purchase 13,076,000 shares of the Company’s common stock at a weighted-average exerciseprice of $2.21 per share were outstanding under the 2013 Plan, of which 6,547,000 were vested. During the year ended December31, 2020, 51,000 and 967,000 options were exercised and cancelled, respectively, under the 2013 Plan.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Generally,options vest 25% on the first anniversary from the date of grant and 1/48 per month thereafter (“Standard Vesting Terms”);however, options may be granted with different vesting terms as determined by the Company’s board of directors. During theyear ended December 31, 2020, the Company granted 425,000 options with Standard Vesting Terms.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 86; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           86           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table summarizes the activity under the Company’s stock option plans for the year ended December 31, 2020 (inthousands, except exercise price and remaining contractual life data):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          WEIGHTED-         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          AVERAGE         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          WEIGHTED-         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          REMAINING         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          AVERAGE         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          CONTRACTUAL         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          AGGREGATE         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          SHARES         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          EXERCISE         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          LIFE         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          INTRINSIC         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          OUTSTANDING         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          PRICE         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          (IN YEARS)         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          VALUE         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 44%">          Balances at December 31, 2019         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 10%; text-align: right">          11,821         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 10%; text-align: right">          2.53         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 10%; text-align: right">          8.2         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 10%; text-align: right">          65         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left">          Options granted         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,650         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          1.16         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt; text-align: left">          Options exercised         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (100         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          1.07         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">          Options cancelled         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (991         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          1.32         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Balances at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          13,380         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          2.32         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          7.7         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          418         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Vested and expected to vest at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          11,823         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          2.44         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6.6         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          357         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Exercisable at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          6,851         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          3.23         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          6.6         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          160         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thetotal intrinsic value of options exercised during the years ended December 31, 2020 and 2019 was $13,000 in each period.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theestimated fair value of options vested during the years ended December 31, 2020 and 2019 was $357,000 and $65,000, respectively.The weighted-average estimated fair value of options granted during the years ended December 31, 2020 and 2019 was $0.38 per shareand $1.43 per share, respectively.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2020, Kevin Helash joined the Company as Chief Executive Officer (“CEO”) and as a member of the Company’sBoard of Directors. In connection with his appointment, Mr. Helash has been granted options to purchase 2,450,000 shares of theCompany’s common stock, under the Company’s 2013 Stock Incentive Plan. The Option is structured as follows:       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            Time-Based    Tranche           </i>           . 225,000 shares of the Option are subject to time-based vesting over a period of four years. Twenty-five percent    of the Time-Based Tranche will vest on the first anniversary of the Vesting Commencement Date, and the remaining 75 percent    of the shares under the Time-Based Tranche will vest over the next following 3 years on a pro-rata basis equally each month.          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            Enhanced    Time-Based Tranche           </i>           . 225,000 shares of the Option are subject to time-based vesting over a period of four years as measured    from the Vesting Commencement Date, on a pro-rata basis equally each month, subject to acceleration on the date on which the    Company files its Annual Report on Form 10-K for the fiscal year ending December 31, 2020, if within such report, the Company    reports the achievement of certain revenue, margin and expense performance targets for its 2020 fiscal year, each of which    are within 10% of the Company’s internal targets for the year with respect to the various target elements.          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           ●          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            Performance    Tranche           </i>           . 2,000,000 shares of the Option are subject to performance-based vesting, but only if the performance criteria    are satisfied by a specific performance deadline. Vesting of the Performance Tranche is contingent on the attainment of a    certain closing price for the Company’s stock, as quoted on the Nasdaq Stock Market, for 30 consecutive trading days,    by that date which is 30 days following the reporting of financial results for the Company’s second quarter of its fiscal    year ending December 31, 2022 (the “Performance Deadline”). If the performance criteria are satisfied on or before    the Performance Deadline, the Performance Tranche will vest on the date that the performance criteria are satisfied. If Mr.    Helash terminates employment prior to the date on which the performance criteria are satisfied, or the performance criteria    are not satisfied on or before the Performance Deadline, then all of the shares under the Performance Tranche will permanently    and irrevocably forfeit at the earlier of the Performance Deadline or his termination date.          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 87; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           87           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Alldates on which vesting is to occur are conditioned upon Mr. Helash’s continued employment with the Company as of that date.Any portion of the Option shares that are not forfeited as of the Performance Deadline shall continue to vest for so long as Mr.Helash provides “Continuous Service” to the Company or a “Related Entity,” as those terms are definedin the Plan. Mr. Helash’s options to purchase common stock was granted at an exercise price of $1.16 and with a fair valueof $899,000. The Company’s fair value of these grants was estimated utilizing either a Black Scholes or Monte Carlo optionpricing model based on the following range of assumptions which have determined consistent with the Company’s historicalmethodology for such assumptions:       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 65%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="text-align: center">         </td>         <td style="font-size: 8.5pt; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-size: 8.5pt; text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             AUGUST 3,            </b>           </font>          </p>          <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             2020            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt; font-size: 8.5pt">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Expected life (years)         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           2.14-6.08          </font>         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="width: 80%; text-align: left">          Estimated volatility factor         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: right">          58.8         </td>         <td style="width: 1%; text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Risk-free interest rate         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          0.28         </td>         <td style="text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Expected dividend yield         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          —         </td>         <td style="text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ExpectedLife.        </i>        Expected life represents the period that share-based payment awards are expected to be outstanding. The Company usesthe “simplified method” in accordance with Staff Accounting Bulletin (“SAB”) No. 107,        <i>         Share-Based Payment        </i>        (“SAB No. 107”), and SAB No. 110,        <i>         Simplified Method for Plain Vanilla Share Options        </i>        (“SAB No. 110”), tocalculate the expected term of stock options determined to be “plain vanilla.” Under this approach, the expected termis presumed to be the midpoint between the vesting date and the contractual end of the stock option grant. For stock options grantedwith an exercise price not equal to the determined fair value, the Company estimates the expected life based on historical dataand management’s expectations about exercises and post-vesting termination behavior. The Company will use the simplifiedmethod until it has sufficient historical data necessary to provide a reasonable estimate of expected life in accordance withSAB No. 107 and SAB No. 110.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         EstimatedVolatility Factor.        </i>        As the Company’s common stock has limited period of normalized trading history, the Company calculatedthe estimated volatility factor based on the Company’s trading history adjusted for certain periods of the Company’strading history, not indicative of normal trading.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Risk-FreeInterest Rate.        </i>        The Company calculates the risk-free interest rate based on the implied yield currently available on U.S. Treasuryconstant-maturity securities with the same or substantially equivalent remaining term as the expected life of the stock options.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ExpectedDividend Yield        </i>        . The Company has not declared dividends, nor does it expect to in the foreseeable future. Therefore, a zerovalue was assumed for the expected dividend yield.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InSeptember 2020, James Boyd announced his intention to retire from his position as the Company’s Chief Financial Officer(“CFO”) and President of the Company. In connection with his retirement, Mr. Boyd entered into an employment separationagreement with the Company (the “Separation Agreement”). The Separation Agreement provides among other terms thatall of his outstanding stock options will become fully vested, and all stock options will remain exercisable until the earlierof (x) the one-year anniversary of the date Mr. Boyd ceases providing consulting services pursuant to his consulting servicesagreement between Mr. Boyd and the Company on September 21, 2020 (the “Consulting Agreement”), and (y) the last dayof the option’s full term. As a result the Company treated the accelerated vesting terms for the options as a modificationunder Accounting Standards Codification (“ASC”) 718 –        <i>         Compensation – Stock Compensation        </i>        , whichrequires the Company to assess the fair value of the instrument pre- and post-modification and recognize any incremental expenseon the modification date dependent on the Company’s assessment of the initial probability of the option award vesting underthe pre-modification terms. The Company recognized an incremental stock-based compensation expense of $138,000 as of December31, 2020. The remaining expense to be recognized in future periods is $22,000.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe years ended December 31, 2020 and 2019, the Company recorded share-based compensation expense related to stock options of$2,299,000 and $1,742,000, respectively. During the years ended December 31, 2020 and 2019, the Company did not realizeany tax benefit associated with its share-based compensation expense as certain of the option grants were incentive stock optionsfor which share-based compensation expense is not deductible and as a result of the full valuation allowance on the Company’sdeferred tax assets (see Note 11 to the consolidated financial statements).       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 88; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           88           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          RestrictedStock         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe year ended December 31, 2020, the Company granted restricted stock units under the 2013 Plan. The vesting periods for therestricted stock are subject to board approval and during the year ended December 31, 2020 varied from immediate to 36 months.One share of common stock is issuable for each vested restricted stock unit upon the earlier of the grantee’s separationof service or a change in control in the case of non-employee directors, or in the case of employees the board can decide to providefor the immediate issuance of common stock once vesting has occurred. As of December 31, 2020, there were 4,588,000 restrictedstock units outstanding under the 2013 Plan. The following table reflects the activity of restricted stock units for the yearended December 31, 2020 (in thousands, except weighted average grant date fair value):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          WEIGHTED         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          AVERAGE         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          GRANT         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          SHARES         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DATE FAIR         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          OUTSTANDING         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          VALUE         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%">          Outstanding at December 31, 2019         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          2,405         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          1.40         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt">          Granted         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,865         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          0.97         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-left: 10pt">          Exercised         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (657         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1.40         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt; padding-bottom: 1.5pt">          Forfeited         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (25         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1.37         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Outstanding at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          4,588         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1.14         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table summarizes the activity of non-vested restricted stock units for the year ended December 31, 2020 (in thousands,except weighted average grant date fair value):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td>         </td>         <td colspan="2">         </td>         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          WEIGHTED         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td>         </td>         <td colspan="2">         </td>         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          AVERAGE         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td>         </td>         <td colspan="2">         </td>         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          GRANT         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          SHARES         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DATE FAIR         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          OUTSTANDING         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          VALUE         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td>         </td>         <td>         </td>         <td colspan="2" style="text-align: right">         </td>         <td>         </td>         <td>         </td>         <td colspan="2" style="text-align: right">         </td>         <td>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%">          Nonvested at December 31, 2019         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          711         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 14%; text-align: right">          1.45         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Granted         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,865         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          0.96         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Vested         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (2,114         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1.00         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt">          Forfeited         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (25         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1.37         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Nonvested at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1,437         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1.16         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefair value of restricted stock units is determined based on the closing bid price of the Company’s common stock on the dateof grant. During the years ended December 31, 2020 and 2019, the Company recognized $1,222,000 and $1,597,00, respectively,of share-based compensation expense related to restricted stock units. Total share-based compensation expense related to restrictedstock units not yet recognized as of December 31, 2020 was $1,383,000, which is expected to be recognized over a weighted averageperiod of 1.27 years.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMay 2020, the Company granted to certain executives restricted stock units in lieu of ten percent of their annual base salariesfor the fiscal year ending December 31, 2020. The total number of restricted stock units granted to these executives was 225,000at an exercise price of $0.71.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMay 2020 the Company also the granted restricted stock units to certain executives and employees in lieu of cash bonuses for performancerelated to the fiscal year ended December 31, 2019. The total number of restricted stock units granted to these employees was890,000 at an exercise price of $0.71. This grant resulted in the reclassification of the total fair value of $632,000 betweenAccrued liabilities and Additional paid in capital in the Company’s consolidated balance sheet.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <!-- Field: Page; Sequence: 89; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           89           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2020, in connection with the Company’s separation and consulting arrangement with its former chief executiveofficer, the Company granted 1,250,000 restricted stock units to Dr. Pamela Marrone at a grant date market valueof $1.16. The restricted stock units will vest at each of the three future anniversary dates of the consultingarrangement.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefollowing table summarizes shares available for grant under the Company’s current stock incentive plans for the year endedDecember 31, 2020 (in thousands):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          SHARES         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          AVAILABLE         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          FOR         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          GRANT         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%">          Balances at December 31, 2019         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: right">          4,051         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-left: 10pt">          Shares authorized         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4,883         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-left: 10pt">          Options granted         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (2,650         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-left: 10pt">          Options cancelled         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          966         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-left: 10pt">          Restricted stock units granted         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (2,865         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Restricted stock units cancelled         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          25         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Balances at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          4,410         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         11.Income Taxes        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Consolidated (loss) before incometaxes for the United States (“U.S.”) and foreign operations consisted of the following (inthousands):      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 79%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="text-align: center; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%">          Domestic         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          (19,774         </td>         <td style="width: 1%; text-align: left">          )         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: right">          (36,692         </td>         <td style="width: 1%; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt">          Foreign         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (365         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (483         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          (Loss) before income taxes         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (20,139         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (37,175         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       The income tax provision attributableto the income before income taxes is as follows (in thousands):      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 79%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font-weight: bold">          CURRENT:         </td>         <td>         </td>         <td colspan="2" style="text-align: right">         </td>         <td>         </td>         <td>         </td>         <td colspan="2" style="text-align: right">         </td>         <td>         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt; width: 60%">          Foreign         </td>         <td style="padding-bottom: 1.5pt; width: 2%">         </td>         <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">          $         </td>         <td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">          35         </td>         <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">         </td>         <td style="padding-bottom: 1.5pt; width: 2%">         </td>         <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">          -         </td>         <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Total Current:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          35         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-weight: bold">          DEFERRED:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt">          Foreign         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (6         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          -         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Total Deferred:         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (6         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          -         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Provision for income taxes         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          29         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          -         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thereconciliation of the U.S. federal statutory tax rate to the actual tax rate is as follows:       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 64%; text-align: left">          U.S. Federal tax benefit at statutory rate         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          21         </td>         <td style="width: 1%; text-align: left">          %         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 14%; text-align: right">          21         </td>         <td style="width: 1%; text-align: left">          %         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          State tax benefit         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          8         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Deferred tax asset true up         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (3         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          9         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Expiring tax attributes         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (240         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Share-based compensation expense         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (2         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Other         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Financing cost, warrants         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (1         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (4         </td>         <td style="text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          PPP Loan Forgiveness         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Adjustment due to change in valuation allowance         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          216         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (29         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Provision for income taxes         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          0         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          %         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          0         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          %         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       Accounting standards require recognitionof a future tax benefit to the extent that realization of such benefit is more likely than not; otherwise, a valuation allowanceis applied. During the years ended December 31, 2020 and 2019, the aggregate valuation allowance for deferred tax assets decreasedby $44,314,000 and increased by $7,201,000, respectively. The decrease for the year ended December 31, 2020 was driven primarilyby a change in ownership as defined under Internal Revenue Code (“IRC”) Section 382 (the “382 Change”)resulting in a loss of tax attributes offset by the realizability of U.S. and certain foreign loss carryforwards and other U.S.and certain foreign deferred tax assets. The increase for the year ended December 31, 2019 was driven primarily by the realizabilityof U.S. and certain foreign loss carryforwards and other U.S. and certain foreign deferred tax assets.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany recorded tax shortfalls resulting from the exercise of nonqualified stock options and the value of vested restricted stockof $315,000 and $19,000 for the years ended December 31, 2020 and 2019, respectively, where amounts reported for such items ascompensation costs under accounting standards related to stock-based compensation were less than the tax deduction.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <!-- Field: Page; Sequence: 90; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           90           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thetax effects of significant temporary differences representing net deferred tax assets and liabilities consistedof the following (in thousands):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">          DECEMBER 31,         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td style="text-align: center; font-weight: bold">         </td>         <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">          DECEMBER 31,         </td>         <td style="text-align: center; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="font-weight: bold; text-align: left">          DEFERRED TAX ASSETS:         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold; text-align: left">         </td>         <td style="font-weight: bold; text-align: right">         </td>         <td style="font-weight: bold; text-align: left">         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold; text-align: left">         </td>         <td style="font-weight: bold; text-align: right">         </td>         <td style="font-weight: bold; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="width: 60%; text-align: left">          Federal &amp; State NOL carryforward         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          31,911         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          74,109         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Research and development tax credits         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,762         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4,223         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Other, net         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          4,835         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          5,745         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Deferred tax assets         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          39,508         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          84,077         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Less valuation allowance         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (33,873         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (78,187         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Net deferred tax assets         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          $         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          5,635         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          $         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          5,890         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="font-weight: bold; text-align: left">          DEFERRED TAX LIABILITIES:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Other Intangibles         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (5,615         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (5,890         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Net deferred tax assets         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          20         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="font-weight: bold; padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">          -         </td>         <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       As of December 31, 2020 and 2019, the Companyhad a federal net operating loss carryforward (“NOL”) of $104,180,000 and $263,675,000, respectively. Federal andstate NOL carryforwards were reduced during the current year due to the 382 Change, as a result of the completion of the Company’sSection 382 study in connection with the Company’s February 5, 2018 financing transactions. The amount of the federal andstate NOL reductions were $176,433,000 and $119,131,000, respectively. The federal net operating loss not subject to expirationat December 31, 2020 and 2019 was $65,140,000 and $50,896,000, respectively, which is subject to a limitation of 80% of taxableincome. The federal net operating loss at December 31, 2020 of $39,040,000 generated prior to 2018, will begin to expire in 2036.      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       As of December 31, 2020 and 2019, the Companyhad a federal research and development (“R&amp;D”) tax credit carryforward of $607,000 and $2,759,000, respectively.The December 31, 2020 federal R&amp;D tax credit carryforward was also reduced by $2,317,000 due to the 382 Change and will beginto expire in 2038. The December 31, 2020 and 2019 California R&amp;D tax credit carryforward of $3,075,000 and $2,871,000, respectively,have no expiration date and were unaffected by the 382 Change.      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany records valuation allowances on U.S. and certain foreign deferred tax assets. In assessing the need for a valuation allowance,the Company considers whether it is more likely than not that the deferred tax assets will be realized. The ultimate realizationof deferred tax assets is dependent upon generation of future taxable income. In the assessment of a valuation allowance, appropriateconsideration is given to all positive and negative evidence including recent operating profitability, forecast of future earnings,ability to carryback, the reversal of net taxable temporary differences, the duration of statutory carryforward periods and taxplanning strategies.       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 13, 2019, as discussed in Note 12 to the consolidated financial statements, the Company completed its acquisitionof Pro Farm. This was accounted for as a non-taxable acquisition. For purposes of the Company’s income tax provision, theacquisition required the Company to consider income tax changes under the Tax Cuts and Jobs Act it was not previously subjectto, including Global Intangible Low-Taxed Income (“GILTI”) and Subpart F. Due to the timing of the acquisition’sconsummation, the impact of these amounts on the Company’s income tax provision and consolidated financial statements asof December 31, 2020 were not material. The Company has elected to treat GILTI as a period cost and accordingly has not recordedany deferred assets or liabilities related to the calculation of future GILTI income. The most significant impact to the Company’stax provision as a result of the Pro Farm acquisition was the recognition of intangible assets which impacted the Company’stemporary differences for depreciation and amortization. Refer to the table above for the inclusion of the foreign entity on theCompany’s overall federal income tax rate and deferred tax liabilities.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 91; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           91           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 10, 2019, as discussed in Note 12 to the consolidated financial statement, the Company completed its acquisitionof the Jet-Ag and Jet-Oxide product lines. These were treated as asset acquisitions. For purposes of the Company’s incometax, the acquisition resulted in the recognition of intangible assets which impacted the Company’s temporary differencesfor depreciation and amortization which did not have a material impact on the Company’s provision and consolidated financialstatements as of December 31, 2019.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJanuary 1, 2019, the Company adopted ASC 842 and all the related amendments. For purposes of the Company’s income tax, theadoption did not have a material impact on the consolidated financial statements as of December 31, 2019.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020 and 2019, the Company had unrecognized tax benefits of $946,000 and $1,431,000, respectively.The unrecognized tax benefits of $22,000 and $0, respectively, if recognized, would impact the Company’s effectivetax rate for December 31, 2020 and 2019. The remaining unrecognized tax benefits would not impact the effective taxrate as tax benefits would be offset by changes in the Company’s valuation allowance. The Company does not believe therewill be any material changes in its unrecognized tax position during the next twelve months.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Areconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 79%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">          DECEMBER 31,         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2020         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>         <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">          2019         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 60%">          Balance at January 1         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          1,431         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          1,348         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Gross increase to tax positions in prior years         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          40         </td>         <td style="text-align: left">         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          14         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Gross decrease to tax positions in prior years         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          (617         </td>         <td style="text-align: left">          )         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          -         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Gross increase to tax positions in current years         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          92         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          69         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Balance at December 31         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          946         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          1,431         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany files income tax returns in the U.S. federal and foreign jurisdiction and various state jurisdictions. TheCompany is subject to U.S. federal and state income tax examination for 2006 through 2020 due to unutilized net operatingloss carryforwards. The Company is subject to state income tax examination for the same periods due to an unutilizedresearch and development tax credit carryforward. The Company’s foreign locations in Finland is subject to incometax examination for 2017 through 2020.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         12.Acquisitions        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         Jet-Agand Jet-Oxide        </i>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 10, 2019, the Company completed the purchase of substantially all rights and assets related to the Jet-Ag and Jet-Oxideproduct lines from Austin Grant, Inc., a Florida corporation d/b/a Jet Harvest Solutions, for approximately $2,534,000 in cash,of which $544,200 was paid upon closing and the remainder is to be paid in four installments over an 16-month window (the “Jet-AgAcquisition”). The Jet-Ag Acquisition is accounted for as an asset acquisition consistent with ASC 2017-01, which requiresthat substantially all of the fair value of the gross assets acquired is concentrated in a single asset or a group of similarassets. The asset purchase agreement also contains a provision providing five yearly earn out payments from 2020 through 2024based on the Company’s total future sales of Jet-Ag and Jet-Oxide purchased through a specified supplier. The fair valueof the contingent consideration was estimated at $190,000 on the close date of the transaction, which the Company has includedin its total cost to be allocated to the acquired assets. The Company intends to assess its contingent consideration estimateperiodically upon the settlement of the revenue contingency at each reporting period. Acquisition costs of $168,000 were alsoincluded in the total consideration for the Jet-Ag Acquisition to be allocated among the acquired assets. The allocation of thetotal consideration was based on each of the acquired asset’s relative fair values as follows (in thousands):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          INITIAL          <br/>          ALLOCATION OF          <br/>          COST OF          <br/>          ASSET          <br/>          ACQUISITION         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%; text-align: left">          Cash paid, inclusive of future payments         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          2,534         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Fair value of contingent consideration         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          190         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Other cost to acquire assets         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          168         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Total acquisition related consideration         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          $         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          2,892         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Intangible assets acquired:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Customer relationships         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          2,333         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Tradename         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          466         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt">          Non-compete         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          93         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Total assets acquired         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          2,892         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 92; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           92           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Thefair value of the acquired customer list, trade name, non-compete were estimated using either an excess earning method, relief-from-royaltyor with and without the asset being in place, based on management’s forecasted cash inflows and outflows. Each of the intangibleassets are being amortized within the expense reflected in “Selling, general and administrative” expenses in the consolidatedstatement of operations.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        DuringDecember 31, 2020, the Company refined its contingent consideration estimate for the remaining period covered in the agreementwhich lead to a decrease in the overall contingent consideration liability by $118,000 and therefore decreased the acquired intangibleassets on a relative basis by approximately $89,000, $18,000 and $3,000 to customer relationships, tradename, and non-compete,respectively. During December 31, 2020 the total amount of payments made in connection with the asset acquisition was $1,240,000.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <i>         ProFarm Technologies OY        </i>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 13, 2019, the Company completed its acquisition of 100% of the outstanding shares of Pro Farm Technologies OY, a Finnishlimited company (“Pro Farm”) for consideration of approximately $27,543,000 (the “Pro Farm Acquisition”),net of cash acquired. Total consideration consisted of cash payments of $2,843,000 to beneficial owners and $3,178,000 in debtrepayments made on behalf of Pro Farm, issuance of a total of 12,666,000 of the Company’s common stock, at the closing marketprice of $1.59, for an aggregate fair value of $20,299,000, inclusive of 100,000 restricted stock units at a fair value of $159,000awarded to a key employee and the fair value of up to $7,466,000 of contingent consideration subject to the achievement of certaindistributor, revenue, earnings before interest, taxes, depreciation and amortization, and debt and equity milestones from thedate of the closing through December 31, 2024, fair valued at $1,395,000. The contingent consideration will be determined at theend of each reporting period and settled through the issuance of the Company’s common shares. The Pro Farm acquisition meetsthe definition of a business in accordance with ASC 805. The goodwill recorded as a result of the acquisition represents the strategicbenefits of growing the Company’s future revenues and product portfolio and the expected revenue growth from increased marketpenetration. The goodwill is not deductible for income tax purposes.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof September 13, 2020, the Company has finalized its purchase accounting. The final fair values of the assets acquired, and liabilitiesassumed are as follows (in thousands):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          <p style="margin-top: 0; margin-bottom: 0">           FINAL          </p>          <p style="margin-top: 0; margin-bottom: 0">           ALLOCATION          </p>         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%; text-align: left">          Accounts receivable         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          583         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Inventory         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          523         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Other current assets         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          211         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Investments in subsidiary         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          537         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Intangible assets:         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Developed technology         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,362         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Tradename         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,659         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          In process research and development         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          2,713         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt">          Goodwill         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          6,740         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Total assets acquired         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          30,328         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Accounts payable         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          408         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Accrued liabilities         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          779         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td>          Debt         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          1,612         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 1.5pt">          Minority interest         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          (14         </td>         <td style="padding-bottom: 1.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 2.5pt">          Net assets acquired         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          27,543         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Cash paid, net of cash acquired         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          5,849         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td>          Fair Value of stock consideration         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          20,299         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="padding-bottom: 1.5pt">          Fair value of contingent consideration         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          1,395         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 1.5pt">          Total purchase price         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">          $         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          27,543         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 93; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           93           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Tangibleassets and liabilities acquired were recorded at their preliminary fair values on the date of close based on management’spreliminary assessment. Included in the tangible assets acquired is an investment a 12% interest in a Russian manufacturing plantand which been accounted for under Accounting Standard Codification        <i>         325 – Investments Other, Cost Method Investments.        </i>        For the year ended December 31, 2020, the Company did not evaluate the investment for impairment. The purchase priceallocated to developed technology, in process technology and trade name were estimated using either an excess earning method orrelief-from-royalty to calculate the fair value of the assets purchased, based on management’s forecasted cash inflows andoutflows. All intangible assets are being amortized with the expense reflected in “Selling, general and administrative”expenses in the consolidated statement of operations.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="text-align: justify; margin: 0">       As of December 31, 2020, the fair value of the contingent consideration is $2,182,000.The preliminary estimate of the fair value of the amount earned as of December 31, 2020 is $698,000, and reflected in AccruedLiabilities. The Company is required to submit the calculation of the fair value of the earned contingent consideration on orbefore March 31, 2021.      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Acquisitioncosts are recorded in “Selling, general and administrative” expenses as incurred. As of December 31, 2019 the Companyhas incurred expenses of $3,084,000 in connection with the Pro Farm Acquisition. The Pro Farm Acquisition was financed partiallythrough the warrant holders’ purchase of 10,000,000 shares of the Company’s common stock in connection with the Company’sexercise of its warrant call option under the Warrant Reorganization Agreement (Refer to Note 9 to the consolidatedfinancial statements).       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theconsolidated statement of operations include $1,433,000 of product revenues and $1,520,000 of operating expenses from ProFarm for the period from September 14, 2019 through December 31, 2019. The Company’s consolidated results as of December31, 2019 include amounts related to a 1% non-controlling interest in Pro Farm’s Brazilian subsidiary, deemed to be immaterialto the consolidated financial statements. The following unaudited pro forma results of operations assume the Pro Farm acquisitionhad occurred on January 1, 2019 (in thousands):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 65%; font: 10pt Times New Roman, Times, Serif">       <tbody>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-size: 8.5pt; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="white-space: nowrap; font-size: 8.5pt; text-align: center; border-bottom: Black 1.5pt solid">          <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             PRO FORMA             <br/>             FOR THE YEAR             <br/>             ENDED            </b>           </font>          </p>          <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            <b>             DECEMBER 31, 2019            </b>           </font>          </p>         </td>         <td style="padding-bottom: 1.5pt; font-size: 8.5pt">         </td>        </tr>        <tr style="vertical-align: bottom">         <td style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>         <td colspan="2" style="font-weight: bold; text-align: center">         </td>         <td style="font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%; text-align: left">          Product revenues         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">          $         </td>         <td style="width: 16%; text-align: right">          30,362         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Cost of product revenues         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          13,630         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Gross profit         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          16,732         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Operating expenses         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          43,956         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left; padding-bottom: 2.5pt">          Loss from operations         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">          $         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          (27,224         </td>         <td style="padding-bottom: 2.5pt; text-align: left">          )         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Basic and Diluted net loss per common share         </td>         <td>         </td>         <td style="text-align: left">          $         </td>         <td style="text-align: right">          (0.30         </td>         <td style="text-align: left">          )         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Significantpro forma adjustments incorporated into the pro forma results above include elimination of nonrecurring acquisition-related costsincurred prior to the close of the Pro Farm Acquisition, amortization of acquired intangible assets. These pro forma results arebased on estimates and assumptions, which the Company believes are reasonable. They are prepared for comparative purposes onlyand do not necessarily reflect the results that would have been realized had the Pro Farm Acquisition occurred at the beginningof the periods ended December 31, 2019 and are not necessarily indicative of the Company’s consolidated results of operationsin future periods.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 94; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           94           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         13.Common Stock        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InAugust 2013, the Company amended and restated its certificate of incorporation to increase the number of shares of common stockauthorized for issuance to 250,000,000 shares with a par value of $0.00001.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Asof December 31, 2020, the Company had reserved shares of common stock for future issuances as follows (in thousands):       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <table align="CENTER" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">       <tbody>        <tr style="vertical-align: bottom">         <td>         </td>         <td style="font-weight: bold; padding-bottom: 1.5pt">         </td>         <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">          SHARES         </td>         <td style="padding-bottom: 1.5pt; font-weight: bold">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="width: 80%; text-align: left">          Shares available for future grant under stock incentive plans         </td>         <td style="width: 2%">         </td>         <td style="width: 1%; text-align: left">         </td>         <td style="width: 16%; text-align: right">          4,410         </td>         <td style="width: 1%; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Stock options outstanding         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          13,380         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Restricted stock units outstanding         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          4,588         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Warrants to purchase common stock         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          14,534         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Common shares to be issued in lieu of agent fees         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          498         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left">          Shares available for future purchase under ESPP         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          618         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="text-align: left">          Maximum contingent consideration shares to be issued         </td>         <td>         </td>         <td style="text-align: left">         </td>         <td style="text-align: right">          5,972         </td>         <td style="text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: White">         <td style="text-align: left; padding-bottom: 1.5pt">          Contingent shares to be issued in connection with consulting service of prior CFO.         </td>         <td style="padding-bottom: 1.5pt">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: left">         </td>         <td style="border-bottom: Black 1.5pt solid; text-align: right">          200         </td>         <td style="padding-bottom: 1.5pt; text-align: left">         </td>        </tr>        <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">         <td style="padding-bottom: 2.5pt">          Balance at December 31, 2020         </td>         <td style="padding-bottom: 2.5pt">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: left">         </td>         <td style="border-bottom: Black 2.5pt double; text-align: right">          44,200         </td>         <td style="padding-bottom: 2.5pt; text-align: left">         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         14.Employee Benefit Plan        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany offers a defined contribution plan to all eligible employees, which is qualified under Section 401(k) of the IRC. TheCompany currently provides a matching contribution based on a formula which provides for a dollar-for-dollar matching contributionof the employee’s 401(k) contribution up to 3% of eligible pay plus a 50% matching contribution on the employee’s401(k) contribution between 3% and 5% of eligible pay. Each participant is 100% vested in elective contributions and the Company’smatching contribution. The Company provided 401(k) matching contributions during the years ended December 31, 2020 and 2019 of$315,000 and $364,000, respectively.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         15.Commitments and Contingencies        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ChiefFinancial Officer Retirement         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnSeptember 21, 2020, James Boyd announced his intention to retire as the CFO and President and an employee of the Company. In connectionwith his retirement, Mr. Boyd entered into the Separation Agreement, which provides that Mr. Boyd’s retirement as an employeeand officer of the Company will become effective immediately prior to the date on which a new CFO is retained. In addition tobeing entitled to any unpaid salary through his retirement date and continued COBRA coverage, in consideration of his executionof certain releases, Mr. Boyd will be entitled under the Separation Agreement to (i) salary continuation (payable at the annualrate of $330,000) for twelve months, (ii) a prorated portion of his 2020 annual bonus, paid in cash (or the full 2020 annual bonusand a prorated portion of the 2021 annual bonus if he remains employed through January 1, 2021), calculated based on achievementof individual goals that are to be agreed to by Mr. Boyd and the Company’s chief executive officer, and with all other termsdetermined in accordance with the Company’s annual bonus plan as applied to other active senior executives of the Company,and (iii) all of his outstanding unvested stock options will become fully vested.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconnection and in conjunction with Mr. Boyd’s retirement, he also entered into the Consulting Agreement, pursuant to which Mr. Boyd will serve as a consultant to the Company for a period of one year following the date of his retirement unlessterminated earlier as discussed below or extended by mutual agreement of the Company and Mr. Boyd, to help the Company createand develop an entity dedicated to the eradication of invasive species with the terms of such services and related deliverablesdetailed in the Consulting Agreement. As consideration for his service as a consultant, Mr. Boyd will receive a one-time awardof 200,000 RSUs as soon as practicable after his retirement date, which will vest in equal installments over twelve months, subjectto his continuous service as a consultant through the applicable vesting dates. Under the terms of the Consulting Agreement, theCompany may terminate Mr. Boyd’s service as a consultant by giving five (5) days prior written notice, in which case anyunvested RSUs granted under the Consulting Agreement will vest immediately. The Company may also terminate the Consulting Agreementupon Mr. Boyd’s breach or default or for certain other grounds, in which case Mr. Boyd’s unvested RSUs will be forfeited.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 95; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           95           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         16.Related Party Transactions        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          August2015 Senior Secured Promissory Notes         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnAugust 20, 2015, the Company entered into a purchase agreement with Ivy Science &amp; Technology Fund, Waddell &amp; Reed AdvisorsScience &amp; Technology Fund and Ivy Funds VIP Science and Technology, each an affiliate of Waddell &amp; Reed, which is a beneficialowner of more than 5% of the Company’s common stock. Pursuant to the purchase agreement, the Company sold to such affiliatessenior secured promissory notes (“August 2015 Senior Secured Promissory Notes”) in the aggregate principal amountof $40,000,000. Until February 5, 2018, the August 2015 Senior Secured Promissory Notes bear interest at a rate of 8% per annumpayable semi-annually on June 30 or December 31 of each year, commencing on December 31, 2015, with $10,000,000 payable threeyears from the closing, $10,000,000 payable four years from the closing and $20,000,000 payable five years from the closing. Inconnection with the note, the Company incurred $302,000 in financing-related costs. These costs were recorded as deferred financingcosts to be amortized to interest expense over the term of the note.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconnection with the August 2015 Senior Secured Promissory Notes, the Company also issued warrants (“August 2015 Warrants”)to purchase 4,000,000 shares of common stock of the Company. The August 2015 Warrants are immediately exercisable at an exerciseprice of $1.91 per share and may be exercised at a holder’s option at any time on or before August 20, 2023 (subject tocertain exceptions). The fair value of the August 2015 Warrants at the date of issuance of $4,610,000 was recorded as a discountto the August 2015 Senior Secured Promissory Notes to be amortized to interest expense over the term of the note.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheAugust 2015 Senior Secured Promissory Notes are secured by substantially all the Company’s personal property assets. Theagent, acting on behalf of the lenders, shall be entitled to have a first priority lien on the Company’s intellectual propertyassets, pursuant to intercreditor arrangements with certain of the Company’s existing lenders.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheAugust 2015 Senior Secured Promissory Notes provide for various events of default, including, among others, default in paymentof principal or interest, breach of any representation or warranty by the Company or any subsidiary under any agreement or documentdelivered in connection with the notes, a continued breach of any other condition or obligation under any loan document, certainbankruptcy, liquidation, reorganization or change of control events, the acquisition by any person or persons acting as group,other than the lenders, of beneficial ownership of 40% or more of the outstanding voting stock of the Company. Upon an event ofdefault, the entire principal and interest may be declared immediately due and payable. As of December 31, 2020, the Company wasin compliance with its covenants under the August 2015 Senior Secured Promissory Notes.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnFebruary 5, 2018, pursuant to an amendment, the Company converted $35,000,000 of the then outstanding debt into 20,000,000 sharesof common stock and warrants to purchase 4,000,000 shares of common stock (the “Waddell Debt Conversion”). After theconversion the remaining principal outstanding was reduced to $5,000,000, the maturity of the August 2015 Senior Secured PromissoryNotes was extended to December 31, 2022, and payment of all future interest was deferred to the maturity of the notes.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconjunction with the Waddell Debt Conversion, the Company accounted for the partial debt extinguishment under the troubled debtrestructuring accounting guidance which resulted in the Company recording a gain and required all future interest to be recognizedas part of the outstanding debt. As a result, the amount of the debt on the Company’s balance sheet related to the August2015 Senior Secured Promissory Notes is $7,300,000, as compared to $5,000,000 of contractual principal amount outstanding thereunderand the Company will not recognize future interest expense on the August 2015 Senior Secured Promissory Notes.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          WarrantExchange         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ospraie,Ivy Science &amp; Technology Fund (“IS&amp;T”), Ivy VIP Science &amp; Technology (“Ivy VIP” and, togetherwith IS&amp;T, the “Waddell Investors”, and Ardsley, are beneficial owners of more than 5% of the Company’scommon stock, holding 40.4%, 16.5%, and 10.3%, respectively, of the Company’s total outstanding common stock as of December31, 2020. In April 2020, in connection with the Company’s execution of the Warrant Exchange Agreement (Refer to Note9 of the consolidated financial statements) various warrants held by Ospraie, the Waddell Investors, and Ardsley aggregatinga total of 30,666,667, 8,000,000, and 5,222,333 shares, respectively, were exchanged for a total of 21,736,081, 3,397,157, and3,780,185, April 2020 Warrants, respectively.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 96; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           96           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          WarrantExercises         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ospraie,Ivy Science &amp; Technology Fund (“IS&amp;T”), Ivy VIP Science &amp; Technology (“Ivy VIP” and, togetherwith IS&amp;T, the “Waddell Investors”, and Ardsley, are beneficial owners of the Company’s securities, holding40.4%, 16.5%, and 10.3%, respectively, of the Company’s total outstanding common stock as of December 31, 2020.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMarch 2020, pursuant to the terms of the February 2018 Warrants, the Company’s utilization of its call option under theWarrant Reorganization Agreement to exercise 6,000,000 warrants. As a result of this transaction, the Company issued 6,000,000common shares and 6,000,000 August 2019 Warrants. The total number of warrants exercised at the request of the Company by Ospraieand Ardsley represented 5,027,325 and 874,314, shares of common stock, respectively. The August 2019 Warrants issued as a resultof this transaction were subsequently forfeited in connection with the Warrant Exchange Agreement (Refer to Warrant Exchangeabove and Note 9 of the consolidated financial statements).       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InMay, September, December 2020 and March 2021, pursuant to the terms of the April 2020 Warrants, 3,392,581, 2,714,065, 13,026,818,and 5,865,382 respectively, April 2020 Warrants were exercised (See Note 7). As a result of these transactions, the Company issuedcommon shares of 18,182,499, 3,162,171, and 2,841,763, to Ospraie, the Waddell Investors, and Ardsley, respectively.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Duringthe year ended December 31, 2019, the Company requested under the Warrant Reorganization Agreement, the exercise of 16,000,000shares underlying the February 2018 Warrants, resulting in the Company issuing 16,000,000 common shares and August 2019 Warrantsfor 16,000,000 shares. The total number of warrants exercised at the request of the Company by Ospraie and Ardsley were 13,406,184shares and 2,331,521 shares, respectively for this warrant exercise transaction.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          OspraieLoan to Pro Farm         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Inconnection with the Company’s closing of the Pro Farm Acquisition in September 2019, the terms of the Share Purchase Agreementincluded as a condition to closing the repayment of certain indebtedness of Pro Farm. One of the indebtedness obligations to berepaid was a convertible loan in a principal amount of $1,000,000, held by Dwight Anderson, an affiliate of Ospraie, the Company’slargest shareholder. The Company paid in total $1,434,000 which is inclusive of the principal, interest and other charges underthe terms of the debt arrangement.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         17.Other Matters        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          PaycheckProtection Program         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        InApril 2020, the Company entered into an unsecured note (the “Note”) in the amount of $1,723,000 under the PPP. TheCompany has accounted for the transaction when it is considered that there is reasonable assurance that the grant amounts willbe received and all necessary qualifying conditions, as stated in the loan agreement, are met, consistent with International AccountingStandards (“IAS”) 20,        <i>         Accounting for Government Grants        </i>        . In November 2020, the Company received correspondencefrom the lender of the PPP that the Company’s PPP loan amount had been forgiven by the Small Business Administration.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       For the year ended December 31, 2020, theCompany recognized as reduction to the expense categories specified under the PPP $702,000 and $695,000, respectively, in research,development patents and Selling, general and administrative, in the consolidated statement of operations. The remaining amountof total PPP funds received of $326,000 was allocated to the related PPP-specified expenses associated with the Company’smanufacturing operations and was originally capitalized into inventory, but as of December 31, 2020, the fullamount was amortized from inventory, offsetting cost of product revenues in the consolidated statement of operationsbased on the Company’s normal recognition policy for similar items.      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <!-- Field: Page; Sequence: 97; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           97           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         18.Subsequent Events        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ChiefFinancial Officer Replacement         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnJanuary 28, 2021, the Company announced the appointment of Suping (Sue) Liu Cheung, Ph.D., CPA, as CFO, which took effectupon her commencement of employment, on February 18, 2021. In connection with her appointment as the Company’s CFO, Ms.Cheung will receive an annual base salary of $275,000, and a target annual award opportunity under the Company’s discretionarybonus plan of up to 40% of her annual base salary, unless adjusted by the Board for any year. Ms. Cheung will also receive a $50,000signing bonus in April 2021, and certain relocation expenses.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Pursuantto her offer letter, subject to approval of the Board or Compensation Committee of the Board, Ms. Cheung will be granted an optionto purchase 400,000 shares of the Company’s common stock under the Company’s 2013 Stock Incentive Plan. The Optionwill be subject to time-based vesting over a period of four years as measured from Ms. Cheung’s first date of employment(the “Vesting Commencement Date”). Twenty-five percent of the option will vest on the first anniversary of the VestingCommencement Date, and the remaining 75 percent of the shares will vest over the next following 3 years on a pro-rata basis equallyeach month, for so long as Ms. Cheung provides services to the Company.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany also entered into a change in control agreement with Ms. Cheung (the “CIC Agreement”), which provides Ms.Cheung with the right to receive certain benefits if, in connection with a Change in Control (as defined in the CIC Agreement),Ms. Cheung terminates her employment with the Company for good reason or the Company terminates her employment without cause.The CIC Agreement provides that in such an event: (i) Ms. Cheung will receive a single lump sum severance payment equal to twelvemonths of her annual salary; (ii) all outstanding and unvested equity compensation awards held by Ms. Cheung will vest; (iii)Ms. Cheung will receive a lump sum bonus payment in an amount equal to 20% of her then-current base salary, prorated based onthe percentage of the current year completed prior to termination; and (iv) the Company will pay for health continuation coveragepremiums for the executive and her family members for twelve months following the date of termination. The benefits provided forin the CIC Agreement are subject to Ms. Cheung’s delivery of a release of claims reasonably acceptable to the Company. Underthe CIC Agreement, Ms. Cheung is also subject to non-solicitation and non-disparagement obligations during employment with theCompany and for one year following termination.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          ShelfRegistration         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        OnFebruary 8, 2021, the Company filed a shelf registration statement on Form S-3 with the SEC. The shelf registration statementhas not yet been declared effective by the SEC. Under the shelf registration statement, if and upon becoming effective, the Companymay offer and sell, from time to time over a three-year period, various securities in an amount of up to $90 million.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany has evaluated its subsequent events from December 31, 2020 through the date these consolidated financial statements wereissued, and has determined that there are no subsequent events required to be disclosed in these consolidated financial statements.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <!-- Field: Page; Sequence: 98; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           98           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <a name="b_02">       </a>       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ITEM9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_03">         </a>         ITEM9A. CONTROLS AND PROCEDURES        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Evaluationof Disclosure Controls and Procedures         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Disclosurecontrols and procedures are controls and other procedures that are designed to ensure that information required to be disclosedin our reports filed or submitted under the Securities Exchange Act is recorded, processed, summarized and reported, within thetime periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include,without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filedunder the Exchange Act is accumulated and communicated to management, including our principal executive officer and our principalfinancial officer, as appropriate, to allow timely decisions regarding required disclosure. As of the end of the period coveredby this report, we carried out an evaluation under the supervision and with the participation of our management, including ourChief Executive Officer (CEO) and our Chief Financial Officer (CFO), of the effectiveness of the design and operation of our disclosurecontrols and procedures in ensuring that material information required to be disclosed in our reports filed or submitted underthe Exchange Act, has been made known to them in a timely fashion. Based on this evaluation, our CEO and CFO concluded that theCompany’s disclosure controls and procedures were effective as of December 31, 2020.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Management’sReport on Internal Control over Financial Reporting         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Ourmanagement is responsible for establishing and maintaining adequate internal control over financial reporting as such term isdefined in Rule 13a-15(f) of the Exchange Act. Our management assessed, with the oversight of the board of directors, the effectivenessof our internal control over financial reporting as of December 31, 2020. In making this assessment, management used the criteriaestablished in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the TreadwayCommission (“COSO”). Based on this assessment, management has concluded that our internal control over financial reportingwas effective as of December 31, 2020.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Changesin Internal Control         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Therehave been no changes in our internal control over financial reporting identified in management’s evaluation pursuant toRules 13a-15(d) or 15d-15(d) of the Exchange Act during the year ended December 31, 2020 that materially affected, or are reasonablylikely to materially affect, our internal control over financial reporting.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <i>          Limitationson Effectiveness of Controls and Procedures         </i>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Indesigning and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matterhow well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives.Because of the inherent limitations in internal control over financial reporting, no evaluation of controls can provide absoluteassurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitationsinclude the realities that judgments in decision making can be faulty and that breakdowns can occur because of a simple erroror mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or bymanagement override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihoodof future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potentialfuture conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree ofcompliance with policies or procedures. In addition, the design of disclosure controls and procedures must reflect the fact thatthere are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controlsand procedures relative to their costs. Because of the inherent limitations in a cost-effective control system, misstatementsdue to error or fraud may occur and not be detected.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_04">         </a>         ITEM9B. OTHER INFORMATION        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Notapplicable.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <!-- Field: Page; Sequence: 99; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           99           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_05">         </a>         PARTIII        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_06">         </a>         ITEM10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theinformation required by this item will be contained under the captions        <i>         Information Regarding our Nominees and Directors,Board of Directors and Corporate Governance        </i>        and        <i>         Executive Officers        </i>        in our definitive Proxy Statement for the AnnualMeeting of Stockholders and is incorporated herein by reference.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_07">         </a>         ITEM11. EXECUTIVE COMPENSATION        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theinformation required by this item will be contained under the captions        <i>         Executive Compensation        </i>        and        <i>         DirectorCompensation        </i>        in our definitive Proxy Statement for the Annual Meeting of Stockholders and is incorporated herein by reference.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_08">         </a>         ITEM12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theinformation required by this item will be contained under the caption        <i>         Security        </i>        <i>         Ownership of Certain BeneficialOwners and Management        </i>        in our definitive Proxy Statement for the Annual Meeting of Stockholders and is incorporatedherein by reference.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_09">         </a>         ITEM13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theinformation required by this item will be contained under the captions        <i>         Transactions with Related Persons        </i>        and        <i>         DirectorIndependence        </i>        in our definitive Proxy Statement for the Annual Meeting of Stockholders and is incorporated herein by reference.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <a name="b_10">       </a>       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         ITEM14. PRINCIPAL ACCOUNTING FEES AND SERVICES        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Theinformation required by this item will be contained under the caption        <i>         Independent Registered Public Accounting Firm FeeInformation        </i>        in our definitive Proxy Statement for the Annual Meeting of Stockholders and is incorporated herein by reference.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_11">         </a>         PARTIV        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_12">         </a>         ITEM15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Wehave filed the following documents as part of this Form 10-K:       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           1.          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Consolidated    financial statements:          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: bottom">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 8.5pt Times New Roman, Times, Serif; width: 0.5in; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <b>            Page           </b>          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_01">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Reports of Independent Registered Public Accounting Firms           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           55          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_02">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidated Balance Sheets as of December 31, 2020 and 2019           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           58          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_03">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidated Statements of Operations for the years ended December 31, 2020 and 2019           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           59          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_04">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2020 and 2019           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           60          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; background-color: #CCEEFF">         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_05">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           61          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; background-color: white">         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">          <a href="#c_06">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Notes to Consolidated Financial Statements           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           62          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           2.          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Financial    Statement Schedules          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Allschedules have been omitted because they are not required, not applicable, not present in amounts sufficient to require submissionof the schedule, or the required information is otherwise included.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.25in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           3.          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Exhibits          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Seethe Exhibit Index immediately preceding the signature page of this Annual Report on Form 10-K, which is incorporated by referencehere.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_13">         </a>         ITEM16. FORM 10-K SUMMARY        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        TheCompany has elected not to include summary information.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 100; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           100           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         INDEXTO EXHIBITS        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="vertical-align: bottom">         <td style="border-bottom: black 1.5pt solid; text-align: center; width: 0.7in">          <font style="font-size: 10pt">           <b>            EXHIBIT           </b>           <br/>           <b>            NUMBER           </b>          </font>         </td>         <td style="text-align: center; width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; border-bottom: black 1.5pt solid">          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">           <b>            EXHIBIT           </b>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">           <b>            DESCRIPTION           </b>          </p>         </td>         <td style="text-align: center; width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: center; width: 0.5in">          <font style="font-size: 10pt">           <b>            FORM           </b>          </font>         </td>         <td style="text-align: center; width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: center; width: 0.75in">          <font style="font-size: 10pt">           <b>            FILE           </b>           <br/>           <b>            NO.           </b>          </font>         </td>         <td style="text-align: center; width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: center; width: 0.7in">          <font style="font-size: 10pt">           <b>            EXHIBIT           </b>           <br/>           <b>            NUMBER           </b>          </font>         </td>         <td style="text-align: center; width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: center; width: 0.95in">          <font style="font-size: 10pt">           <b>            FILING           </b>           <br/>           <b>            DATE           </b>          </font>         </td>         <td style="text-align: center; width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; text-align: center; width: 0.75in">          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">           <b>            FILED           </b>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">           <b>            HEREWITH           </b>          </p>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           3.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312514114512/d652207dex31.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Fourth Amended and Restated Certificate of Incorporation of Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           3.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           March 25, 2014          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           3.2          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315219005993/ex3-1.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Fifth Amended and Restated Bylaws of Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           3.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           April 26, 2019          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513296453/d329931dex41.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Marrone Bio Innovations, Inc.’s common stock certificate.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           S-1/A          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           333-189753          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.4          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           July 22, 2013          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.2          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312515301704/d56569dex41.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Senior Secured Promissory Notes issued by Marrone Bio Innovations, Inc. to Ivy Science &amp; Technology Fund, Waddell &amp; Reed Advisors Science &amp; Technology Fund and Ivy Funds VIP Science &amp; Technology dated August 20, 2015.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           August 25, 2015          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.3          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312515301704/d56569dex42.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrants issued by Marrone Bio Innovations, Inc. to Ivy Science &amp; Technology Fund, Waddell &amp; Reed Advisors Science &amp; Technology Fund and Ivy Funds VIP Science &amp; Technology dated August 20, 2015.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.2          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           August 25, 2015          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.4          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218004788/ex4-4.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrants issued by Marrone Bio Innovations, Inc. pursuant to the Third Amendment to Loan Agreement, dated as of November 11, 2016, by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.4          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           April 5, 2018          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.5          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000156459017017685/mbii-ex41_567.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Warrant issued by Marrone Bio Innovations, Inc. to MZHCI, LLC, dated June 6, 2017.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10-Q          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           August 14, 2017          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.6          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217014699/ex4-1.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrants issued by Marrone Bio Innovations, Inc. on February 5, 2018 to the Buyers listed in that certain Securities Purchase Agreement dated December 15, 2017.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           December 18, 2017          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.7          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: left">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217014699/ex4-2.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrants issued by Marrone Bio Innovations, Inc. on February 5, 2018 to Ivy Science &amp; Technology Fund, Waddell &amp; Reed Advisors Science &amp; Technology Fund and Ivy VIP Science &amp; Technology.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.2          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           December 18, 2017          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.8          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217014699/ex4-3.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrants issued by Marrone Bio Innovations, Inc. on February 5, 2018 to Gordon Snyder, as agent, and certain of its affiliates to that certain Loan Agreement, as amended.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.3          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           December 18, 2017          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 101; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           101           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="vertical-align: top">         <td style="width: 0.7in">          <font style="font-size: 10pt">           4.9          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217014699/ex4-4.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrants issued by Marrone Bio Innovations, Inc. on February 5, 2018 to National Securities Corporation and certain of its affiliates.           </font>          </a>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.5in">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.75in">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.7in">          <font style="font-size: 10pt">           4.4          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.95in">          <font style="font-size: 10pt">           December 18, 2017          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.75in">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.10          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513279834/d329931dex1033.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrants issued by Marrone Bio Innovations, Inc. in connection with June 2013 Credit Facility.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           S-1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           333-189753          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.33          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           July 1, 2013          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.11          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315219011909/ex4-1.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Warrant Amendment and Plan of Reorganization Agreement, dated August 6, 2019, by and among Marrone Bio Innovations, Inc., Ospraie AG Science LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           August 8, 2019          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.12          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315219011909/ex4-2.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrant issued by Marrone Bio Innovations, Inc. in connection with the August 6, 2019 Warrant Agreement           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.2          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           August 8, 2019          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.13          </font>         </td>         <td>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220007401/ex4-1.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Form of Warrant issued by Marrone Bio Innovations, Inc. in connection with April 29, 2020 Warrant Exchange Agreement           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.1          </font>         </td>         <td>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           April 30, 2020          </font>         </td>         <td>         </td>         <td style="text-align: center">         </td>        </tr>        <tr style="vertical-align: top">         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.14          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220004083/ex4-14.htm" style="-sec-extract: exhibit">            Description of Registrant’s Securities           </a>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           4.15          </font>         </td>         <td>         </td>         <td>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">           <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315221000158/ex4-1.htm" style="-sec-extract: exhibit">            Amendment to the Van Herk Warrant, by and among, Marrone Bio Innovations, Inc., Ospraie Ag Science LLC, and Van Herk Investments B.V., dated December 29, 2020.           </a>          </p>          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">          </p>         </td>         <td>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           8-K          </font>         </td>         <td>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           4.11          </font>         </td>         <td>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           January 5, 2021          </font>         </td>         <td>         </td>         <td style="text-align: center">         </td>        </tr>        <tr style="vertical-align: top">         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.2          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220007401/ex4-1.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Office Lease, dated April 30, 2014, by and between Marrone Bio Innovations, Inc. and Seven Davis, LLC.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10-Q          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.4          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           May 15, 2014          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.3#          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513279834/d329931dex101.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Marrone Bio Innovations, Inc. Stock Option Plan and related documents.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           S-1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           333-189753          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           July 1, 2013          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.4#          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513279834/d329931dex102.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Marrone Bio Innovations, Inc. 2011 Stock Plan and related documents.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           S-1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           333-189753          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.2          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           July 1, 2013          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.5#          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513296453/d329931dex103.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Marrone Bio Innovations, Inc. 2013 Stock Incentive Plan and related documents.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           S-1/A          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           333-189753          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.3          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           July 22, 2013          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.6#          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513296453/d329931dex104.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Indemnification Agreement by and between Marrone Bio Innovations, Inc. and each of its directors and executive officers.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           S-1/A          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           333-189753          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.4          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           July 22, 2013          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.7#          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513279834/d329931dex105.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Offer letter, dated June 29, 2006, between Marrone Organic Innovations, Inc. and Dr. Pamela G. Marrone.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           S-1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           333-189753          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.5          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           July 1, 2013          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="margin: 0">      </p>      <!-- Field: Page; Sequence: 102; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           102           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="margin: 0">      </p>      <p style="margin: 0">      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="vertical-align: top">         <td style="width: 0.7in">          <font style="font-size: 10pt">           10.8(a)#          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312514114512/d652207dex108.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Offer letter, dated February 10, 2014, between Marrone Bio Innovations, Inc. and James B. Boyd.           </font>          </a>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.5in">          <font style="font-size: 10pt">           10-K          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.75in">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.7in">          <font style="font-size: 10pt">           10.8          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.95in">          <font style="font-size: 10pt">           March 25, 2014          </font>         </td>         <td style="width: 0.1in">          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center; width: 0.75in">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.8(b)#          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312515372823/d90912dex109.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Letter Agreement, dated March 3, 2015, between Marrone Bio Innovations, Inc. and James B. Boyd.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10-K          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.9          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           November 10, 2015          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.8(c)#          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217013258/ex10-46.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Promotion Agreement, dated August 14, 2017, between Marrone Bio Innovations, Inc. and James Boyd.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10-Q          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.46          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           November 14, 2017          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.10#          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218011825/ex10-2.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            Offer letter, dated April 16, 2018, between the Company and Kevin Hammill.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10-Q          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           001-36030          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.2          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           August 14, 2018          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           10.11          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513279834/d329931dex1025.htm" style="-sec-extract: exhibit">           <font style="font-size: 10pt">            License Agreement, dated November 13, 2007, between the U.S. Government, as represented by the U.S. Department of Agriculture, Agricultural Research Service, and Marrone Organic Innovations, Inc.           </font>          </a>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           S-1          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           333-189753          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           10.25          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">           July 1, 2013          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td style="text-align: center">          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>         <td>         </td>         <td style="text-align: center">         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.14          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312514308547/d758270dex104.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Business Loan Agreement, dated June 13, 2014, by and between Five Star Bank and jointly and severally Marrone Michigan Manufacturing LLC and Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-Q          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.4          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           August    13, 2014          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif">         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.15(a)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000156459017010843/mbii-ex1044_101.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Invoice Purchase Agreement, made on March 24, 2017 between Marrone Bio Innovations, Inc. and LSQ Funding Group, L.C.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-Q          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.44          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           May    15, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif">         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.15(b)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218011825/ex10-3.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            First Amendment to Invoice Purchase Agreement, dated June 30, 2018, between Marrone Bio Innovations, Inc. and LSQ Funding Group, L.C.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-Q          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.3          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           August    14, 2018          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.16          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000156459017010843/mbii-ex1045_175.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Subordination Agreement, dated as of March 28, 2017 by and among Five Star Bank, Marrone Bio Innovations, Inc., and LSQ Funding Group L.C.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-Q          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.45          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           May    15, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.17          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000156459017010843/mbii-ex1043_174.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Intercreditor Agreement, dated as of March 22, 2017, between Ivy Investment Management Company, administrative agent for the Waddell Lenders (defined therein), Gordon Snyder, administrative agent for Snyder Lenders (defined therein) and LSQ Funding Group, L.C.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-Q          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.43          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           May    15, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(a)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513279834/d329931dex1017.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Loan Agreement, dated October 2, 2012, by and among Marrone Bio Innovations, Inc., the Investors party thereto and Gordon Snyder, as agent, including form of promissory note and warrant.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           S-1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           333-189753          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.17          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           July    1, 2013          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 103; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           103           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.7in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(b)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513279834/d329931dex1023.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Amendment and Consent, dated April 10, 2013, by and among Marrone Bio Innovations, Inc. and the administrative agent party thereto.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           S-1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           333-189753          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.7in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.23          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.95in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           July    1, 2013          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(c)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312515301704/d56569dex102.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Omnibus Amendment to Loan Agreement, dated as of August 19, 2015, by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           August    25, 2015          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(d)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000156459017005870/mbii-ex1042_537.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Third Amendment to Loan Agreement, dated as of November 11, 2016, by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.42          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    3, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(e)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218004788/ex10-18e.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Fourth Amendment to Loan Agreement, dated as of October 12, 2017, by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(e)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    5, 2018          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(f)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218004788/ex10-18f.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Fifth Amendment to Loan Agreement, dated as of October 23, 2017, by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(f)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    5, 2018          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18(g)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217014699/ex10-3.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Sixth Amendment to Loan Agreement, dated as of December 15, 2017, by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.3          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           December    18, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.19          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312513279834/d329931dex1018.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Security Agreement, dated October 2, 2012, by and among Marrone Bio Innovations, Inc. and the administrative and collateral agent.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           S-1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           333-189753          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.18          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           July    1, 2013          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.20(a)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312516610591/d341514dex101.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Omnibus Amendment No. 1 to Notes, dated as of May 31, 2016, by and among Ivy Science &amp; Technology Fund, Waddell &amp; Reed Advisors Science &amp; Technology Fund and Ivy Funds VIP Science &amp; Technology and Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.01          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           June    2, 2016          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.20(b)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218004788/ex10-20b.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Omnibus Amendment No. 2, dated as of October 6, 2017, by and among Ivy Science &amp; Technology Fund, Waddell &amp; Reed Advisors Science &amp; Technology Fund Ivy Funds VIP Science &amp; Technology and Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.20    (b)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    5, 2018          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.20(c)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218004788/ex10-20c.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Omnibus Amendment No. 3, dated as of October 23, 2017, by and among Ivy Science &amp; Technology Fund, Waddell &amp; Reed Advisors Science &amp; Technology Fund, Ivy Funds VIP Science &amp; Technology and Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.20    (c)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    5, 2018          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 104; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           104           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.7in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.20(d)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217014699/ex10-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Omnibus Amendment No. 4 to Notes, dated December 15, 2017, by and among Ivy Science &amp; Technology Fund, Waddell &amp; Reed Advisors Science &amp; Technology Fund, Ivy VIP Science &amp; Technology, Marrone Bio Innovations, Inc. and Ospraie Management LLC.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.7in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.95in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           December    18, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.21          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312515301704/d56569dex101.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Security Agreement, dated as of August 20, 2015, by and among Marrone Bio Innovations, Inc. and the counterparties thereto.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           August    25, 2015          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.22(a)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218004788/ex10-22a.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Promissory Note, dated October 12, 2017, by and between Marrone Bio Innovations, Inc. and Dwight W. Anderson.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.22(a)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    5, 2018          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.22(b)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315218004788/ex10-22b.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Amended and Restated Promissory Note, dated October 23 2017, by and between Marrone Bio Innovations, Inc. and Dwight W. Anderson.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.22(b)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    5, 2018          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.22(c)          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217015293/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Secured Promissory Note, dated December 22, 2017 between Marrone Bio Innovations, Inc. and Dwight W. Anderson.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           December    29, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.23          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217015293/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Security Agreement, dated as of December 22, 2017 between Marrone Bio Innovations, Inc. and Dwight W. Anderson.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           December    29, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.24          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315217014699/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Securities Purchase Agreement, dated December 15, 2017, by and among Marrone Bio Innovations, Inc. and the investors listed on the Schedule of Buyers attached therein.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           December    18, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.28#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000156459017005870/mbii-ex1036_412.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Change in Control Agreement, dated as of June 17, 2016, by and between Marrone Bio Innovations, Inc. and James B. Boyd.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.35          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    3, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.29#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000156459017005870/mbii-ex1037_413.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Change in Control Agreement, dated as of June 17, 2016, by and between Marrone Bio Innovations, Inc. and Linda V Moore.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.37          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    3, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.29          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315219011903/ex10-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            First Amendment to Lease, dated April 25, 2019, by and between San Carlos Retail Venture, L.P., Verbenta URP Partners, LP, Fulcrum URP Investors, LP, Gray &amp; Affrime Family LLC, and Flores-Lopez Anvary LLC.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-Q          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           August    8, 2019          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.30†          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315219011909/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Share Purchase Agreement, dated August 7, 2019, by and among Marrone Bio Innovations, Inc., Pro Farm Technologies OY, the Shareholders and Matti Tiainen as Shareholders’ Representative.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           August    8, 2019          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 105; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           105           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.7in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.31          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315219011909/ex10-3.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Registration Rights Agreement, dated August 6, 2019, by and between Marrone Bio Innovations, Inc. and the investors named therein.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.7in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.3          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.95in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           August    8, 2019          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.32†          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315219017871/ex10-3.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Asset Purchase Agreement dated September 10, 2019, by and among Austin Grant, Inc., Marrone Bio Innovations, Inc., and Bill Grant and Lucie Grant           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-Q          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.3          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           November    19, 2019          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.33#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220004083/ex10-33.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Employment Separation Agreement, dated December 1, 2019, between Marrone Bio Innovations, Inc. and Dr. Pamela G. Marrone.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.33          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           March    16, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.34#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220004083/ex10-34.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consulting Agreement, dated December 1, 2019, between Marrone Bio Innovations, Inc. and Dr. Pamela G. Marrone.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.33          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           March    16, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.35#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315219006127/formdef14a.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Marrone Bio Innovations, Inc. 2019 Employee Stock Purchase Plan           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           DEF    14A          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Appendix    A          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    30, 2019          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.36          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220006592/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Promissory Note dated April 13, 2020, between Five Star Bank and Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36060          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    17, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.37          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220007401/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Warrant Exchange Agreement, dated April 29, 2020, between Marrone Bio Innovations, Inc., Ospraie Ag Science LLC, Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science &amp; Technology Fund, and Ivy VIP Science &amp; Technology, and the Waddell Investors           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    30, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.38          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220007401/ex10-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Registration Rights Agreement, dated April 29, 2020, by and among Marrone Bio Innovations, Inc., Ospraie Ag Science LLC, Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science &amp; Technology Fund, and Ivy VIP Science &amp; Technology, and the Waddell Investors           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           April    30, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.37#†          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220012647/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Offer letter, dated July 3, 2020, by and between Marrone Bio Innovations, Inc. and Kevin Helash           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           July    6, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.38#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220012647/ex10-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Change in Control Agreement, dated as of July 3, 2020, by and between Marrone Bio Innovations, Inc. and Kevin Helash           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           July    6, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.39#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220018208/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Employment Separation Agreement, dated September 21, 2020, between James B. Boyd and Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           September    23, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 106; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           106           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.7in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.40#†          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220018208/ex10-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consulting Agreement, dated September 21, 2020, between Marrone Bio Innovations, Inc., and James B. Boyd           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.5in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.7in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.95in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           September    23, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 0.1in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center; width: 0.75in">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.41#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315221002108/ex10-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Offer letter, effective January 25, 2021, by and between Marrone Bio Innovations, Inc. and Suping Liu Cheung.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           January    29, 2021          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.42#          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315221002108/ex10-2.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Change in Control Agreement, dated as of January 26, 2021, by and between Marrone Bio Innovations, Inc. and Suping Liu Cheung.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           10.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           January    29, 2021          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           14.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000119312517251382/d439610dex141.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Code of Business Conduct and Ethics           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           8-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           14.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           August    8, 2017          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           21.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="https://www.sec.gov/Archives/edgar/data/1441693/000149315220004083/ex21-1.htm" style="-sec-extract: exhibit">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            List of Subsidiaries of Marrone Bio Innovations, Inc.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="text-align: center; font: 8.5pt Times New Roman, Times, Serif">          <p style="font: 8.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           </font>          </p>          <p style="font: 8.5pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            10-K           </font>          </p>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           001-36030          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           2.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           March    16, 2020          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           23.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="ex23-1.htm">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Consent of Marcum LLP, Independent Registered Public Accounting Firm.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           X          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           31.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="ex31-1.htm">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           X          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           31.2          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="ex31-2.htm">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended.           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           X          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           32.1          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <a href="ex32-1.htm">           <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">            Certification of Principal Executive Officer and Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350           </font>          </a>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           X          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           101          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Interactive    Data Files Pursuant to Rule 405 of Regulation S-T: (i) Consolidated Balance Sheets as of December 31, 2019 and 2018; (ii)    Consolidated Statements of Operations for the years ended December 31, 2019 and 2018; (iii) Consolidated Statements of Convertible    Preferred Stock and Stockholders’ Equity (Deficit) for the years ended December 31, 2019 and 2018; (iv) Consolidated    Statements of Cash Flows for the years ended December 31, 2019 and 2018 and (vi) Notes to Consolidated Financial Statements          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           X          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           104          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Cover    Page Interactive Data File Pursuant to Item 601 of Regulation S-K          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: center">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           X          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 24px">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           #          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Indicates    a management contract or compensatory plan or arrangement.          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           †          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Confidential    portions of this document have been redacted as permitted by applicable regulations.          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; text-align: justify">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 107; Value: 2 -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           107           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <div style="break-before: page; margin-top: 6pt">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="width: 34%">          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         <a name="b_14">         </a>         SIGNATURES        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Pursuantto the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this AnnualReport on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Davis, State of California,on March 23, 2021.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 8.5pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 50%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif; width: 50%">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           MARRONE    BIO INNOVATIONS, INC.          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>           </i>          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>           </i>          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>           </i>          </font>         </td>         <td style="border-bottom: black 1.5pt solid; font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           <i>            /s/    Kevin Helash           </i>          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Kevin    Helash          </font>         </td>        </tr>        <tr style="font: 8.5pt Times New Roman, Times, Serif; vertical-align: top">         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">          </font>         </td>         <td style="font: 8.5pt Times New Roman, Times, Serif">          <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">           Chief    Executive Officer          </font>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: center">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        <b>         POWEROF ATTORNEY        </b>       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        KNOWALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kevin Helash her or histrue and lawful attorney-in-fact and agent, with full power of substitution and, for her or him and in her or his name, placeand stead, in any and all capacities to sign any and all amendments to this Annual Report on Form 10-K, and to file the same,with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting untosaid attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessaryto be done in connection therewith, as fully to all intents and purposes as she or he might or could do in person, hereby ratifyingand confirming all that said attorney-in-fact and agent, or her substitute or substitutes, may lawfully do or cause to be doneby virtue hereof.       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">        Pursuantto the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed by the following personson behalf of the Registrant and in the capacities and on the dates indicated:       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font: 10pt Times New Roman, Times, Serif">       </font>      </p>      <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">       <tbody>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid; width: 26%">          <font style="font-size: 10pt">           <b>            SIGNATURE           </b>          </font>         </td>         <td style="width: 1%">          <font style="font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; width: 50%; text-align: center">          <font style="font-size: 10pt">           <b>            TITLE           </b>          </font>         </td>         <td style="width: 1%">          <font style="font-size: 10pt">          </font>         </td>         <td style="border-bottom: black 1.5pt solid; width: 22%; text-align: center">          <font style="font-size: 10pt">           <b>            DATE           </b>          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid">          <font style="font-size: 10pt">           <i>            /s/ Kevin Helash           </i>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           Chief Executive Officer          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Kevin Helash          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           (Principal Executive Officer)          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid">          <font style="font-size: 10pt">           /           <i>            s/ Suping (Sue) Cheung           </i>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           Chief Financial Officer          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Suping (Sue) Cheung          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           (Principal Financial Officer and Principal Accounting Officer)          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid">          <font style="font-size: 10pt">           <i>            /s/ Robert A. Woods           </i>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           Chair of the Board          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Robert A. Woods          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid">          <font style="font-size: 10pt">           <i>            /s/ Pamela G. Marrone           </i>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           Director          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Pamela G. Marrone          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid">          <font style="font-size: 10pt">           <i>            /s/ Yogesh Mago           </i>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           Director          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Yogesh Mago          </font>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid">          <font style="font-size: 10pt">           <i>            /s/ Zachary S. Wochok           </i>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           Director          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Zachary S. Wochok          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid">          <font style="font-size: 10pt">           <i>            /s/ Keith McGovern           </i>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           Director          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Keith McGovern          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: black 1.5pt solid">          <font style="font-size: 10pt">           <i>            /s/ Stuart Woolf           </i>          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           Director          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Stuart Woolf          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>         <td>          <font style="font-size: 10pt">          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>        </tr>        <tr style="vertical-align: top">         <td style="border-bottom: Black 1.5pt solid">          <font style="font-size: 10pt">           <i>            /s/ Lara L. Lee           </i>          </font>         </td>         <td>         </td>         <td>          <font style="font-size: 10pt">           Director          </font>         </td>         <td>         </td>         <td>          <font style="font-size: 10pt">           March 23, 2021          </font>         </td>        </tr>        <tr style="vertical-align: top">         <td>          <font style="font-size: 10pt">           Lara L. Lee          </font>         </td>         <td>         </td>         <td>         </td>         <td>         </td>         <td>         </td>        </tr>       </tbody>      </table>      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>      <!-- Field: Page; Sequence: 108; Options: Last -->      <div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid">       <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">        <tbody>         <tr style="vertical-align: top; text-align: left">          <td style="width: 33%">          </td>          <td style="text-align: center; width: 34%">           <!-- Field: Sequence; Type: Arabic; Name: PageNo -->           108           <!-- Field: /Sequence -->          </td>          <td style="width: 33%">          </td>         </tr>        </tbody>       </table>      </div>      <!-- Field: /Page -->      <p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0">       <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">       </font>      </p>     </text>    </filename>   </sequence>  </type> </document></body>